New Animal Drugs for Use in Animal Feed; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications, 94991-95025 [2016-31083]
Download as PDF
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Final rule; technical
amendment.
animal drug applications (ANADAs) for
revised labeling reflecting a change in
marketing status from over-the-counter
(OTC) use to use by veterinary feed
directive (VFD) for antimicrobial drugs
of importance to human medicine
administered to food-producing animals
in medicated feed. Where applicable,
FDA is also withdrawing approval of
those parts of the NADAs that pertain to
use of these antimicrobial drugs for
growth promotion indications. These
actions are being taken at the sponsors’
requests because these particular
medicated feeds will no longer be
manufactured or marketed. These
applications were submitted in
voluntary compliance with the goals of
FDA Center for Veterinary Medicine’s
(CVM’s) Judicious Use Initiative. In
addition, the animal drug regulations
are being amended to reflect the
voluntary withdrawal of approval of
certain entire NADAs and ANADAs that
were affected by this initiative. The
animal drug regulations are also being
amended to reflect several nonsubstantive changes in format. These
technical amendments are being made
to improve the consistency and
readability of the regulations.
DATES: This rule is effective December
30, 2016.
FOR FURTHER INFORMATION CONTACT:
George K. Haibel, Center for Veterinary
Medicine (HFV–6), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–402–5689,
george.haibel@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect
approval of 71 supplemental new
animal drug applications (NADAs) and
35 supplemental abbreviated new
I. Supplemental Approval of Revised
Labeling and Withdrawal of Approval
of Portions of NADAs Pertaining to
Production Indications
FDA is amending the animal drug
regulations to reflect approval of 71
PART 529—CERTAIN OTHER DOSAGE
FORM NEW ANIMAL DRUGS
23. The authority citation for part 529
continues to read as follows:
■
Authority: 21 U.S.C. 360b.
24. In § 529.1660, add paragraph (d)(3)
to read as follows:
■
§ 529.1660
Oxytetracycline.
*
*
*
*
*
(d) * * *
(3) Limitations. Federal law restricts
this drug to use by or on the order of
a licensed veterinarian.
Dated: December 20, 2016.
Tracey H. Forfa,
Deputy Director, Center for Veterinary
Medicine.
[FR Doc. 2016–31084 Filed 12–23–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 556 and 558
[Docket No. FDA–2016–N–0002]
New Animal Drugs for Use in Animal
Feed; Approval of New Animal Drug
Applications; Withdrawal of Approval
of New Animal Drug Applications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
SUMMARY:
94991
supplemental NADAs and 35
supplemental ANADAs for revised
labeling reflecting a change in marketing
status from OTC use to use by VFD for
antimicrobial drugs of importance to
human medicine administered to foodproducing animals in medicated feed.
Where applicable, FDA is also
withdrawing approval of those parts of
the NADAs that pertain to use of these
antimicrobial drugs for growth
promotion indications. These actions
are being taken at the sponsors’ requests
because these particular medicated
feeds will no longer be manufactured or
marketed.
These applications were identified as
being affected by guidance for industry
(GFI) #213, ‘‘New Animal Drugs and
New Animal Drug Combination
Products Administered in or on
Medicated Feed or Drinking Water of
Food-Producing Animals:
Recommendations for Drug Sponsors for
Voluntarily Aligning Product Use
Conditions with GFI #209’’, December
2013 (https://www.fda.gov/downloads/
AnimalVeterinary/
GuidanceComplianceEnforcement/
GuidanceforIndustry/UCM299624.pdf).
Their change to VFD marketing status is
consistent with FDA CVM’s initiative
for the Judicious Use of Antimicrobials.
The animal drug regulations for
medicated feeds are also being amended
to reflect several non-substantive
changes in format. These technical
amendments are being made to improve
the consistency and readability of the
regulations.
The affected applications for Type A
medicated articles for which
supplemental applications with revised
labeling were approved follow:
Animal drug product
Sponsor
006–391 ........
S.Q. 40% (sulfaquinoxaline) Type A Medicated Article .............
008–804 ........
TM–50 or TM–100 (oxytetracycline) Type A Medicated Article
010–092 ........
GALLIMYCIN–100P (erythromycin) Type A Medicated Article ..
010–918 ........
HYGROMIX 8 (hygromycin B) Type A Medicated Article ..........
012–491 ........
033–950 ........
asabaliauskas on DSK3SPTVN1PROD with RULES
File No.
TYLAN (tylosin) Type A Medicated Article .................................
Sulfamerazine In Fish Grade ......................................................
035–688 ........
AUREOMIX S 40/40 (chlortetracycline and sulfamethazine)
Granular Type A Medicated Article.
AUREO S 700 (chlortetracycline and sulfamethazine) Granular
Type A Medicated Article.
TERRAMYCIN 200 (oxytetracycline) for Fish Type A Medicated Article.
ROFENAID 40 (sulfadimethoxine and ormetoprim) Type A
Medicated Article.
Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113
Sophia, Bulgaria (Huvepharma EOOD).
Phibro Animal Health Corp., GlenPointe Centre East, 3d Floor,
300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666
(Phibro Animal Health Corp.).
Cross Vetpharm Group Ltd., Broomhill Rd., Tallaght, Dublin
24, Ireland (Cross Vetpharm Group Ltd.).
Elanco US Inc., 2500 Innovation Way, Greenfield, IN 46140
(Elanco US Inc.).
Elanco US Inc.
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007 (Zoetis
Inc.).
Zoetis Inc.
035–805 ........
038–439 ........
040–209 ........
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00083
Fmt 4700
Zoetis Inc.
Phibro Animal Health Corp.
Zoetis Inc.
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
94992
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
File No.
Animal drug product
041–275 ........
TYLAN 40 Sulfa-G (tylosin and sulfamethazine) Type A Medicated Article.
AUREOMIX S 700–A (chlortetracycline and sulfamethazine)
Type A Medicated Article.
AUREOMIX S 700–D (chlortetracycline and sulfamethazine)
Type A Medicated Article.
AUREOMIX S 700–G (chlortetracycline and sulfamethazine)
Type A Medicated Article.
AUREOMIX S 700–E (chlortetracycline and sulfamethazine)
Type A Medicated Article.
AUREOMIX S 700–F (chlortetracycline and sulfamethazine)
Type A Medicated Article.
AUREOMIX S 700–C–2 (chlortetracycline and sulfamethazine)
Type A Medicated Article.
AUREOMIX S 700–B (chlortetracycline and sulfamethazine)
Type A Medicated Article.
AUREOMIX S 700–H (chlortetracycline and sulfamethazine)
Type A Medicated Article.
Tylosin Type A Medicated Article ...............................................
CHLORMAX (chlortetracycline) Type A Medicated Article ........
CHLORATET (chlortetracycline) Type A Medicated Article .......
041–647 ........
041–648 ........
041–649 ........
041–650 ........
041–651 ........
041–652 ........
041–653 ........
041–654 ........
046–415 ........
046–699 ........
048–480 ........
048–761 ........
049–287 ........
091–749 ........
092–286 ........
092–287 ........
094–975 ........
095–143 ........
097–505 ........
098–431 ........
100–901 ........
125–933 ........
126–050 ........
138–934 ........
138–935 ........
138–938 ........
138–939 ........
140–976 ........
200–314 ........
200–484 ........
200–510 ........
Sponsor
AUREOMYCIN (chlortetracycline) Type A Medicated Article ....
CHLORACHEL (chlortetracycline)Type A Medicated Article .....
TYLAN 40 Plus Sulfa-G (tylosin and sulfamethazine) Type A
Medicated Article.
CLTC–50 MR (chlortetracycline) Type A Medicated Article .......
CLTC 100 MR (chlortetracycline) Type A Medicated Article .....
NEO-TERRAMYCIN 100/100 (oxytetracycline and neomycin)
Type A Medicated Article.
TERRAMYCIN 10, 30, 50, 100, or 200 (oxytetracycline) Type
A Medicated Article.
LINCOMIX 20 (lincomycin) Type A Medicated Article ...............
TYLAN 10 (tylosin) Premix Type A Medicated Article ...............
PFICHLOR 100S (chlortetracycline) Milk Replacer Type A
Medicated Article.
ROMET–30 (ormetoprim and sulfadimethoxine) Type A Medicated Article.
APRALAN 75 (apramycin) Type A Medicated Article ................
PENNCHLOR S 40/40 (chlortetracycline and sulfamethazine)
Type A medicated article.
PENNCHLOR 100 MR (chlortetracycline) Type A Medicated
Article.
PENNOX 50, 100, or 200 Hi-Flo, or 100–MR (oxytetracycline)
Type A Medicated Article.
NEO-OXY 100/100 MR (oxytetracycline and neomycin) Type A
Medicated Article.
NEOMIX 325 Milk Replacer (neomycin) Type A Medicated Article.
PENNCHLOR S (chlortetracycline and sulfamethazine) Type A
Medicated Article.
TYLOVET 100 (tylosin) Type A Medicated Article .....................
DERACIN 100 (chlortetracycline) Type A Medicated Article .....
Elanco US Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Pharmgate LLC, 1015 Ashes Dr., Suite 102, Wilmington, NC
28405 (Pharmgate LLC).
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Phibro Animal Health Corp.
Phibro Animal Health Corp.
Phibro Animal Health Corp.
Phibro Animal Health Corp.
Zoetis Inc.
Phibro Animal Health Corp.
Zoetis Inc.
Pharmaq AS.
Elanco US Inc.
Pharmgate LLC.
Pharmgate LLC.
Pharmgate LLC.
Pharmgate LLC.
Zoetis Inc.
Pharmgate LLC.
Huvepharma.
Pharmgate LLC.
The affected applications for
manufacturing combination drug
medicated feeds follow:
Animal drug product
036–361 .............
asabaliauskas on DSK3SPTVN1PROD with RULES
File No.
045–444 .............
046–209 .............
CTC Sodium Sulfate (chlortetracycline and sodium sulfate)/
AMPROL PLUS (amprolium and ethopabate).
CHLORMAX (chlortetracycline)/DECCOX (decoquinate) ........
CTC (chlortetracycline)/COYDEN (clopidol) ............................
092–507 .............
099–006 .............
AUREOMYCIN (chlortetracycline)/ROBENZ (robenidine) .......
TERRAMYCIN (oxytetracycline)/COBAN (monensin) .............
101–666 .............
TERRAMYCIN (oxytetracycline)/ROBENZ (robenidine) ..........
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00084
Sponsor
Fmt 4700
Sfmt 4700
Zoetis Inc., 333 Portage St., Kalamazoo,
Inc.).
Zoetis Inc.
Huvepharma EOOD, 5th Floor, 3A Nikolay
Sophia, Bulgaria (Huvepharma EOOD).
Zoetis Inc.
Phibro Animal Health Corp., GlenPointe
Floor, 300 Frank W. Burr Blvd., Suite
07666 (Phibro Animal Health Corp.).
Phibro Animal Health Corp.
E:\FR\FM\27DER1.SGM
27DER1
MI 49007 (Zoetis
Haytov Str., 1113
Centre East, 3d
21, Teaneck, NJ
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
94993
File No.
Animal drug product
Sponsor
104–646 .............
TYLAN (tylosin)/RUMENSIN (monensin) .................................
110–047
116–044
121–553
138–870
138–941
138–992
138–995
139–192
140–448
140–859
140–954
141–011
141–054
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
.............
TYLAN (tylosin)/BANMINTH (pyrantel) ....................................
LINCOMIX (lincomycin)/BANMINTH (pyrantel) .......................
AUREOMYCIN (chlortetracycline)/COBAN (monensin) ..........
TYLAN (tylosin)/RUMENSIN (monensin)/MGA (melengestrol)
LINCOMIX (lincomycin)/BANMINTH (pyrantel) .......................
TYLAN (tylosin)/BOVATEC (lasalocid)/MGA (melengestrol) ...
TYLAN (tylosin)/MGA (melengestrol) .......................................
TYLAN (tylosin)/MGA (melengestrol) .......................................
TERRAMYCIN (oxytetracycline)/BIO–COX (salinomycin) .......
AUREOMYCIN (chlortetracycline)/BIO–COX (salinomycin) ....
LINCOMIX (lincomycin)/SAFE–GUARD (fenbendazole) .........
CTC (chlortetracycline)/DENAGARD (tiamulin) .......................
LINCOMIX (lincomycin)/IVOMEC (ivermectin) ........................
141–059 .............
141–147 .............
141–149 .............
CHLORMAX (chlortetracycline)/BMD (bacitracin) ...................
CHLORMAX (chlortetracycline)/DECCOX (decoquinate) ........
TYLAN
(tylosin)/RUMENSIN
(monensin)/DECCOX
(decoquinate).
TYLAN (tylosin)/PAYLEAN (ractopamine) ...............................
AUREOMYCIN (chlortetracycline)/DECCOX (decoquinate) ....
AUREOMYCIN (chlortetracycline)/CATTLYST (laidlomycin) ...
TERRAMYCIN (oxytetracycline)/(carbadox) ............................
TYLAN
(tylosin)/RUMENSIN
(monensin)/OPTAFLEXX
(ractopamine).
TYLAN
(tylosin)/RUMENSIN
(monensin)/OPTAFLEXX
(ractopamine)/MGA (melengestrol).
AUREOMYCIN (chlortetracycline)/BOVATEC (lasalocid) ........
TYLAN (tylosin)/RUMENSIN (monensin)/ZILMAX (zilpaterol)
Elanco US Inc., 2500 Innovation Way, Greenfield, IN 46140
(Elanco US Inc.).
Phibro Animal Health Corp.
Phibro Animal Health Corp.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Phibro Animal Health Corp.
Zoetis Inc.
Intervet, Inc.
Elanco US Inc.
Merial, Inc., 3239 Satellite Blvd., Bldg. 500, Duluth, GA
30096–4640.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
141–172
141–185
141–201
141–211
141–224
.............
.............
.............
.............
.............
141–233 .............
141–250 .............
141–276 .............
141–280 .............
200–095
200–096
200–242
200–261
200–262
200–263
200–354
.............
.............
.............
.............
.............
.............
.............
200–356
200–357
200–358
200–359
200–375
.............
.............
.............
.............
.............
200–424 .............
200–427 .............
200–430 .............
200–480 .............
200–530
200–531
200–532
200–533
.............
.............
.............
.............
200–534 .............
200–535 .............
asabaliauskas on DSK3SPTVN1PROD with RULES
200–544 .............
200–547 .............
200–558 .............
200–561 .............
200–562 .............
200–566 .............
200–567 .............
VerDate Sep<11>2014
TYLAN (tylosin)/RUMENSIN (monensin)/ZILMAX (zilpaterol)/
MGA (melengestrol).
AUREOMYCIN (chlortetracycline)/SACOX (salinomycin) .......
TERRAMYCIN (oxytetracycline)/SACOX (salinomycin) ..........
AUREOMYCIN (chlortetracycline)/BMD (bacitracin) ...............
CHLORMAX (chlortetracycline)/BIO–COX (salinomycin) ........
CHLORMAX (chlortetracycline)/SACOX (salinomycin) ...........
CHLORMAX (chlortetracycline)/COBAN (monensin) ..............
PENNCHLOR (chlortetracycline)/COBAN (monensin) ............
PENNCHLOR (chlortetracycline)/DENAGARD (tiamulin) ........
PENNCHLOR (chlortetracycline)/BIO–COX (salinomycin) ......
PENNCHLOR (chlortetracycline)/BMD (bacitracin) .................
PENNCHLOR (chlortetracycline)/DECCOX (decoquinate) ......
TYLAN
(tylosin)/RUMENSIN
(monensin)/HEIFERMAX
(melengestrol).
TYLAN
(tylosin)/RUMENSIN
(monensin)/OPTAFLEXX
(ractopamine)/HEIFERMAX (melengestrol).
TYLAN (tylosin)/HEIFERMAX 500 (melengestrol) Liquid ........
TYLAN (tylosin)/BOVATEC (lasalocid)/HEIFERMAX 500
(melengestrol) Liquid.
TYLAN (tylosin)/RUMENSIN (monensin)/ZILMAX (zilpaterol)/
HEIFERMAX 500 (melengestrol).
TYLOVET (tylosin)/PAYLEAN (ractopamine) ..........................
TYLOVET (tylosin)/RUMENSIN (monensin) ............................
TYLOVET (tylosin)/MGA (melengestrol) ..................................
TYLOVET
(tylosin)/RUMENSIN
(monensin)/DECCOX
(decoquinate).
TYLOVET
(tylosin)/RUMENSIN
(monensin)/MGA
(melengestrol).
TYLOVET
(tylosin)/BOVATEC
(lasalocid)/MGA
(melengestrol).
TYLOVET
(tylosin)/RUMENSIN
(monensin)/ZILMAX
(zilpaterol)/MGA (melengestrol).
TYLOVET
(tylosin)/RUMENSIN
(monensin)/ZILMAX
(zilpaterol).
TYLAN (tylosin)/ENGAIN (ractopamine) ..................................
TYLAN
(tylosin)/RUMENSIN
(monensin)/ACTOGAIN
(ractopamine).
TYLAN
(tylosin)/RUMENSIN
(monensin)/ACTOGAIN
(ractopamine).
TYLOVET (tylosin)/RUMENSIN (monensin) ............................
TYLOVET (tylosin)/RUMENSIN (monensin) ............................
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00085
Fmt 4700
Sfmt 4700
Elanco US Inc.
Zoetis Inc.
Zoetis Inc.
Phibro Animal Health Corp.
Elanco US Inc.
Elanco US Inc.
Zoetis Inc.
Intervet, Inc., 2 Giralda Farms, Madison, NJ 07940 (Intervet,
Inc.).
Intervet, Inc.
Huvepharma EOOD.
Huvepharma EOOD.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Pharmgate LLC, 1015 Ashes Dr., Suite 102, Wilmington, NC
28405 (Pharmgate LLC).
Pharmgate LLC.
Pharmgate LLC.
Pharmgate LLC.
Pharmgate LLC.
Elanco US Inc.
Elanco US Inc.
Elanco US Inc.
Elanco US Inc.
Elanco US Inc.
Huvepharma
Huvepharma
Huvepharma
Huvepharma
EOOD.
EOOD.
EOOD.
EOOD.
Huvepharma EOOD.
Huvepharma EOOD.
Huvepharma EOOD.
Huvepharma EOOD.
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
Huvepharma EOOD.
Huvepharma EOOD.
E:\FR\FM\27DER1.SGM
27DER1
94994
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
File No.
Animal drug product
200–583 .............
TYLOVET
(tylosin)/RUMENSIN
(monensin)/ACTOGAIN
(ractopamine)/MGA (melengestrol).
TYLOVET (tylosin)/ENGAIN (ractopamine) .............................
TYLOVET
(tylosin)/RUMENSIN
(monensin)/ACTOGAIN
(ractopamine).
200–584 .............
200–585 .............
The animal drug regulations are also
being amended to reflect several nonsubstantive changes in format. These
technical amendments are being made
to improve the consistency and
readability of the regulations.
Elsewhere in this issue of the Federal
Register, FDA is amending the animal
drug regulations to reflect approval of
similar supplemental NADAs and
ANADAs changing the marketing status
of antimicrobial drugs administered to
food-producing animals in medicated
water.
Sponsor
Zoetis Inc.
Zoetis Inc.
Zoetis Inc.
II. Changes of Sponsorship
Elanco US Inc., 2500 Innovation Way,
Greenfield, IN 46140 has informed FDA
that it has transferred ownership of, and
all rights and interest in, NADA 141–
110, providing for the manufacture of
combination drug medicated turkey
feeds containing STAFAC
(virginiamycin) and COBAN (monensin)
to Phibro Animal Health Corp.,
GlenPointe Centre East, 3d Floor, 300
Frank W. Burr Blvd., Suite 21, Teaneck,
NJ 07666. As provided in the regulatory
text of this document, the animal drug
regulations are amended to reflect this
change of sponsorship.
III. Withdrawals of Approval
In addition, approval of the following
applications for medicated feeds
containing antimicrobial drugs of
importance to human medicine
administered to food-producing animals
is being withdrawn at the sponsors’
requests because the products are no
longer manufactured or marketed:
File No.
Product name
Sponsor
034–085 .............
LINCOMIX (lincomycin hydrochloride monohydrate) Type A
Medicated Article.
OM–5 Premix (oleandomycin) Type A Medicated Article ........
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007 (Zoetis
Inc.).
Phibro Animal Health Corp., GlenPointe Centre East, 3d
Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ
07666 (Phibro Animal Health Corp.).
Phibro Animal Health Corp.
Zoetis Inc.
035–287 .............
046–668 .............
091–668 .............
140–443 .............
140–947 .............
Penicillin G Procaine 50% Type A Medicated Article ..............
CHLORMAX–SP 500 (chlortetracycline, sulfamethazine, penicillin G procaine) Type A Medicated Article.
LINCOMIX (lincomycin)/NICARB (nicarbazin) .........................
Virginiamycin Type A Medicated Article ..................................
STAFAC
(virginiamycin)/STENEROL
(halofuginone
hydrobromide).
LINCOMIX
(lincomycin)/STENOROL
(halofuginone
hydrobromide).
HYGROMIX 1.6 (hygromycin B) Type A Medicated Article ....
LINCOMIX (lincomycin)/MAXIBAN (narasin and nicarbazin) ..
141–090 .............
200–171 .............
STAFAC (virginiamycin)/CLINICOX (diclazuril) .......................
LINCOMIX (lincomycin)/NICARMIX (nicarbazin) .....................
200–569 .............
200–570 .............
200–580 .............
TYLAN (tylosin)/SACOX (salinomycin) ....................................
TYLOVET 100 (tylosin)/BIO–COX (salinomycin) .....................
TYLOVET 100 (tylosin)/SACOX (salinomycin) ........................
108–116 .............
133–334 .............
139–473 .............
asabaliauskas on DSK3SPTVN1PROD with RULES
140–340 .............
Elsewhere in this issue of the Federal
Register, FDA gave notice that approval
of NADAs 034–085, 035–287, 046–668,
091–668, 108–116, 133–334, 139–473,
140–340, 140–443, 140–947, and 141–
090, and ANADAs 200–171, 200–569,
200–570, and 200–580, and all
supplements and amendments thereto,
is withdrawn, effective January 6, 2017.
As provided in the regulatory text of
this document, the animal drug
regulations are amended to reflect these
voluntary withdrawals of approval.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
Phibro Animal Health Corp.
Zoetis Inc.
Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113
Sophia, Bulgaria (Huvepharma EOOD).
Huvepharma EOOD.
Zoetis Inc.
Elanco US Inc., 2500 Innovation Way, Greenfield, IN 46140
(Elanco US Inc.).
Huvepharma EOOD.
Planalquimica Industrial Ltda., Rua das Magnolias nr. 2405,
Jardim das Bandeiras, CEP 13053–120, Campinas, Sao
Paulo, Brazil.
Huvepharma EOOD.
Huvepharma EOOD.
Huvepharma EOOD.
List of Subjects
PART 556—TOLERANCES FOR
RESIDUES OF NEW ANIMAL DRUGS
IN FOOD
21 CFR Part 556
Animal drugs, Foods.
1. The authority citation for part 556
continues to read as follows:
■
21 CFR Part 558
Authority: 21 U.S.C. 342, 360b, 371.
Animal drugs, Animal feeds.
Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR parts 556 and 558 are amended as
follows:
PO 00000
§ 556.480
■
[Removed]
2. Remove § 556.480.
PART 558—NEW ANIMAL DRUGS FOR
USE IN ANIMAL FEEDS
3. The authority citation for part 558
continues to read as follows:
■
Authority: 21 U.S.C. 354, 360b, 360ccc,
360ccc–1, 371.
Frm 00086
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
94995
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
4. In § 558.4, in paragraph (d), in the
Category I table, in the column headings
for ‘‘Assay limits 1 percent type A’’ and
‘‘Assay limits percent 1 type B/C 2’’,
remove ‘‘type’’ and in its place add
■
§ 558.4 Requirement of a medicated feed
mill license.
‘‘Type’’, and remove the row entries for
‘‘Erythromycin (thiocyanate salt)’’ and
‘‘Oleandomycin’’; and in the Category II
table, alphabetically add an entry for
‘‘Erythromycin’’ to read as follows:
*
*
*
(d) * * *
*
*
CATEGORY II
Assay limits
percent 1
Type A
Drug
*
*
Erythromycin ....................................
*
*
*
*
85–115
*
*
*
*
*
*
Amprolium and ethopabate.
*
*
*
*
(f) Amprolium and ethopabate may
also be used in combination with:
(1) [Reserved]
(2) [Reserved]
(3) Chlortetracycline as in § 558.128.
(4) Lincomycin as in § 558.325.
(5) Virginiamycin as in § 558.635.
■ 6. Revise § 558.59 to read as follows:
5. In § 558.58, remove and reserve
paragraphs (e)(2), (7), and (8); remove
paragraphs (e)(10) and (11); and add
paragraph (f) to read as follows:
*
Assay limits
percent 1
Type B/C 2
*
*
*
4.625 g/lb (1.02%) .....................................................................................
*
■
§ 558.58
Type B
maximum
(100×)
*
§ 558.59
*
75–125
*
Apramycin.
(a) Specifications. Type A articles
containing 75 grams apramycin (as
apramycin sulfate) per pound.
(b) Sponsor. See No. 058198 in
§ 510.600(c) of this chapter.
(c) Related tolerances. See § 556.52 of
this chapter.
(d) Conditions of use in swine—
Apramycin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(1) 150 ...................
........................
For control of porcine colibacillosis (weanling pig
scours) caused by susceptible strains of Escherichia coli.
Feed as the sole ration for 14 consecutive days. Withdraw 28 days
before slaughter.
Sponsor
058198
(2) [Reserved].
7. In § 558.76, redesignate paragraphs
(e)(2)(iii) through (xvi) as paragraphs
(e)(2)(iv) through (xvii); and add new
paragraph (e)(2)(iii) to read as follows:
■
§ 558.76
Bacitracin methylenedisalicylate.
*
*
*
*
*
(e) * * *
(2) * * *
(iii) Chlortetracycline as in § 558.128.
*
*
*
*
*
■
8. Revise § 558.128 to read as follows:
§ 558.128
Chlortetracycline.
asabaliauskas on DSK3SPTVN1PROD with RULES
(a) Specifications. Type A medicated
articles containing either
chlortetracycline calcium complex
equivalent to chlortetracycline
hydrochloride, or for products intended
for use in milk replacer,
chlortetracycline hydrochloride.
(b) Approvals. See sponsors in
§ 510.600(c) of this chapter for use as in
paragraph (e) of this section.
(1) Nos. 054771: 50, 65, or 100 grams
per pound (g/lb) Type A medicated
article.
(2) No. 066104: 10, 20, 30, 50, 70, or
100 g/lb of Type A medicated article.
(3) No. 069254: 50, 90, or 100 g/lb of
Type A medicated article.
(c) Related tolerances. See § 556.150
of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
chlortetracycline medicated feeds must
not exceed 6 months from the date of
issuance. VFDs for chlortetracycline
shall not be refilled.
(3) In milk replacers or starter feed;
include on labeling the warning: ‘‘A
withdrawal period has not been
established for this product in
preruminating calves. Do not use in
calves to be processed for veal.’’
(4) Manufacture for use in free-choice
feeds as in paragraph (e)(4)(iii) of this
section must conform to § 510.455 of
this chapter.
(5) When manufactured for use as in
paragraph (e)(5)(iii) of this section,
include on labeling the warning:
‘‘Psittacosis, avian chlamydiosis, or
ornithosis is a reportable communicable
disease, transmissible between wild and
domestic birds, other animals, and man.
Contact appropriate public health and
regulatory officials.’’
(e) Conditions of use—(1) Chickens. It
is used as follows:
Chlortetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
(i) 100 to 200 g/ton
................................
Chickens: For control of infectious synovitis caused by Mycoplasma synoviae
susceptible to chlortetracycline.
Feed continuously for 7 to 14 days. Do
not feed to chickens producing eggs
for human consumption.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00087
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
054771
066104
069254
94996
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Combination in
grams/ton
Indications for use
Limitations
(ii) 100 to 200 g/ton
Clopidol, 113.5 .......
Broiler and replacement chickens: As
an aid in the prevention of coccidiosis
caused by Eimeria tenella, E.
necatrix, E. acervulina, E. maxima, E.
mivati, and E. brunetti; and for control
of infectious synovitis caused by M.
synoviae susceptible to chlortetracycline.
(iii) 100 to 200 g/ton
Decoquinate, 27.2 ..
Chickens: For prevention of coccidiosis
caused by Eimeria tenella, E.
necatrix, E. mivati, E. acervulina, E.
maxima, and E. brunetti; and for control of infectious synovitis caused by
M, synoviae susceptible to chlortetracycline.
(iv) 100 g/ton ..........
Robenidine, 30 ......
................................
(vi) 200 g/ton ..........
Amprolium, 227 and
ethopabate, 3.6.
Broiler and fryer chickens: As an aid in
the prevention of coccidiosis caused
by E. mivati, E. brunetti, E. tenella, E.
acervulina, E. maxima, and E.
necatrix; as an aid in the control of
chronic respiratory disease (CRD)
caused by Mycoplasma gallisepticum
susceptible to chlortetracycline; and
as an aid in the control of infectious
synovitis caused by M. synoviae susceptible to chlortetracycline.
Chickens: For the control of chronic respiratory disease (CRD) and air sac infection caused by M. gallisepticum
and Escherichia coli susceptible to
chlortetracycline.
For chickens where immunity to coccidiosis is not desired: For prevention of
coccidiosis; and for treatment of
chronic respiratory disease (CRD)
caused by M. gallisepticum susceptible to chlortetracycline.
Feed continuously as the sole ration
from the time chicks are placed in
floor pens for 7 to 14 days. Do not
feed to chickens over 16 weeks of
age. Do not feed to chickens producing eggs for human consumption.
Chlortetracycline as provided by No.
054771; clopidol as provided by No.
016592 in § 510.600(c) of this chapter.
Feed continuously for 7 to 14 days.
Bentonite should not be used in
decoquinate feeds. Do not feed to
chickens producing eggs for human
consumption.
Chlortetracycline and decoquinate as
provided
by
No.
054771
in
§ 510.600(c) of this chapter.
Feed continuously as sole ration. Do
not use this product in feeds conta.
Chlortetracycline and robenidine as provided by No. 054771 in § 510.600(c)
of this chapter.
(v) 200 to 400 g/ton
(vii) 200 g/ton .........
Decoquinate, 27.2 ..
Broilers: As an aid in the prevention of
coccidiosis caused by Eimeria tenella,
E. necatrix, E. acervulina, E. mivati,
E. maxima, and E. brunetti; and for
the treatment of chronic respiratory
disease (air sac infection) and the
prevention of synovitis.
(viii) 200 g/ton ........
asabaliauskas on DSK3SPTVN1PROD with RULES
Chlortetracycline
amount
Robenidine 30 .......
(ix) 500 g/ton ..........
................................
Broiler and fryer chickens: As an aid in
the prevention of coccidiosis caused
by E. mivati, E. brunetti, E. tenella, E.
acervulina, E. maxima, and E.
necatrix; as an aid in the control of
chronic respiratory disease (CRD)
caused by M. gallisepticum susceptible to chlortetracycline; and as an
aid in the control of infectious synovitis caused by M. synoviae susceptible to chlortetracycline.
Chickens: For the reduction of mortality
due to E. coli infections susceptible to
chlortetracycline.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00088
Fmt 4700
Sfmt 4700
Sponsor
016592
054771
054771
Feed continuously for 7 to 14 days. Do
not feed to chickens producing eggs
for human consumption.
054771
066104
069254
Use in low calcium feed containing
0.8% dietary calcium and 1.5% sodium sulfate; feed continuously as
sole ration for 7 to 14 days; do not
feed to chickens producing eggs for
human
consumption.
Chlortetracycline as provided by No. 054771;
amprolium and ethopabate as provided by No. 016592 in § 510.600(c)
of this chapter.
Feed continuously as the sole ration for
no more than 8 weeks. Use in low
calcium feed containing 0.8% dietary
calcium. Bentonite should not be
used in decoquinate feeds. Do not
feed to chickens producing eggs for
human consumption.
Chlortetracycline and decoquinate as
provided
by
No.
054771
in
§ 510.600(c) of this chapter.
Feed continuously as sole ration. Do
not use this product in feeds containing bentonite. Do not feed to
chickens producing eggs for human
consumption. Withdraw 5 days prior
to slaughter.
Chlortetracycline and robenidine as provided by No. 054771 in § 510.600(c)
of this chapter.
054771
1. Feed for 5 days. To sponsor No.
054771 under NADA 048–761 and
No. 069254 under ANADA 200–510:
zero withdrawal time.
2. Feed for 5 days; withdraw 24 hours
prior to slaughter. Do not feed to
chickens producing eggs for human
consumption.
E:\FR\FM\27DER1.SGM
27DER1
054771
054771
054771
069254
054771
066104
069254
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Chlortetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
Feed for 5 days as the sole ration. Do
not feed to laying chickens. Not to be
fed continuously for more than 5
days. Do not feed to chickens over
16 weeks of age. Withdraw 24 hours
before slaughter. See § 558.355(d) of
this chapter. Chlortetracycline as provided by No. 054771; monensin as
provided
by
No.
058198
in
§ 510.600(c) of this chapter.
Feed continuously as sole ration for up
to 5 days. Do not use this product in
feeds containing bentonite. Do not
feed to chickens producing eggs for
human consumption. Withdraw 5
days prior to slaughter.
Chlortetracycline and robenidine as provided by No. 054771 in § 510.600(c)
of this chapter.
For use in low calcium feeds containing
0.8% calcium. Not approved for use
with pellet binders. Not to be fed continuously for more than 5 days. Do
not feed to laying chickens producing
eggs for human consumption. Withdraw 24 hours before slaughter. May
be fatal if accidentally fed to adult turkeys or horses. Chlortetracycline as
provided by Nos. 054771 or 069254;
salinomycin as provided by Nos.
054771 or 016592 in § 510.600(c) of
this chapter.
(x) 500 g/ton ...........
Monensin, 90 to
110.
Chickens: As an aid in the reduction of
mortality due to E. coli infections susceptible to chlortetracycline; and as
an aid in the prevention of coccidiosis
caused by Eimeria tenella, E.
necatrix, E. acervulina, E. maxima, E.
brunetti, and E. mivati.
(xi) 500 g/ton ..........
Robenidine, 30 ......
Broiler and fryer chickens: As an aid in
the prevention of coccidiosis caused
by Eimeria mivati, E. brunetti, E.
tenella, E. acervulina, E. maxima, and
E. necatrix; as an aid in the reduction
of mortality due to E. coli susceptible
to chlortetracycline.
(xii) 500 g/ton .........
Salinomycin, 40 to
60.
Broiler chickens: As an aid in the prevention of coccidiosis caused by
Eimeria tenella, E. necatrix, E.
acervulina, E. maxima, E. brunetti,
and E. mivati; and as an aid in the reduction of mortality due to E. coli susceptible to chlortetracycline.
94997
Sponsor
054771
069254
054771
016592
054771
069254
(2) Turkeys. It is used as follows:
Chlortetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
(i) 200 g/ton ............
................................
(ii) 400 g/ton ...........
................................
................................
................................
Feed continuously for 7 to 14 days. Do
not feed to turkeys producing eggs
for human consumption.
Feed continuously for 7 to 14 days. Do
not feed to turkeys producing eggs
for human consumption.
................................................................
054771
066104
069254
054771
066104
069254
054771
066104
069254
(iii) 25 mg/lb of
body weight.
................................
Turkeys: For control of infectious synovitis caused by M. synoviae susceptible to chlortetracycline.
1. Turkeys: For control of hexamitiasis
caused by Hexamita meleagridis susceptible to chlortetracycline.
2. Turkey poults not over 4 weeks of
age: For reduction of mortality due to
paratyphoid caused by Salmonella
typhimurium susceptible to chlortetracycline.
Turkeys: For control of complicating
bacterial organisms associated with
bluecomb (transmissible enteritis;
coronaviral enteritis) susceptible to
chlortetracycline.
Feed continuously for 7 to 14 days. Do
not feed to turkeys producing eggs
for human consumption.
054771
066104
069254
Sponsor
(3) Swine. It is used as follows:
asabaliauskas on DSK3SPTVN1PROD with RULES
Chlortetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
(i) 50 to 100 g/ton ..
................................
Swine: For reducing the incidence of
cervical lymphadenitis (jowl abscesses) caused by Group E
Streptococci susceptible to chlortetracycline.
................................................................
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00089
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
054771
066104
069254
94998
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Chlortetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
(ii) 400 g/ton ...........
................................
Feed continuously for not more than 14
days.
054771
066104
069254
(iii) 10 mg/lb of
body weight.
................................
Feed approximately 400 g/ton, varying
with body weight and feed consumption to provide 10 mg/lb per day.
Feed for not more than 14 days.
Withdraw 5 d prior to slaughter for
sponsor No. 069254 in § 510.600(c)
of this chapter.
054771
066104
069254
(iv) 10 mg/lb of
body weight.
Bacitracin
methylenedisalicylate, 10 to 30.
Feed approximately 400 g/ton, varying
with body weight and feed consumption to provide 10 mg/lb per day.
Feed for not more than 14 days.
054771
(v) 10 mg/lb of body
weight.
Bacitracin
methylenedisalicylate, 10 to 30.
Breeding swine: For the control of leptospirosis (reducing the incidence of
abortion and shedding of leptospirae)
caused by Leptospira pomona susceptible to chlortetracycline.
Swine: For treatment of bacterial enteritis caused by Escherichia coli and S.
choleraesuis and bacterial pneumonia
caused by Pasteurella multocida susceptible to chlortetracycline; for the
control
of
porcine
proliferative
enteropathies (ileitis) caused by
Lawsonia intracellularis susceptible to
chlortetracycline.
Swine: For treatment of bacterial enteritis caused by E. coli and S.
choleraesuis and bacterial pneumonia
caused by P. multocida susceptible to
chlortetracycline; for the control of
porcine proliferative enteropathies (ileitis)
caused
by
Lawsonia
intracellularis susceptible to chlortetracycline; and for increased rate of
weight gain and improved feed efficiency.
Swine: For treatment of bacterial enteritis caused by E. coli and S.
choleraesuis and bacterial pneumonia
caused by P. multocida susceptible to
chlortetracycline; and for increased
rate of weight gain and improved feed
efficiency.
069254
(vi) 500 to 4,000 to
provide 10 mg/lb
of body weight
daily.
Tiamulin hydrogen
fumarate, 35.
Feed chlortetracycline at approximately
400 g/ton of feed, varying with body
weight and food consumption, to provide 10 mg/lb of body weight. Feed
for not more than 14 days. Withdraw
5 d prior to slaughter for sponsor No.
069254.
Bacitracin
methylenedisalicylate provided by No.
054771; chlortetracycline provided by
Nos. 054771 and 069254 in
§ 510.600(c) of this chapter.
Feed continuously as the sole ration for
14 days. Withdraw medicated feed 2
days before slaughter. Tiamulin as
provided by Nos. 058198 or 069254in
§ 510.600(c) of this chapter.
For control of swine dysentery associated with Brachyspira (formerly
Serpulina
or
Treponema)
hyodysenteriae susceptible to tiamulin
and for treatment of swine bacterial
enteritis caused by E. coli and Salmonella choleraesuis sensitive to
chlortetracycline and treatment of
bacterial pneumonia caused by P.
multocida sensitive to chlortetracycline.
Sponsor
058198
069254
(4) Cattle. It is used as follows:
Combination in
grams/ton
Indications for use
Limitations
(i) 0.5 mg/lb of body
weight daily.
asabaliauskas on DSK3SPTVN1PROD with RULES
Chlortetracycline
amount
................................
Beef cattle (over 700 lb): For control of
active infection of anaplasmosis
caused by Anaplasma marginale susceptible to chlortetracycline.
Withdraw 48 hours prior to slaughter.
To sponsor Nos. 054771 and 069254:
Zero withdrawal time.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00090
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
054771
066104
069254
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Chlortetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
Feed continuously on a hand-fed basis
0.5 mg chlortetracycline per lb. body
weight per day and not less than 60
mg or more than 300 mg lasalocid
per head daily in at least 1 pound of
feed. Daily lasalocid intakes in excess
of 200 mg/head/day in pasture cattle
have not been shown to be more effective than 200 mg lasalocid/head/
day. Do not allow horses or other
equines access to feeds containing
lasalocid. No withdrawal period is required. A withdrawal period has not
been established for this product in
pre-ruminating calves. Do not use in
calves to be processed for veal. See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
In free-choice cattle feeds such as feed
blocks or salt-mineral mixes manufactured from approved Type A articles.
See paragraph (d)(4) of this section.
054771
Feed approximately 400 g/ton, varying
with body weight and feed consumption to provide 10 mg/lb per day.
Treat for not more than 5 days. In
feed including milk replacers withdraw
10 days prior to slaughter. To sponsor No. 069254: zero withdrawal time.
See paragraph (d)(3) of this section.
See paragraph (d)(3) of this section ......
054771
066104
069254
(ii) 25 to 1,100 to
provide 0.5 mg/lb
of body weight
daily.
Lasalocid, 30 to
600.
Pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers)
over 700 pounds: For control of active infection of anaplasmosis caused
by A. marginale susceptible to chlortetracycline; and for increased rate of
weight gain.
(iii) 0.5 to 2.0 mg/lb
of body weight
daily.
................................
(iv) 10 mg/lb of
body weight daily.
................................
Beef cattle and nonlactating dairy cattle:
As an aid in the control of active infection of anaplsmosis caused by A.
marginale susceptible to chlortetracycline.
1. Calves, beef and nonlactating dairy
cattle: For treatment of bacterial enteritis caused by Escherichia coli and
bacterial pneumonia caused by
Pasteurella multocida organisms susceptible to chlortetracycline.
Laidlomycin, 5 ........
(vi) 10 mg/lb of
body weight daily.
Laidlomycin, 5 to 10
(vii) 500 to 2,000 to
provide 10 mg/lb
of body weight
daily.
asabaliauskas on DSK3SPTVN1PROD with RULES
(v) 10 mg/lb of body
weight daily.
Lasalocid, 10 to 30
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
94999
2. Calves (up to 250 lb): For the treatment of bacterial enteritis caused by
E. coli susceptible to chlortetracycline.
Cattle fed in confinement for slaughter: Feed continuously at a rate of 30 to 75
For treatment of bacterial enteritis
mg laidlomycin propionate potassium
caused by E. coli and bacterial pneuper head per day for not more than 5
monia caused by P. multocida orgadays. A withdrawal period has not
nisms susceptible to chlortetracycline;
been established for this product in
and for increased rate of weight and
pre-ruminating calves. Do not use in
improved feed efficiency.
calves to be processed for veal. See
§ 558.305(d)
of
this
chapter.
Laidlomycin as provided by No.
054771 in § 510.600(c) of this chapter.
Cattle fed in confinement for slaughter: Feed continuously at a rate of 30 to 75
For treatment of bacterial enteritis
mg laidlomycin propionate potassium
caused by E. coli and bacterial pneuper head per day for not more than 5
monia caused by P. multocida orgadays. A withdrawal period has not
nisms susceptible to chlortetracycline;
been established for this product in
and for improved feed efficiency.
pre-ruminating calves. Do not use in
calves to be processed for veal. See
§ 558.305(d)
of
this
chapter.
Laidlomycin as provided by No.
054771 in § 510.600(c) of this chapter.
Cattle fed in confinement for slaughter: Feed continuously in complete feed for
For treatment of bacterial enteritis
not more than 5 days to provide 10
caused by E. coli and bacterial pneumg chlortetracycline per lb. body
monia caused by P. multocida orgaweight per day and not less than 100
nisms susceptible to chlortetracycline;
mg or more than 360 mg lasalocid
and for improved feed efficiency.
per head per day. Do not allow
horses or other equines access to
feeds containing lasalocid. No withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
PO 00000
Frm 00091
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
054771
054771
066104
069254
054771
054771
054771
95000
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Combination in
grams/ton
Indications for use
Limitations
(viii) 500 to 1,200 to
provide 10 mg/lb
of body weight
daily.
Lasalocid, 25 to 30
Cattle fed in confinement for slaughter:
For treatment of bacterial enteritis
caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline;
and for increased rate of weight gain
and improved feed efficiency.
(ix) 500 to 4,000 to
provide 10 mg/lb
of body weight
daily.
Lasalocid, 30 to
600.
Pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement
heifers): For treatment of bacterial enteritis caused by E. coli and bacterial
pneumonia caused by P. multocida
organisms susceptible to chlortetracycline; and for increased rate of
weight gain and improved feed efficiency.
(x) 500 to 4,000 g/
ton.
................................
Calves, beef and nonlactating dairy cattle: For the treatment of bacterial enteritis caused by E. coli and bacterial
pneumonia caused by P. multocida
susceptible to chlortetracycline.
(xi) 500 to 4,000 .....
Decoquinate, 12.9
to 90.8.
Calves, beef and non-lactating dairy
cattle: For the treatment of bacterial
enteritis caused by E. coli and bacterial pneumonia caused by P.
multocida susceptible to chlortetracycline; and for the prevention of coccidiosis caused by Eimeria bovis and
E. zuernii.
(xii) 4,000 to 20,000
g/ton.
asabaliauskas on DSK3SPTVN1PROD with RULES
Chlortetracycline
amount
................................
Calves, beef and nonlactating dairy cattle: For the treatment of bacterial enteritis caused by E. coli and bacterial
pneumonia caused by P. multocida
organisms susceptible to chlortetracycline.
Feed continuously in complete feed for
not more than 5 days to provide 10
mg chlortetracycline per lb. body
weight per day and not less than 250
mg or more than 360 mg lasalocid
per head per day. Do not allow
horses or other equines access to
feeds containing lasalocid. No withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
Feed continuously on a hand-fed basis
for not more than 5 days to provide
10 mg chlortetracycline per lb. body
weight per day and not less than 60
mg or more than 300 mg lasalocid
per head per day. Daily lasalocid intakes in excess of 200 mg/head/day
in pasture cattle have not been
shown to be more effective than 200
mg lasalocid/head/day. Do not allow
horses or other equines access to
feeds containing lasalocid. No withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
Feed continuously for not more than 5
days to provide 10 mg/lb body weight
per day. To sponsor No. 054771
under NADA 046–699: 24-hour withdrawal period. To sponsor No.
054771 under NADA 048–761 and
No. 069254 under ANADA 200–510:
Zero withdrawal period.
Feed at a rate of 1g chlortetracycline
per 100 lb body weight/day and 22.7
mg decoquinate per 100 lb of body
weight/day for not more than 5 days.
When it is fully consumed, resume
feeding 22.7 mg decoquinate per 100
lb of body weight/day for a total of 28
days to prevent coccidiosis. Withdraw
24 hours prior to slaughter. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be processed for veal. Do not feed to
animals producing milk for food.
Decoquinate as provided by No.
054771 in § 510.600(c) of this chapter.
As a top dress, varying with body
weight and feed consumption, to provide 10 mg/lb per day. Treat for not
more than 5 days. See paragraph
(d)(3) of this section.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00092
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
054771
054771
054771
069254
054771
069254
054771
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Chlortetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
Administer as a top dress supplement
or mix into the daily ration to provide
22.7 mg decoquinate per 100 lb of
body weight per day and 1 g chlortetracycline per 100 lb body weight/
day for not more than 5 days. When
it is fully consumed, resume feeding
22.7 mg decoquinate per 100 lb of
body weight/day for a total of 28 days
to prevent coccidiosis. Withdraw 24
hours prior to slaughter. A withdrawal
period has not been established for
this product in pre-ruminating calves.
Do not use in calves to be processed
for veal. Do not feed to animals producing milk for food. Decoquinate as
provided
by
No.
054771
in
§ 510.600(c) of this chapter.
See paragraph (d)(3) of this section ......
(xiii) 4,000 to
20,000 g/ton.
Decoquinate, 90.8
to 535.7.
Calves, beef and non-lactating dairy
cattle: For the treatment of bacterial
enteritis caused by E. coli and bacterial pneumonia caused by P.
multocida susceptible to chlortetracycline; and for the prevention of coccidiosis caused by E. bovis and E.
zuernii.
(xiv) 70 mg/head/
day.
................................
Growing cattle (over 400 lb): For reduction of incidence of liver abscesses.
(xv) 350 mg/head/
day.
................................
1. Beef cattle: For control of bacterial
pneumonia associated with shipping
fever complex caused by Pasteurella
spp. susceptible to chlortetracycline.
2. Beef cattle (under 700 lb): For control
of active infection of anaplasmosis
caused by A. marginale susceptible
to chlortetracycline.
Laidlomycin, 5 ........
Cattle fed in confinement for slaughter:
For control of bacterial pneumonia
associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline; and for
increased rate of weight and improved feed efficiency.
(xvii) 350 mg/head/
day.
Laidlomycin, 5 to 10
Cattle fed in confinement for slaughter:
For control of bacterial pneumonia
associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline; and for
improved feed efficiency.
(xviii) 25 to 42.2 g/
ton to provide
350 mg/head/day.
asabaliauskas on DSK3SPTVN1PROD with RULES
(xvi) 350 mg/head/
day.
Lasalocid, 25 to 30
Cattle under 700 pounds fed in confinement for slaughter: For control of active infection of anaplasmosis caused
by A. marginale susceptible to chlortetracycline; and for increased rate of
weight gain and improved feed efficiency.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00093
Fmt 4700
Sfmt 4700
Withdraw 48 h prior to slaughter. To
sponsor No. 054771 under NADA
046–699: 48-hour withdrawal time. To
sponsor No. 054771 under NADA
048–761 and No. 069254 under
ANADA 200–510: zero withdrawal period.
Withdraw 48 h prior to slaughter. To
sponsor No. 054771 under NADA
046–699: 48-hour withdrawal time. To
sponsor No. 054771 under NADA
048–761 and No. 069254 under
ANADA 200–510: zero withdrawal
time.
Feed continuously at a rate of 30 to 75
mg laidlomycin propionate potassium
per head per day. A withdrawal period has not been established for this
product in pre-ruminating calves. Do
not use in calves to be processed for
veal. See § 558.305(d) of this chapter. Laidlomycin as provided by No.
054771 in § 510.600(c) of this chapter.
Feed continuously at a rate of 30 to 75
mg laidlomycin propionate potassium
per head per day. A withdrawal period has not been established for this
product in pre-ruminating calves. Do
not use in calves to be processed for
veal. See § 558.305(d) of this chapter. Laidlomycin as provided by No.
054771 in § 510.600(c) of this chapter.
Feed continuously in complete feed at a
rate of 350 mg chlortetracycline and
not less than 250 mg nor more than
360 mg lasalocid per head daily. Do
not allow horses or other equines access to feeds containing lasalocid. No
withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
E:\FR\FM\27DER1.SGM
27DER1
95001
Sponsor
054771
054771
066104
069254
054771
066104
069254
054771
066104
069254
054771
054771
054771
95002
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Combination in
grams/ton
Indications for use
Limitations
(xix) 25 to 42.2 g/
ton to provide
350 mg/head/day.
Lasalocid, 25 to 30
Cattle fed in confinement for slaughter:
For control of bacterial pneumonia
associated with shipping fever complex caused by P. multocida organisms susceptible to chlortetracycline;
and for increased rate of weight gain
and improved feed efficiency.
(xx) 25 to 100 g/ton
to provide 350
mg/head/day.
Lasalocid, 10 to 30
Cattle under 700 pounds fed in confinement for slaughter: For control of active infection of anaplasmosis caused
by A. marginale susceptible to chlortetracycline; and for improved feed efficiency.
(xxi) 25 to 100 g/ton
to provide 350
mg/head/day.
Lasalocid, 10 to 30
Cattle fed in confinement for slaughter:
For control of bacterial pneumonia
associated with shipping fever complex caused by P. multocida organisms susceptible to chlortetracycline;
and for improved feed efficiency.
(xxii) 25 to 700 to
provide 350 mg/
head/day.
asabaliauskas on DSK3SPTVN1PROD with RULES
Chlortetracycline
amount
Lasalocid, 30 to
600.
Pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement
heifers): For control of bacterial pneumonia associated with shipping fever
complex caused by P. multocida organisms susceptible to chlortetracycline; and for increased rate of
weight gain.
Feed continuously in complete feed at a
rate of 350 mg chlortetracycline and
not less than 250 mg nor more than
360 mg lasalocid per head daily. Do
not allow horses or other equines access to feeds containing lasalocid. No
withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
Feed continuously in complete feed at a
rate of 350 mg chlortetracycline and
not less than 100 mg nor more than
360 mg lasalocid per head daily. Do
not allow horses or other equines access to feeds containing lasalocid. No
withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
Feed continuously in complete feed at a
rate of 350 mg chlortetracycline and
not less than 100 mg nor more than
360 mg lasalocid per head daily. Do
not allow horses or other equines access to feeds containing lasalocid. No
withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
Feed continuously on a hand-fed basis
at a rate of 350 mg chlortetracycline
and not less than 60 mg nor more
than 300 mg lasalocid per head per
day in at least 1 pound of feed. Daily
lasalocid intakes in excess of 200
mg/head/day in pasture cattle have
not been shown to be more effective
than 200 mg lasalocid/head/day. Do
not allow horses or other equines access to feeds containing lasalocid. No
withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00094
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
054771
054771
054771
054771
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Chlortetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
Feed continuously on a hand-fed basis
at a rate of 350 mg chlortetracycline
and not less than 60 mg nor more
than 300 mg lasalocid per head per
day in at least 1 pound of feed. Daily
lasalocid intakes in excess of 200
mg/head/day in pasture cattle have
not been shown to be more effective
than 200 mg lasalocid/head/day. Do
not allow horses or other equines access to feeds containing lasalocid. No
withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
Hand feed continuously at a rate of 350
mg chlortetracycline and 1 mg
lasalocid per 2.2 lb. body weight daily
to cattle with a maximum of 360 mg
of lasalocid per head per day. Do not
allow horses or other equines access
to feeds containing lasalocid. No withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
Hand feed continuously at a rate of 350
mg chlortetracycline and 1 mg
lasalocid per 2.2 lb. body weight daily
to cattle with a maximum of 360 mg
of lasalocid per head per day. Do not
allow horses or other equines access
to feeds containing lasalocid. No withdrawal period is required. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to
be
processed
for
veal.
See
§ 558.311(d)
of
this
chapter.
Lasalocid as provided by No. 054771
in § 510.600(c) of this chapter.
(xxiii) 25 to 700 to
provide 350 mg/
head/day.
Lasalocid, 30 to
600.
Pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers)
under 700 pounds: For control of active infection of anaplasmosis caused
by A. marginale susceptible to chlortetracycline; and for increased rate of
weight gain.
(xxiv) 25 to 2,800 to
provide 350 mg/
head/day.
Lasalocid, 30 to
181.8.
Beef cattle weighing up to 800 pounds:
For control of bacterial pneumonia
associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline; and for
the control of coccidiosis caused by
E. bovis and E. zuernii.
(xxv) 500 to 4,000
to provide 350
mg/head/day.
Lasalocid, 30 to
181.8.
Cattle weighing up to 800 pounds: For
the treatment of bacterial enteritis
caused by E. coli and bacterial pneumonia caused by P. multocida susceptible to chlortetracycline; and for
the control of coccidiosis caused by
E. bovis and E. zuernii.
95003
Sponsor
054771
054771
054771
(5) Minor species. It is used as
follows:
Chlortetracycline
amount
(i) 80 mg/head/day
asabaliauskas on DSK3SPTVN1PROD with RULES
(ii) 200 to 400 g/ton
(iii) 10 mg/g of finished feed daily.
VerDate Sep<11>2014
Indications for use
Limitations
Breeding sheep; reducing the incidence of
(vibrionic) abortion caused by Campylobacter
fetus infection susceptible to chlortetracycline.
Ducks: For the control and treatment of fowl cholera caused by Pasteurella multocida susceptible
to chlortetracycline.
..................................................................................
Psittacine birds (cockatoos, macaws, and parrots)
suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to
chlortetracycline.
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00095
Fmt 4700
Feed in complete ration to provide from 8 to 28
mg/lb of body weight per day, depending upon
age and severity of disease, for not more than
21 days. Do not feed to ducks producing eggs
for human consumption.
Feed continuously for 45 days. Each bird should
consume daily an amount of medicated feed
equal to one fifth of its body weight. See paragraph (d)(5) of this section.
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
054771
066104
069254
054771
054771
95004
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
(6) It is used as a free-choice, loose
mineral Type C feed as follows:
(i) Specifications.
Ingredient
Percent
Dicalcium Phosphate ...................................................................................................................................
Sodium Chloride (Salt) ................................................................................................................................
Magnesium Oxide ........................................................................................................................................
Cottonseed Meal ..........................................................................................................................................
Trace Mineral/Vitamin Premix 1 ...................................................................................................................
Calcium Carbonate ......................................................................................................................................
Dried Cane Molasses ..................................................................................................................................
Potassium Chloride ......................................................................................................................................
Mineral Oil ....................................................................................................................................................
Iron Oxide ....................................................................................................................................................
Chlortetracycline Type A medicated article (90 gram/lb) ............................................................................
46.20
15.00
10.67
10.00
3.80
3.50
3.00
2.00
2.00
0.50
3.33
International feed
No.
6–26–335
6–04–152
6–02–756
5–01–625
..............................
6–01–069
4–04–695
6–03–755
8–03–123
6–02–431
..............................
1 Content of vitamin and trace mineral premixes may be varied. However, they should be comparable to those used for other free-choice feeds.
Formulation modifications require FDA approval prior to marketing. Selenium must comply with 21 CFR 573.920. Ethylenediamine dihydroiodide
(EDDI) should comply with FDA Compliance Policy Guides Sec. 651.100 (CPG 7125.18).
(ii) Amount. 6,000 grams per ton.
(iii) Indications for use. Beef and
nonlactating dairy cattle: As an aid in
the control of active infection of
anaplasmosis caused by Anaplasma
marginale susceptible to
chlortetracycline.
(iv) Limitations. Feed continuously on
a free-choice basis at a rate of 0.5 to 2.0
mg chlortetracycline per pound of body
weight per day.
(v) Sponsor. See No. 054771 in
§ 510.600(c) of this chapter.
9. In § 558.140, redesignate paragraph
(d) as paragraph (e) and add new
paragraph (d) to read as follows:
■
§ 558.140 Chlortetracycline and
sulfamethazine.
*
*
*
*
*
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
chlortetracycline and sulfamethazine
medicated feeds must not exceed 6
months from the date of issuance. VFDs
for chlortetracycline and sulfamethazine
shall not be refilled.
*
*
*
*
*
§ 558.145
[Removed]
§ 558.175
Clopidol.
*
*
*
*
*
(c) Related tolerances. See § 556.160
of this chapter.
*
*
*
*
*
(e) Clopidol may also be used in
combination with:
(1) [Reserved]
(2) [Reserved]
(3) Chlortetracycline as in § 558.128.
(4) Lincomycin as in § 558.325.
■ 12. In § 558.195, remove and reserve
paragraphs (e)(1)(iv) through (vi),
(e)(2)(ii), (e)(2)(iv), and (e)(2)(vii); and
add paragraph (e)(4) to read as follows:
§ 558.195
13. In § 558.198, remove and reserve
paragraphs (d)(1)(iv) and (v); and add
paragraph (d)(3) to read as follows:
■
10. Remove § 558.145.
■ 11. In § 558.175, in paragraph (b),
remove ‘‘Approvals’’ and in its place
add ‘‘Sponsor’’; add paragraph (c);
remove and reserve paragraphs (d)(5)
and (6); and add paragraph (e) to read
as follows:
■
Decoquinate.
*
*
*
*
*
(e) * * *
(4) Decoquinate may also be used in
combination with:
(i) [Reserved]
(ii) [Reserved]
(iii) Chlortetracycline as in § 558.128.
(iv) Lincomycin as in § 558.325.
§ 558.198
Diclazuril.
*
*
*
*
*
(d) * * *
(3) Diclazuril may also be used in
combination with virginiamycin as in
§ 558.635.
■ 14. In § 558.248, revise paragraph (a);
redesignate paragraph (d) as paragraph
(e); add new paragraph (d); and revise
redesignated paragraph (e) to read as
follows:
§ 558.248
Erythromycin.
(a) Specifications. Type A medicated
articles containing 92.5 grams per
pound erythromycin (as the thiocyanate
salt).
*
*
*
*
*
(d) Special considerations.—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
erythromycin medicated feeds must not
exceed 6 months from the date of
issuance. VFDs for erythromycin shall
not be refilled.
(e) Conditions of use—(1) Chickens—
Combination in
grams/ton
Indications for use
Limitations
(i) 92.5 ....................
asabaliauskas on DSK3SPTVN1PROD with RULES
Erythromycin in
grams/ton
................................
(ii) 92.5 ...................
................................
(iii) 185 ...................
................................
Chickens: As an aid in the prevention of
chronic respiratory disease during periods of stress.
Chickens: As an aid in the prevention of
infectious coryza.
Chickens: As an aid in the prevention
and reduction of lesions and in lowering severity of chronic respiratory
disease (CRD).
Feed for 2 days before stress and 3 to
6 days after stress. Withdraw 24
hours before slaughter.
Feed for 7 to 14 days. Withdraw 24
hours before slaughter.
Feed for 5 to 8 days. Withdraw 48
hours before slaughter. Do not use in
birds producing eggs for food.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00096
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
061623
061623
061623
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
95005
(2) Turkeys—
Erythromycin
thiocyanate in
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 92.5 ....................
................................
Feed for 2 days before stress and 3 to
6 days after stress.
061623
(ii) 185 ....................
................................
Turkeys: As an aid in the prevention of
chronic respiratory disease during periods of stress.
Turkeys: As an aid in the prevention
and reduction of lesions and in lowering severity of chronic respiratory
disease (CRD).
Feed for 5 to 8 days. Do not use in
birds producing eggs for food.
061623
15. In § 558.258, remove and reserve
paragraphs (e)(2)(ii) through (v); and
add paragraph (e)(6) to read as follows:
■
§ 558.258
Fenbendazole.
*
*
*
*
*
(e) * * *
(6) Fenbendazole may also be used in
combination with:
(i) [Reserved]
(ii) Lincomycin as in § 558.325.
■ 16. In § 558.265, remove and reserve
paragraphs (d)(1)(iii), (d)(1)(iv), and
(d)(1)(vii); and add paragraph (d)(4) to
read as follows:
§ 558.265
*
*
Halofuginone.
*
*
*
(d) * * *
(4) Halofuginone may also be used in
combination with:
(i) [Reserved]
(ii) Lincomycin as in § 558.325.
(iii) Virginiamycin as in § 558.635.
17. Revise § 558.274 to read as
follows:
■
§ 558.274
Hygromycin B.
(a) Specifications. Type A medicated
articles containing 2.4 or 8 grams
hygromycin B per pound (g/lb).
(b) Sponsor. See No. 058198 in
§ 510.600(c) of this chapter for as
follows:
Sponsor
(c) Related tolerances. See § 556.330
of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
hygromycin B medicated feeds must not
exceed 6 months from the date of
issuance. VFDs for hygromycin B shall
not be refilled.
(e) Conditions of use. It is used in feed
as follows:
(1) Chickens—
Hygromycin B
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 8 to 12 ...............
................................
Chickens: For control of infections of
large roundworms (Ascaris galli),
cecal worms (Heterakis gallinae), and
capillary worms (Capillaria obsignata).
Use in complete feed. Withdraw 3 days
before slaughter.
Hygromycin B
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 12 .......................
................................
Swine: For control of infections of large
roundworms (A. suis), nodular worms
(O. dentatum), and whipworms
(Trichuris suis).
In market hogs, use in complete feed
for 8 weeks during the growing period. Withdraw 15 days before
slaughter.
Sponsor
058198
(ii) [Reserved]
(2) Swine—
Sponsor
058198
(ii) [Reserved]
§ 558.305
18. In § 558.300, remove and reserve
paragraphs (e)(4) through (7); and add
paragraph (f) to read as follows:
■
§ 558.300
Ivermectin.
asabaliauskas on DSK3SPTVN1PROD with RULES
*
*
*
*
*
(f) Ivermectin may also be used in
combination with:
(1) [Reserved]
(2) Lincomycin as in § 558.325.
■ 19. In § 558.305, remove paragraphs
(e)(2), (e)(3), (e)(5), and (e)(6);
redesignate paragraph (e)(4) as new
paragraph (e)(2); and add paragraph (f)
to read as follows:
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
Laidlomycin.
*
*
*
*
*
(f) Laidlomycin may also be used in
combination with chlortetracycline as in
§ 558.128.
■ 20. In § 558.311, in paragraph (e)(1)(i),
in the row entry for ‘‘Bambermycins 1
to 2’’, in the ‘‘Lasalocid sodium in grams
per ton’’ column, add ‘‘(ii) 68 (0.0075
pct) to 113 (0.0125 pct).’’; in paragraphs
(e)(1)(vi) and (vii), remove the row
entries for ‘‘Oxytetracycline 7.5’’; in
paragraph (e)(1)(xv), remove the row
entry for ‘‘Virginiamycin 10 to 20’’;
remove and reserve paragraphs
PO 00000
Frm 00097
Fmt 4700
Sfmt 4700
(e)(1)(iii), (e)(1)(v), and (e)(1)(xx)
through (e)(1)(xxviii); redesignate
paragraph (e)(5)(i) as paragraph (e)(5)(ii);
and add new paragraphs (e)(5)(i) and
(e)(5)(iii) to read as follows:
§ 558.311
Lasalocid.
*
*
*
*
*
(e) * * *
(5) * * *
(i) Chlortetracycline as in § 558.128.
*
*
*
*
*
(iii) Virginiamycin as in § 558.635.
■ 21. Revise § 558.325 to read as
follows:
E:\FR\FM\27DER1.SGM
27DER1
95006
§ 558.325
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Lincomycin.
(a) Specifications. Type A medicated
articles containing 20 or 50 grams of
lincomycin (as lincomycin
hydrochloride) per pound.
(b) Sponsors. See No. 054771 in
§ 510.600(c) of this chapter.
(c) Related tolerances. See § 556.360
of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
chlortetracycline and sulfamethazine
medicated feeds must not exceed 6
months from the date of issuance. VFDs
for chlortetracycline and sulfamethazine
shall not be refilled.
(3) Labeling of Type A medicated
articles and Type B and Type C
medicated feeds containing lincomycin
shall bear the following:
(i) ‘‘CAUTION: Do not allow rabbits,
hamsters, guinea pigs, horses, or
ruminants access to feeds containing
lincomycin. Ingestion by these species
may result in severe gastrointestinal
effects.’’
(4) Labeling of medicated feeds
containing lincomycin intended for use
in swine shall bear the following:
(i) ‘‘CAUTION: Occasionally, swine
fed lincomycin may within the first 2
days after the onset of treatment develop
diarrhea and/or swelling of the anus. On
rare occasions, some pigs may show
reddening of the skin and irritable
behavior. These conditions have been
self-correcting within 5 to 8 days
without discontinuing the lincomycin
treatment.’’
(ii) ‘‘CAUTION: The effects of
lincomycin on swine reproductive
performance, pregnancy, and lactation
have not been determined.’’
(e) Conditions of use—(1) Chickens—
Lincomycin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 2 .........................
................................
Broilers: For the control of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to lincomycin.
Feed as the sole ration. Not for use in
layers, breeders, or turkeys.
Lincomycin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 40 .......................
................................
For control of swine dysentery and the
control
of
porcine
proliferative
enteropathies (ileitis) caused by
Lawsonia intracellularis.
(ii) 40 ......................
Fenbendazole, 10
to 80.
For control of swine dysentery in animals on premises with a history of
swine dysentery, but where symptoms have not yet occurred; and for
the
removal
of:
Adult
stage
lungworms (Metastrongylus apri and
M. pudendotectus); adult and larvae
(L3, 4 stages—liver, lung, intestinal
forms) large roundworms (Ascaris
suum); adult stage nodular worms
(Oesophagostomum dentatum, O.
quadrispinulatum); adult stage small
stomach
worms
(Hyostrongylus
rubidus); adult and larvae (L2, 3, 4
stages—intestinal mucosal forms)
whipworms (Trichuris suis); adult and
larvae kidney worms (Stephanurus
dentatus).
Feed as sole ration. For use in swine
on premises with a history of swine
dysentery but where symptoms have
not yet occurred, or following use of
lincomycin at 100 grams (g)/ton for
the treatment of swine dysentery and
the control of porcine proliferative
enteropathies (ileitis).
Feed as sole ration to provide a total
dose of 9 mg fenbendazole/kg of
body weight within 3 to 12 days. Do
not feed to swine that weigh more
than 250 pounds. Lincomycin as provided by No. 054771; fenbendazole
as provided by No. 000061 in
§ 510.600(c) of this chapter.
Sponsors
054771
(ii) [Reserved]
asabaliauskas on DSK3SPTVN1PROD with RULES
(2) Swine—
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00098
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsors
054771
000061
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
95007
Combination in
grams/ton
Indications for use
Limitations
(iii) 40 .....................
Ivermectin, 1.8 .......
050604
Pyrantel, 96 ...........
Feed as the sole ration. Not to be fed to
swine that weigh more than 250
pounds. Withdraw 6 days prior to
slaughter. Lincomycin as provided by
No. 054771; pyrantel as provided by
No. 066104 in § 510.600(c) of this
chapter.
066104
(v) 40 ......................
Pyrantel, 96 ...........
Weaned, growing and finishing swine:
For control of swine dysentery on
premises with a history of swine dysentery, but where symptoms have not
yet occurred; and for treatment and
control of gastrointestinal roundworms
(Ascaris suum, adults and fourthstage larvae; Ascarops strongylina,
adults; Hyostrongylus rubidus, adults
and
fourth-stage
larvae;
Oesophagostomum spp., adults and
fourth-stage larvae); kidney worms
(Stephanurus dentatus, adults and
fourth-stage
larvae);
lungworms
(Metastrongylus spp., adults); lice
(Haematopinus suis); and mange
mites (Sarcoptes scabiei var. suis).
For control of swine dysentery on premises with a history of swine dysentery,
but where symptoms have not yet occurred; as an aid in the prevention of
migration and establishment of large
roundworm (Ascaris suum) infections;
and as an aid in the prevention of establishment
of
nodular
worm
(Oesophagostomum spp.) infections.
For the treatment and/or control of
swine dysentery; for removal and
control of large roundworm (Ascaris
suum) infections.
Feed as the only feed for 7 consecutive
days to provide 0.1 mg ivermectin/kg
of body weight per day. A separate
feed containing 40 g/ton lincomycin
may be continued to complete the lincomycin treatment. Not to be fed to
swine that weigh more than 250 lbs.
Withdraw 5 days before slaughter.
Lincomycin as provided by No.
054771; ivermectin as provided by
No. 050604 in § 510.600(c) of this
chapter.
(iv) 40 .....................
Pyrantel, 96 ...........
For the treatment and/or control of
swine dysentery; as an aid in the prevention of migration and establishment of large roundworm (Ascaris
suum) infections; and as an aid in the
prevention of establishment of nodular worm (Oesophagostomum spp.)
infections.
(vii) 100 ..................
................................
(viii) 100 .................
Fenbendazole, 10
to 80.
For treatment of swine dysentery and
the control of porcine proliferative
enteropathies (ileitis) caused by
Lawsonia intracellularis.
For the treatment of swine dysentery;
and for the removal of: Adult stage
lungworms (Metastrongylus apri and
M. pudendotectus); adult and larvae
(L3, 4 stages—liver, lung, intestinal
forms) large roundworms (Ascaris
suum); adult stage nodular worms
(Oesophagostomum dentatum, O.
quadrispinulatum); adult stage small
stomach
worms
(Hyostrongylus
rubidus); adult and larvae (L2, 3, 4
stages—intestinal mucosal forms)
whipworms (Trichuris suis); adult and
larvae kidney worms (Stephanurus
dentatus).
Feed for 3 days as the sole ration. Not
to be fed to swine that weigh more
than 250 pounds. Withdraw 24 hours
prior to slaughter. Lincomycin as provided by No. 054771; pyrantel as provided by No. 066104 in § 510.600(c)
of this chapter.
For treatment of swine dysentery, feed
100 grams of lincomycin and 96
grams of pyrantel tartrate per ton of
complete feed for 3 weeks or until
clinical signs of the disease disappear, following with 40 grams of
lincomycin and 96 grams of pyrantel
tartrate per ton of complete feed as
the sole ration. Not to be fed to swine
that weigh more than 250 pounds.
Withdraw 6 days prior to slaughter.
Lincomycin as provided by No.
054771; pyrantel as provided by No.
066104 in § 510.600(c) of this chapter.
Feed as the sole ration for 3 weeks or
until clinical signs of the disease disappear.
066104
(vi) 40 or 100 .........
asabaliauskas on DSK3SPTVN1PROD with RULES
Lincomycin
grams/ton
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00099
Fmt 4700
Sfmt 4700
Feed as sole ration to provide a total
dose of 9 mg fenbendazole/kg of
body weight within 3 to 12 days. Do
not feed to swine that weigh more
than 250 pounds. Do not use within 6
days of slaughter. Lincomycin as provided by No. 054771; fenbendazole
as provided by No. 000061 in
§ 510.600(c) of this chapter.
E:\FR\FM\27DER1.SGM
27DER1
Sponsors
066104
054771
000061
95008
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Combination in
grams/ton
Indications for use
Limitations
(ix) 100 ...................
Ivermectin, 1.8 .......
050604
Pyrantel, 96 ...........
Weaned, growing and finishing swine:
For the treatment of swine dysentery;
and for treatment and control of gastrointestinal roundworms (Ascaris
suum, adults and fourth-stage larvae;
Ascarops
strongylina,
adults;
Hyostrongylus rubidus, adults and
fourth-stage
larvae;
Oesophagostomum spp., adults and
fourth-stage larvae); kidneyworms
(Stephanurus dentatus, adults and
fourth-stage
larvae);
lungworms
(Metastrongylus spp., adults); lice
(Haematopinus suis); and mange
mites (Sarcoptes scabiei var. suis).
For the treatment of swine dysentery;
as an aid in the prevention of migration and establishment of large
roundworm (Ascaris suum) infections;
and as an aid in the prevention of establishment
of
nodular
worm
(Oesophagostomum spp.) infections.
Feed as the only feed for 7 consecutive
days to provide 0.1 mg ivermectin/kg
of body weight per day. A separate
feed containing 100 g/ton lincomycin
may be continued to complete the lincomycin treatment. Not to be fed to
swine that weigh more than 250 lbs.
Withdraw 6 days before slaughter.
Lincomycin as provided by No.
054771; ivermectin as provided by
No. 050604 in § 510.600(c) of this
chapter.
(x) 100 ....................
Pyrantel, 96 ...........
For the treatment and/or control of
swine dysentery; for removal and
control of large roundworm (Ascaris
suum) infections.
(xii) 100 ..................
Pyrantel, 800 .........
For the treatment and/or control of
swine dysentery; for removal and
control of large roundworm (Ascaris
suum)
and
nodular
worm
(Oesophagostomum spp.) infections.
(xiii) 200 .................
................................
(xiv) 200 .................
Fenbendazole, 10
to 80.
For reduction in the severity of swine
mycoplasmal pneumonia caused by
Mycoplasma hyopneumoniae.
For reduction in the severity of swine
mycoplasmal pneumonia caused by
Mycoplasma hyopneumoniae; and for
the
removal
of:
Adult
stage
lungworms (Metastrongylus apri and
M. pudendotectus); adult and larvae
(L3, 4 stages—liver, lung, intestinal
forms) large roundworms (Ascaris
suum); adult stage nodular worms
(Oesophagostomum dentatum, O.
quadrispinulatum); adult stage small
stomach
worms
(Hyostrongylus
rubidus); adult and larvae (L2, 3, 4
stages—intestinal mucosal forms)
whipworms (Trichuris suis); adult and
larvae kidney worms (Stephanurus
dentatus).
Feed as the sole ration for 3 weeks or
until clinical signs of the disease disappear. Not to be fed to swine that
weigh more than 250 pounds. Withdraw 6 days prior to slaughter. Lincomycin as provided by No. 054771;
pyrantel as provided by No. 066104
in § 510.600(c) of this chapter.
Feed for 3 days as the sole ration. Not
to be fed to swine that weigh more
than 250 pounds. Withdraw 24 hours
prior to slaughter. Lincomycin as provided by No. 054771; pyrantel as provided by No. 066104 in § 510.600(c)
of this chapter.
Feed as a single therapeutic treatment.
Not to be fed to swine that weigh
more than 250 pounds. Withdraw 24
hours prior to slaughter. Lincomycin
as provided by No. 054771; pyrantel
as provided by No. 066104 in
§ 510.600(c) of this chapter.
Feed as sole ration for 21 days .............
066104
(xi) 100 ...................
asabaliauskas on DSK3SPTVN1PROD with RULES
Lincomycin
grams/ton
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00100
Fmt 4700
Sfmt 4700
Feed as sole ration to provide a total
dose of 9 mg fenbendazole/kg of
body weight within 3 to 12 days. Do
not feed to swine that weigh more
than 250 pounds. Do not use within 6
days of slaughter. Lincomycin as provided by No. 054771; fenbendazole
as provided by No. 000061 in
§ 510.600(c) of this chapter.
E:\FR\FM\27DER1.SGM
27DER1
Sponsors
066104
066104
054771
000061
95009
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Lincomycin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(xv) 200 ..................
Ivermectin, 1.8 .......
Feed as the only feed for 7 consecutive
days to provide 0.1 mg ivermectin/kg
of body weight per day. A separate
feed containing 200 g/ton lincomycin
may be continued for an additional 14
days to complete the lincomycin treatment. Not to be fed to swine that
weigh more than 250 lbs. Withdraw 6
days before slaughter. Lincomycin as
provided by No. 054771; ivermectin
as provided by No. 050604 in
§ 510.600(c) of this chapter.
050604
(xvi) 200 .................
Pyrantel, 96 ...........
For reduction in the severity of swine
mycoplasmal pneumonia caused by
Mycoplasma hyopneumoniae; and for
treatment and control of gastrointestinal roundworms (Ascaris suum,
adults and fourth-stage larvae;
Ascarops
strongylina,
adults;
Hyostrongylus rubidus, adults and
fourth-stage
larvae;
Oesophagostomum spp., adults and
fourth-stage larvae); kidneyworms
(Stephanurus dentatus, adults and
fourth-stage
larvae);
lungworms
(Metastrongylus spp., adults); lice
(Haematopinus suis); and mange
mites (Sarcoptes scabiei var. suis).
For reduction in the severity of swine
mycoplasmal pneumonia caused by
Mycoplasma hyopneumoniae; and as
an aid in the prevention of migration
and
establishment
of
large
roundworm (Ascaris suum) infections;
aid in the prevention of establishment
of nodular worm (Oesophagostomum
spp.) infections.
Feed as the sole ration for 21 days. Not
for use in swine that weigh more than
250 pounds. Withdraw 6 days before
slaughter. Lincomycin as provided by
No. 054771; pyrantel as provided by
No. 066104 in § 510.600(c) of this
chapter.
054771
22. In § 558.342, remove and reserve
paragraphs (e)(1)(iii), (e)(1)(iv),
(e)(1)(viii), (e)(1)(ix), and (e)(1)(xi); and
revise paragraph (e)(2) to read as
follows:
■
§ 558.342
Melengestrol.
*
*
*
*
*
(e) * * *
(2) Melengestrol may also be used in
combination with:
(i) Ractopamine as in § 558.500.
(ii) Tylosin as in § 558.625.
(iii) Zilpaterol as in § 558.665.
■ 23. In § 558.355, revise paragraphs (a)
and (b); remove and reserve paragraphs
(f)(1)(viii), (f)(1)(ix), (f)(1)(xiii),
(f)(1)(xiv), (f)(1)(xxi), (f)(1)(xxii),
(f)(1)(xxxi), (f)(2)(iv), (f)(3)(ii), and
(f)(3)(xii); and revise paragraph (f)(8) to
read as follows:
asabaliauskas on DSK3SPTVN1PROD with RULES
§ 558.355
Monensin.
(a) Specifications. Type A medicated
articles containing 45, 60, 90.7, or 110
grams monensin, USP, per pound.
(b) Approvals. See sponsor numbers
in § 510.600(c) of this chapter for
conditions of use as in paragraph (f) of
this section:
(1) No. 058198 for use as in paragraph
(f) of this section.
(2) No. 054771 for use as in
paragraphs (f)(1)(xxiv) and (xxv) of this
section.
(3) No. 058198 for use as in
paragraphs (f)(1)(i), (iii), (iv), and (v) of
this section.
*
*
*
*
*
(f) * * *
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
(8) Monensin may also be used in
combination with:
(i) Chlortetracycline as in § 558.128.
(ii) Decoquinate as in § 558.195.
(iii) Lincomycin as in § 558.325.
(iv) Melengestrol acetate as in
§ 558.342.
(v) Oxytetracycline as in § 558.128.
(vi) Ractopamine alone or in
combination as in § 558.500.
(vii) Tilmicosin as in § 558.618.
(viii) Tylosin as in § 558.625.
(ix) Virginiamycin as in § 558.635.
(x) Zilpaterol alone or in combination
as in § 558.665.
■ 24. In § 558.364, redesignate
paragraph (d) as paragraph (e) and
revise paragraphs (a) through (d) to read
as follows:
§ 558.364
Neomycin sulfate.
(a) Specifications. Type A medicated
article containing 325 grams neomycin
sulfate per pound.
(b) Sponsor. See No. 054771 in
§ 510.600(c) of this chapter.
(c) Related tolerances. See § 556.430
of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
neomycin medicated feeds must not
exceed 6 months from the date of
issuance. VFDs for neomycin shall not
be refilled.
*
*
*
*
*
PO 00000
Frm 00101
Fmt 4700
Sfmt 4700
Sponsors
25. In § 558.366, in the table in
paragraph (d), remove the row entries
under ‘‘Nicarbazin in grams per ton’’
‘‘27 to 45’’ for ‘‘Narasin 27 to 45 and
Lincomycin 2 to 4’’; and under
‘‘Nicarbazin in grams per ton’’ ‘‘113.5
(0.0125 pct)’’ for ‘‘Lincomycin 2
(0.00044 pct)’’; and add paragraph (e) to
read as follows:
■
§ 558.366
Nicarbazin.
*
*
*
*
*
(e) * * *
(6) Nicarbazin may also be used in
combination with:
(i) [Reserved]
(ii) Lincomycin as in § 558.325.
§ 558.435
[Removed]
26. Remove § 556.435.
■ 27. Revise § 558.450 to read as
follows:
■
§ 558.450
Oxytetracycline.
(a) Specifications. Each pound of
Type A medicated article contains:
(1) Oxytetracycline (from
oxytetracycline quaternary salt)
equivalent to 50 or 100 grams
oxytetracycline hydrochloride; or
oxytetracycline (from oxytetracycline
dihydrate base) equivalent to 10, 30, 50,
100, or 200 grams oxytetracycline
hydrochloride.
(2) Oxytetracycline (from
oxytetracycline dihydrate base)
equivalent to 50, 100, or 200 grams
oxytetracycline hydrochloride; or 100
grams oxytetracycline hydrochloride.
(b) Sponsors. See sponsors in
§ 510.600(c) of this chapter as follows:
E:\FR\FM\27DER1.SGM
27DER1
95010
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
(1) No. 066104: Type A medicated
articles as in paragraph (a)(1) of this
section.
(2) No. 069254: Type A medicated
articles as in paragraph (a)(2) of this
section.
(c) Related tolerances. See § 556.500
of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
oxytetracycline medicated feeds must
not exceed 6 months from the date of
issuance. VFDs for oxytetracycline shall
not be refilled.
(3) In accordance with § 558.5,
labeling shall bear the statement: ‘‘For
use in dry animal feed only. Not for use
in liquid feed supplements.’’
(e) Conditions of use—(1) Chickens—
Combination in
grams/ton
Indications for use
Limitations
(i) 100 to 200 g/ton
................................
Chickens: For control of infectious synovitis caused by Mycoplasma synoviae
and control of fowl cholera caused by
Pasteurella multocida susceptible to
oxytetracycline.
(ii) 200 g/ton ...........
Monensin, 90 to
110.
Broiler chickens: As an aid in the prevention of coccidiosis caused by
Eimeria necatrix, E. tenella, E.
acervulina, E. brunetti, E. mivati, and
E. maxima; and for the control of
complicated chronic respiratory disease (CRD or air sac infection)
caused by Mycoplasma gallisepticum
and Escherichia coli.
(iii) 400 g/ton ..........
................................
Chickens: For control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma
gallisepticum and Escherichia coli
susceptible to oxytetracycline.
(iv) 400 g/ton ..........
Robenidine, 30 ......
Broiler chickens: As an aid in the prevention of coccidiosis caused by
Eimeria necatrix, E. tenella, E.
acervulina, E. brunetti, E. mivati, and
E. maxima; and for the control of
chronic respiratory disease (CRD)
and air sac infection caused by Mycoplasma gallisepticum and Escherichia
coli susceptible to oxytetracycline.
(v) 500 g/ton ...........
................................
Chickens: For reduction of mortality due
to air sacculitis (air sac infection)
caused by E. coli susceptible to oxytetracycline.
(vi) 500 g/ton ..........
asabaliauskas on DSK3SPTVN1PROD with RULES
Oxytetracycline
amount
Monensin, 90 to
100.
Broiler chickens: As an aid in the prevention of coccidiosis caused by
Eimeria necatrix, E. tenella, E.
acervulina, E. brunetti, E. mivati, and
E. maxima; and as an aid in the reduction of mortality due to airsacculitis (air sac infection) caused by
Escherichia coli sensitive to oxytetracycline.
Feed continuously for 7 to 14 days. Do
not feed to chickens producing eggs
for human consumption. Do not use
in feed containing less than 0.55% dietary calcium. Use in such low calcium feeds may result in violative residues. Zero-day withdrawal period.
Feed continuously as the sole ration.
Do not feed to laying chickens. Do
not feed to chickens over 16 weeks
of age. Do not use in feed containing
less than 0.55% dietary calcium. Use
in such low calcium feeds may result
in violative residues. Withdraw 72
hours
before
slaughter.
See
§ 558.355(d) of this chapter Oxytetracycline as provided by No. 066104;
monensin as provided by No. 058198
in § 510.600(c) of this chapter.
Feed continuously for 7 to 14 days. Do
not feed to chickens producing eggs
for human consumption. Do not use
in feed containing less than 0.55% dietary calcium. Use in such low calcium feeds may result in violative residues. Zero-day withdrawal period.
Feed continuously for 7 to 14 days. Do
not feed to chickens producing eggs
for human consumption. Do not use
in feed containing less than 0.55% dietary calcium. Use in such low calcium feeds may result in violative residues. Withdraw 5 days before
slaughter. Oxytetracycline as provided by No. 066104; robenidine as
provided
by
No.
054771
in
§ 510.600(c) of this chapter.
Feed continuously for 5 days. Do not
feed to chickens producing eggs for
human consumption. Do not use in
feed containing less than 0.55% dietary calcium. Use in such low calcium
feeds may result in violative residues.
Withdraw 24 hours before slaughter.
Feed for 5 days as the sole ration.
Treat at first clinical signs of the disease. Do not feed to laying chickens.
Do not feed to chickens over 16
weeks of age. Do not use in feed
containing less than 0.55% dietary
calcium. Use in such low calcium
feeds may result in violative residues.
Withdraw 72 hours before slaughter.
See § 558.355(d) of this chapter. Oxytetracycline as provided by No.
066104; monensin as provided by
No. 058198 in § 510.600(c) of this
chapter.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00102
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
066104
069254
066104
066104
069254
066104
066104
069254
066104
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Oxytetracycline
amount
(vii) 500 g/ton .........
Combination in
grams/ton
Salinomycin, 40 to
60.
Indications for use
Limitations
Chickens: For the prevention of coccidiosis caused by Eimeria necatrix, E.
tenella, E. acervulina, E. brunetti, E.
mivati, and E. maxima; and as an aid
in the reduction of mortality due to
air-sacculitis
(air
sac
infection)
caused by E. coli sensitive to oxytetracycline.
Feed for 5 days as the sole ration.
Treat at first clinical signs of the disease. Do not feed to laying chickens.
Do not use in feed containing less
than 0.55% dietary calcium. Use in
such low calcium feeds may result in
violative residues. Withdraw 24 hours
before slaughter. Oxytetracycline as
provided by No. 066104; salinomycin
as provided by No. 016592 in
§ 510.600(c) of this chapter.
95011
Sponsor
066104
016592
(2) Turkeys—
Oxytetracycline
amount
Indications for use
Limitations
(i) 100 g/ton ............
Turkeys: For control of hexamitiasis caused by
Hexamita meleagridis susceptible to oxytetracycline.
Turkeys: For control of infectious synovitis caused
by M. synoviae susceptible to oxytetracycline.
Feed continuously for 7 to 14 days. Do not feed to
turkeys producing eggs for human consumption.
Zero-day withdrawal period.
Feed continuously for 7 to 14 days. Do not feed to
turkeys producing eggs for human consumption.
For No. 066104, withdraw 5 days before slaughter. For No. 069254, zero-day withdrawal period.
Feed continuously for 7 to 14 days. Do not feed to
turkeys producing eggs for human consumption.
For No. 066104, withdraw 5 days before slaughter. For No. 069254, zero-day withdrawal period.
(ii) 200 g/ton ...........
(iii) 25 mg/lb of body
weight daily.
Turkeys: For control of complicating bacterial organisms associated with bluecomb (transmissible
enteritis; coronaviral enteritis) susceptible to oxytetracycline.
Sponsor
066104
069254
066104
069254
066104
069254
(3) Swine—
Oxytetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
(i) 10 mg/lb of body
weight daily.
................................
1. Swine: For treatment of bacterial enteritis caused by Escherichia coli and
Salmonella choleraesuis susceptible
to oxytetracycline and treatment of
bacterial pneumonia caused by
Pasteurella multocida susceptible to
oxytetracycline.
2. Breeding swine: For control and
treatment of leptospirosis (reducing
the incidence of abortion and shedding of leptospirae) caused by
Leptospira pomona susceptible to oxytetracycline.
Swine: For treatment of bacterial enteritis caused by E. coli and Salmonella
choleraesuis susceptible to oxytetracycline and treatment of bacterial
pneumonia caused by Pasteurella
multocida susceptible to oxytetracycline; and for increased rate of
weight gain and improved feed efficiency.
Feed continuously for 7 to 14 days .......
066104
069254
Feed continuously for 14 days ..............
066104
069254
Feed continuously as the sole ration for
7 to 14 days. Not for use in pregnant
swine or swine intended for breeding
purposes. Do not mix in feeds containing bentonite. Do not feed to
swine within 42 days of slaughter.
Oxytetracycline and carbadox as provided by No. 066104 in § 510.600(c)
of this chapter.
066104
(ii) 10 mg/lb of body
weight daily.
Carbadox, 10 to 25
asabaliauskas on DSK3SPTVN1PROD with RULES
(4) Cattle—
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00103
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
95012
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Oxytetracycline
amount
Combination in
grams/ton
Indications for use
Limitations
(i) 10 mg/lb of body
weight daily.
................................
1. Calves and beef and nonlactating
dairy cattle: For treatment of bacterial
enteritis caused by Escherichia coli
and bacterial pneumonia (shipping
fever complex) caused by Pasteurella
multocida susceptible to oxytetracycline.
2. Calves: For treatment of bacterial enteritis caused by E. coli susceptible to
oxytetracycline.
Feed continuously for 7 to 14 days. For
No. 069254, withdraw 5 days before
slaughter. For No. 066104, zero-day
withdrawal period.
066104
069254
Feed continuously for 7 to 14 days in
milk replacer or starter feed. This
product is not approved for use in female dairy cattle 20 months of age or
older, including dry dairy cows. Use
in these cattle may cause drug residues in milk and/or in calves born to
these cows. For No. 069254, withdraw 5 days before slaughter. For
No. 066104, zero-day withdrawal period.
Feed continuously ..................................
066104
069254
(ii) 75 mg/head/day
................................
(iii) 0.5 to 2.0 g/
head/day.
................................
Growing cattle (over 400 lb): For reduction of incidence of liver abscesses.
Cattle: For prevention and treatment of
the early stages of shipping fever
complex.
Feed 3 to 5 days before and after arrival in feedlots.
Sponsor
066104
069254
066104
069254
(5) Minor species—
Oxytetracycline amount
(i) 10 mg/lb of body
weight daily.
(ii) 200 mg/colony ..........
(iii) 250 mg/kilogram of
fish/day (11.35 g/100
lb of fish/day).
(iv) 2.5 to 3.75 g/100 lb
of fish/day.
(v) 3.75 g/100 lb of fish/
day.
Indications for use
Limitations
Sheep: For treatment of bacterial enteritis
caused by E. coli and bacterial pneumonia
caused by P. multocida susceptible to oxytetracycline.
Honey bees: For control of American foulbrood
caused by Paenibacillus larvae and European
foulbrood caused by Streptococcus pluton susceptible to oxytetracycline.
Pacific salmon: For marking of skeletal tissue ....
Feed continuously for 7 to 14 days; withdraw 5
days before slaughter.
066104
069254
Remove at least 6 weeks prior to main honey
flow.
066104
069254
For salmon not over 30 g body weight; administer as sole ration for 4 consecutive days; fish
not to be liberated for at least 7 days following
the last administration of medicated feed.
Administer in mixed ration for 10 days; do not
liberate fish or slaughter fish for food for 21
days following the last administration of medicated feed.
066104
1. Salmonids: For control of ulcer disease
caused by Haemophilus piscium, furunculosis
caused by Aeromonas salmonicida, bacterial
hemorrhagic septicemia caused by A.
liquefaciens, and pseudomonas disease.
2. Catfish: For control of bacterial hemorrhagic
septicemia caused by A. liquefaciens and
pseudomonas disease.
1. Freshwater-reared salmonids: For control of
mortality due to coldwater disease associated
with Flavobacterium psychrophilum.
2. Freshwater-reared Oncorhynchus mykiss: For
control of mortality due to columnaris disease
associated with Flavobacterium columnare.
asabaliauskas on DSK3SPTVN1PROD with RULES
(vi) 1 g/lb of medicated
feed.
Lobsters: For control of gaffkemia caused by
Aerococcus viridans.
28. In § 558.455, revise paragraph (d);
remove and reserve paragraphs (e)(1)(i),
(e)(2)(i), (e)(3)(i), (e)(4)(i), (e)(4)(ii), and
(e)(4)(iv); and in paragraph (e)(4)(v),
remove ‘‘increased rate of weight gain;
■
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
Administer in mixed ration for 10 days; do not
liberate fish or slaughter fish for food for 21
days following the last administration of medicated feed; do not administer when water temperature is below 16.7 °C (62 °F).
Administer in mixed ration for 10 days; do not
liberate fish or slaughter fish for food for 21
days following the last administration of medicated feed.
Administer in mixed ration for 10 days; do not
liberate fish or slaughter fish for food for 21
days following the last administration of medicated feed.
Administer as sole ration for 5 consecutive days;
withdraw medicated feed 30 days before harvesting lobsters.
improved feed efficiency, and’’ to read
as follows:
§ 558.455
Oxytetracycline and neomycin.
*
*
*
*
*
(d) Special considerations—(1)
Federal law restricts medicated feed
PO 00000
Frm 00104
Fmt 4700
Sfmt 4700
Sponsor
066104
066104
066104
066104
066104
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
oxytetracycline and neomycin
E:\FR\FM\27DER1.SGM
27DER1
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
medicated feeds must not exceed 6
months from the date of issuance. VFDs
for oxytetracycline and neomycin shall
not be refilled.
(3) Cattle feeds shall bear the
following warning statement: ‘‘Use of
more than one product containing
neomycin or failure to follow
withdrawal times may result in illegal
drug residues.’’
*
*
*
*
*
§ 558.460
(e) Robenidine may also be used in
combination with:
(1) Chlortetracycline as in § 558.128.
(2) Lincomycin as in § 558.325.
(3) Oxytetracycline as in § 558.450.
■ 33. In § 558.550, remove and reserve
paragraphs (d)(1)(x), (d)(1)(xi),
(d)(1)(xiii), and (d)(1)(xvi); and revise
paragraph (d)(4) to read as follows:
§ 558.550
[Removed]
29. Remove § 558.460.
■ 30. In § 558.485, remove paragraphs
(e)(1)(v) through (xii); and add
paragraph (e)(3) to read as follows:
■
§ 558.485
Pyrantel.
*
*
*
*
*
(e) * * *
(3) Pyrantel may also be used in
combination with:
(i) Lincomycin as in § 558.325.
(ii) Tylosin as in § 558.325.
■ 31. In § 558.500, remove and reserve
paragraphs (e)(1)(ii), (iii), and (iv),
(e)(2)(iv), (e)(2)(ix) and (x); remove
paragraph (e)(2)(xiii); and add paragraph
(e)(4) to read as follows:
§ 558.500
Ractopamine.
*
*
*
*
*
(e) * * *
(4) Ractopamine may also be used in
combination with tylosin in as in
§ 558.625.
■ 32. In § 558.515, in the table in
paragraph (d), remove the row entries
for ‘‘Chlortetracycline 100 to 200’’,
‘‘Chlortetracycline 200 to 400’’,
‘‘Chlortetracycline 500’’, ‘‘Lincomycin
2’’, and ‘‘Oxytetracycline 400’’ in the
‘‘Combination in grams/ton’’ column;
and add paragraph (e) to read as follows:
§ 558.515
*
*
Robenidine.
*
*
Sulfamerazine
grams/ton
(1) To deliver 10
grams of sulfamerazine per 100
pounds of fish per
day.
*
Salinomycin.
*
*
*
*
*
(d) * * *
(5) Salinomycin may also be used in
combination with:
(i) [Reserved]
(ii) [Reserved]
(iii) Chlortetracycline as in § 558.128.
(iv) Lincomycin as in § 558.325.
(v) Oxytetracycline as in § 558.450.
(vi) Virginiamycin as in § 558.635.
■ 34. In § 558.555, remove paragraphs
(d)(3) through (5); (e)(3) and (e)(4);
remove and reserve paragraph (e)(2);
and add paragraph (f) to read as follows:
§ 558.555
95013
(1) No. 054771 for use of the product
described in paragraph (a)(1) as in
paragraphs (e)(1), (e)(2), (e)(3), (e)(4),
and (e)(7) of this section.
(2) No. 015331 for use of the product
described in paragraph (a)(2) as in
paragraphs (e)(5) and (e)(6) of this
section.
*
*
*
*
*
(d) Special considerations.—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
sulfadimethoxine and ormetoprim
medicated feeds must not exceed 6
months from the date of issuance. VFDs
for sulfadimethoxine and ormetoprim
shall not be refilled.
*
*
*
*
*
■ 36. Revise § 558.582 to read as
follows:
Semduramycin.
*
*
*
*
*
(f) Semduramycin may also be used in
combination with virginiamycin as in
§ 558.635.
■ 35. In § 558.575, revise the section
heading; redesignate paragraphs (b), (c),
and (d) as paragraphs (c), (d), and (e);
revise paragraph (a); and add new
paragraphs (b) and (d) to read as
follows:
§ 558.575 Sulfadimethoxine and
ormetoprim.
(a) Specifications. Type A medicated
articles containing either:
(1) 25 percent sulfadimethoxine and
15 percent ormetoprim; or
(2) 25 percent sulfadimethoxine and 5
percent ormetoprim.
(b) Sponsors. See sponsors in
§ 510.600(c) of this chapter for use as in
paragraph (d) of this section:
§ 558.582
Sulfamerazine.
(a) Specifications. Type A medicated
articles containing 99 percent
sulfamerazine.
(b) Sponsor. See No. 054771 in
§ 510.600(c) of this chapter.
(c) Related tolerances. See § 556.660
of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
sulfamerazine medicated feeds must not
exceed 6 months from the date of
issuance. VFDs for sulfamerazine shall
not be refilled.
(e) Conditions of use. It is used in fish
feed for as follows:
Combination in
grams/ton
Indications for use
Limitations
................................
Rainbow trout, brook trout, and brown
trout: For control of furunculosis.
Formulate to deliver 10 grams of sulfamerazine per 100 pounds of fish per
day. Treat for not more than 14
days. Do not treat within 3 weeks of
marketing or stocking in stream open
to fishing.
Sponsor
054771
asabaliauskas on DSK3SPTVN1PROD with RULES
(2) [Reserved].
37. Revise § 558.586 to read as
follows:
■
§ 558.586
Sulfaquinoxaline.
(a) Specifications. Type A medicated
articles containing 40 percent
sulfaquinoxaline.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
(b) Sponsor. See No. 016592 in
§ 510.600(c) of this chapter.
(c) Related tolerances. See § 556.685
of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
PO 00000
Frm 00105
Fmt 4700
Sfmt 4700
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
sulfaquinoxaline medicated feeds must
not exceed 6 months from the date of
issuance. VFDs for sulfaquinoxaline
shall not be refilled.
(e) Conditions of use—(1) Chickens—
E:\FR\FM\27DER1.SGM
27DER1
95014
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Sulfaquinoxaline
in grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 0.015 percent .....
................................
As an aid in preventing outbreaks of
coccidiosis caused by Eimeria tenella,
E. necatrix, E. acervulina, E. maxima,
and E. brunetti under average conditions of exposure.
(ii) 0.0175 percent ..
................................
As an aid in preventing outbreaks of
coccidiosis caused by Eimeria tenella,
E. necatrix, E. acervulina, E. maxima,
and E. brunetti where excessive exposure to coccidia is increased due to
overcrowding or other management
factors.
(iii) 0.1 to 0.05 percent.
................................
As an aid in controlling outbreaks of
coccidiosis caused by Eimeria tenella,
E. necatrix, E. acervulina, E. maxima,
and E. brunetti.
(iv) 0.05 or 0.1 percent.
................................
As an aid in the control of acute fowl
cholera
caused
by
Pasteurella
multocida
susceptible
to
sulfaquinoxaline and fowl typhoid
caused by Salmonella gallinarum susceptible to sulfaquinoxaline.
Feed continuously from the time birds
are placed on litter and continue past
the age when coccidiosis is ordinarily
a hazard. If death losses exceed 0.5
percent in a 2-day period, obtain a
laboratory diagnosis. If coccidiosis is
the cause, use the sulfaquinoxaline
levels recommended for control of
outbreaks, returning to the original
dosage schedule after the outbreak
has subsided. Losses may result from
intercurrent disease, other conditions
affecting drug intake, or variant
strains of coccidia species which can
contribute to the virulence of coccidiosis under field conditions. Do not
treat chickens within 10 days of
slaughter. Do not medicate chickens
producing eggs for human consumption.
Feed continuously from the time birds
are placed on litter and continue past
the age when coccidiosis is ordinarily
a hazard. If death losses exceed 0.5
percent in a 2-day period, obtain a
laboratory diagnosis. If coccidiosis is
the cause, use the sulfaquinoxaline
levels recommended for control of
outbreaks, returning to the original
dosage schedule after the outbreak
has subsided. Losses may result from
intercurrent disease, other conditions
affecting drug intake, or variant
strains of coccidia species which can
contribute to the virulence of coccidiosis under field conditions. Do not
treat chickens within 10 days of
slaughter. Do not medicate chickens
producing eggs for human consumption.
Feed at 0.1 percent level for first 48 to
72 hours. Skip 3 days; 0.05 percent
for 2 days, skip 3 days; 0.05 percent
for 2 days. If bloody droppings recur,
give 0.05 percent for another 2 days.
Do not treat chickens within 10 days
of slaughter. Do not medicate chickens producing eggs for human consumption.
Feed 0.1 percent for 48 to 72 hours.
Mortality should be brought under
control. After medication, move birds
to clean ground or to a clean house.
If disease recurs, use 0.05 percent in
feed again for 2 days. Do not treat
chickens or turkeys within 10 days of
slaughter for food. Do not medicate
chickens or turkeys producing eggs
for human consumption.
asabaliauskas on DSK3SPTVN1PROD with RULES
(2) Turkeys—
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00106
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsor
016592
016592
016592
016592
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Sulfaquinoxaline
in grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 0.0175 percent ...
................................
As an aid in preventing outbreaks of
coccidiosis
caused
by
Eimeria
meleagrimitis and E. adenoeides.
(ii) 0.05 percent ......
................................
As an aid in controlling outbreaks of
coccidiosis
caused
by
Eimeria
meleagrimitis and E. adenoeides.
(iii) 0.05 or 0.1 percent.
................................
As an aid in the control of acute fowl
cholera
caused
by
Pasteurella
multocida
susceptible
to
sulfaquinoxaline and fowl typhoid
caused by Salmonella gallinarum susceptible to sulfaquinoxaline.
Feed continuously during time birds are
closely confined. May be continued
for a week to 10 days after flock is
transferred to range to reduce danger
of an outbreak following moving of
the flock. Do not treat turkeys within
10 days of slaughter. Do not medicate turkeys producing eggs for
human consumption.
Feed for 2 days. Follow with 3 days on
regular feed and 2 more days on 0.05
percent sulfaquinoxaline feed. Again
follow with 3 days on regular feed
and 2 more days on 0.05 percent
sulfaquinoxaline feed. Continue this
schedule if necessary until all signs of
the outbreaks have subsided. Do not
treat turkeys within 10 days of
slaughter. Do not medicate turkeys
producing eggs for human consumption.
Feed 0.1 percent for 48 to 72 hours.
Mortality should be brought under
control. After medication, move birds
to clean ground or to a clean house.
If disease recurs, use 0.05 percent in
feed again for 2 days. Do not treat
chickens or turkeys within 10 days of
slaughter for food. Do not medicate
chickens or turkeys producing eggs
for human consumption.
Sulfaquinoxaline
in grams/ton
Combination in
grams/ton
Indications for use
(i) 0.025 percent .....
................................
As an aid in preventing coccidiosis
caused by Eimeria stiedae.
(ii) 0.1 percent ........
................................
95015
Sponsor
016592
016592
016592
(3) Rabbits—
Treatment to be started after weaning.
Feed continuously for 30 days or feed
medicated feed for 2 days out of
every week until marketing. Do not
treat within 10 days of slaughter.
As an aid in controlling outbreaks of Feed for 2 weeks. Do not treat within
coccidiosis caused by Eimeria stiedae.
10 days of slaughter.
38. In § 558.612, remove paragraphs
(e)(1)(i) and (e)(1)(iii); redesignate
paragraphs (e)(1)(ii) and (e)(1)(iv) as
new paragraphs (e)(1)(i) and (ii); and
add paragraph (e)(2) to read as follows:
■
§ 558.612
Tiamulin.
asabaliauskas on DSK3SPTVN1PROD with RULES
*
*
*
*
*
(e) * * *
(2) Tiamulin may also be used in
combination with chlortetracycline as in
§ 558.128.
■ 39. Amend § 558.625 as follows:
■ a. Remove paragraph (d);
■ b. Redesignate paragraphs (c), (e), and
(f) as paragraphs (d), (c) and (e); and
■ c. Revise paragraph (b) and
redesignated paragraphs (d) and (e).
The revisions read as follows:
§ 558.625
*
*
Tylosin.
*
VerDate Sep<11>2014
*
*
19:06 Dec 23, 2016
Jkt 241001
Limitations
(b) Sponsors. See sponsor numbers in
§ 510.600(c) of this chapter.
(1) No. 016592: Type medicated
article containing 100 grams per pound.
(2) No. 054771: Type medicated
article containing 40 grams per pound.
(3) No. 058198: Type medicated
article containing 10, 40, or 100 grams
per pound.
(4) No. 066104: Type medicated
article containing 20 or 40 grams per
pound.
(c) Related tolerances. See § 556.360
of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
oxytetracycline medicated feeds must
PO 00000
Frm 00107
Fmt 4700
Sfmt 4700
Sponsor
016592
016592
not exceed 6 months from the date of
issuance. VFDs for oxytetracycline shall
not be refilled.
(3) Type C medicated feeds for cattle
may be manufactured from tylosin
liquid Type B medicated feeds which
have a pH between 4.5 and 6.0 and
which bear appropriate mixing
directions as follows:
(i) For liquid feeds stored in
recirculating tank systems: Recirculate
immediately prior to use for not less
than 10 minutes, moving not less than
1 percent of the tank contents per
minute from the bottom of the tank to
the top. Recirculate daily as described
even when not used.
(ii) For liquid feeds stored in
mechanical, air, or other agitation-type
tank systems: Agitate immediately prior
to use for not less than 10 minutes,
creating a turbulence at the bottom of
E:\FR\FM\27DER1.SGM
27DER1
95016
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
the tank that is visible at the top. Agitate
daily as described even when not used.
(e) Conditions of use—(1) Swine—
Combination in
grams/ton
Indications for use
Limitations
(i) 40 or 100 ...........
................................
For control of swine dysentery associated with Brachyspira hyodysenteriae.
(ii) 40 or 100 ..........
Pyrantel, 96 ...........
016592
054771
058198
066104
066104
................................
For control of swine dysentery associated with Brachyspira hyodysenteriae;
and as an aid in the prevention of migration and establishment of large
roundworm (Ascaris suum) infections;
aid in the prevention of establishment
of nodular worm (Oesophagostomum
spp.) infections.
For control of porcine proliferative
enteropathies (ileitis) associated with
Lawsonia intracellularis.
Feed as the sole ration 100 g of tylosin
per ton of complete feed for at least 3
weeks. Follow with 40 grams per ton
of complete feed until market weight.
Feed as the sole ration 100 g of tylosin
per ton of complete feed for at least 3
weeks. Follow with 40 grams per ton
of complete feed until market weight.
Tylosin phosphate and pyrantel as
provided
by
No.
066104
in
§ 510.600(c) of this chapter.
(iii) 40 or 100 ..........
(iv) 40 or 100 .........
Pyrantel, 96 ...........
Feed as the sole ration 100 g of tylosin
per ton of complete feed for at least 3
weeks. Follow with 40 grams per ton
of complete feed until market weight.
Feed as the sole ration 100 g of tylosin
per ton of complete feed for at least 3
weeks. Follow with 40 grams per ton
of complete feed until market weight.
Tylosin phosphate and pyrantel as
provided
by
No.
066104
in
§ 510.600(c) of this chapter.
016592
054771
058198
066104
066104
(v) 40 or 100 ..........
Ractopamine, 4.5 to
9.0.
Feed continuously as the sole ration to
finishing swine weighing not less than
150 lbs for the last 45 to 90 lbs
(group average) of weight gain prior
to slaughter. Include 100 g/ton of
tylosin for at least 3 weeks, followed
by 40 g/ton until market weight.
Tylosin phosphate as provided by
Nos.
058198
and
016592;
ractopamine as provided by Nos.
058198 and 054771 in § 510.600(c)
of this chapter.
016592
054771
058198
(vi) 40 to 100 ..........
................................
Pyrantel, 96 ...........
Administer as tylosin phosphate in feed
continuously as the sole ration for 2
to 6 weeks, immediately after treatment with tylosin tartrate in drinking
water for 3 to 10 days as in
§ 520.2640(d)(3) of this chapter.
Administer as tylosin phosphate in feed
continuously as the sole ration for 2
to 6 weeks, immediately after treatment with tylosin tartrate in drinking
water for 3 to 10 days as in
§ 520.2640(d)(3) of this chapter.
Tylosin phosphate and pyrantel as
provided
by
No.
066104
in
§ 510.600(c) of this chapter.
016592
054771
058198
066104
(vii) 40 to 100 .........
(viii) 40 to 100 ........
asabaliauskas on DSK3SPTVN1PROD with RULES
Tylosin
grams/ton
................................
Administer as tylosin phosphate in feed
continuously as the sole ration for 2
to 6 weeks, immediately after treatment with tylosin tartrate in drinking
water for 3 to 10 days as in
§ 520.2640(d)(3) of this chapter.
016592
054771
058198
066104
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
For control of porcine proliferative
enteropathies (ileitis) associated with
Lawsonia intracellularis; and as an
aid in the prevention of migration and
establishment of large roundworm
(Ascaris suum) infections; aid in the
prevention of establishment of nodular worm (Oesophagostomum spp.)
infections.
Finishing swine: For the control of
swine dysentery associated with
Brachyspira hyodysenteriae; for control
of
porcine
proliferative
enteropathies (ileitis) associated with
Lawsonia intracellularis; and for increased rate of weight gain, improved
feed efficiency, and increased carcass leanness in finishing swine
weighing not less than 150 lbs, fed a
complete ration containing at least
16% crude protein for the last 45 to
90 lbs of gain prior to slaughter.
For the treatment and control of swine
dysentery
associated
with
Brachyspira hyodysenteriae immediately after medicating with tylosin in
drinking water.
For the treatment and control of swine
dysentery
associated
with
Brachyspira hyodysenteriae immediately after medicating with tylosin in
drinking water; and as an aid in the
prevention of migration and establishment of large roundworm (Ascaris
suum) infections; aid in the prevention of establishment of nodular worm
(Oesophagostomum spp.) infections.
For the control of porcine proliferative
enteropathies (PPE, ileitis) associated
with Lawsonia intracellularis immediately after medicating with tylosin in
drinking water.
PO 00000
Frm 00108
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsors
066104
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
95017
Tylosin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(ix) 40 to 100 ..........
Pyrantel, 96 ...........
Administer as tylosin phosphate in feed
continuously as the sole ration for 2
to 6 weeks, immediately after treatment with tylosin tartrate in drinking
water for 3 to 10 days as in
§ 520.2640(d)(3) of this chapter.
Tylosin phosphate and pyrantel as
provided
by
No.
066104
in
§ 510.600(c) of this chapter.
066104
(x) 40 to 100 ..........
Ractopamine, 4.5 to
9.0.
For the control of porcine proliferative
enteropathies (PPE, ileitis) associated
with Lawsonia intracellularis immediately after medicating with tylosin in
drinking water; and as an aid in the
prevention of migration and establishment of large roundworm (Ascaris
suum) infections; aid in the prevention of establishment of nodular worm
(Oesophagostomum spp.) infections.
Finishing swine: For the treatment and
control of swine dysentery associated
with Brachyspira hyodysenteriae, for
control
of
porcine
proliferative
enteropathies (PPE, ileitis) associated
with Lawsonia intracellularis; and for
increased rate of weight gain, improved feed efficiency, and increased
carcass leanness in finishing swine
weighing not less than 150 lbs, fed a
complete ration containing at least
16% crude protein for the last 45 to
90 lbs of gain prior to slaughter.
016592
054771
058198
(xi) 100 ...................
................................
For reduction in severity of effects of
atrophic rhinitis.
Feed continuously as the sole ration to
finishing swine weighing not less than
150 lbs for the last 45 to 90 lbs
(group average) of weight gain prior
to slaughter. Include 40 to 100 grams
of tylosin phosphate per ton of complete feed for 2 to 6 weeks, immediately after treatment with tylosin tartrate in drinking water for 3 to 10
days as in § 520.2640(d)(3) of this
chapter. Tylosin phosphate as provided by Nos. 058198 and 016592;
ractopamine as provided by Nos.
058198 and 054771 in § 510.600(c)
of this chapter.
Feed continuously as the sole ration .....
(xii) 100 ..................
Pyrantel, 96 ...........
(xiii) 100 .................
Ractopamine, 4.5 to
9.0.
For reduction in severity of effects of
atrophic rhinitis; aid as an aid in the
prevention of migration and establishment of large roundworm (Ascaris
suum) infections; aid in the prevention of establishment of nodular worm
(Oesophagostomum spp.) infections.
For the control of porcine proliferative
enteropathies (PPE, ileitis) associated
with Lawsonia intracellularis; and for
increased rate of weight gain, improved feed efficiency, and increased
carcass leanness in finishing swine
weighing not less than 150 lbs, fed a
complete ration containing at least
16% crude protein for the last 45 to
90 lbs of gain prior to slaughter.
Feed continuously as the sole ration.
Tylosin phosphate and pyrantel as
provided
by
No.
066104
in
§ 510.600(c) of this chapter. Tylosin
phosphate and pyrantel as provided
by No. 066104 in § 510.600(c) of this
chapter.
Feed continuously as the sole ration to
finishing swine weighing not less than
150 lbs for the last 45 to 90 lbs
(group average) of weight gain prior
to slaughter. Include 100 g/ton of
tylosin for 3 weeks. Tylosin phosphate as provided by Nos. 058198
and 016592; ractopamine as provided
by Nos. 058198 and 054771 in
§ 510.600(c) of this chapter.
Sponsors
016592
054771
058198
066104
066104
016592
054771
058198
(2) Cattle—
Combination in
grams/ton
Indications for use
Limitations
(i) 8 to 10 ...............
asabaliauskas on DSK3SPTVN1PROD with RULES
Tylosin
grams/ton
................................
Beef cattle: For reduction of incidence
of liver abscesses caused by
Fusobacterium necrophorum and
Arcanobacterium
(Actinomyces)
pyogenes.
Feed continuously as the sole ration to
provide 60 to 90 mg/head/day tylosin.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00109
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsors
016592,
054771,
058198,
066104
95018
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Tylosin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
Feed continuously as sole ration. Feed
to heifers at the rate of 0.5 to 2.0
pound(s) per head per day (specify
one level) to provide 0.25 to 0.5 mg
melengestrol acetate per head per
day (specify one level), 100 to 360
mg lasalocid per head per day (specify one level), and 90 mg tylosin per
head per day. This Type C product
may be top dressed onto or mixed
into a complete feed prior to feeding.
Tylosin as provided by Nos. 058198
and 016592; lasalocid as provided by
No. 054771; melengestrol as provided by Nos. 054771 and 058198 in
§ 510.600(c) of this chapter.
Feed continuously as sole ration. Each
pound contains 0.125 to 1.0 mg
melengestrol acetate and 45 to 180
mg of tylosin. Feed to heifers at a
rate of 0.5 to 2.0 pounds per head
per day to provide 0.25 to 0.5 mg
melengestrol acetate and 60 to 90
mg tylosin per head per day. Prior to
feeding, this Type C product must be
top-dressed onto a complete feed or
mixed into the amount of complete
feed consumed by an animal per day.
Tylosin provided by No. 058198;
melengestrol provided by No. 054771
in § 510.600(c) of this chapter.
Feed continuously as sole ration to provide 50 to 480 monensin mg/head/
day and 60 to 90 mg/head/day
tylosin. A withdrawal time has not
been established for pre-ruminating
calves. Do not use in calves to be
processed for veal. Tylosin provided
by Nos. 016592 or 058198; monensin
as provided by No. 058198 in
§ 510.600(c) of this chapter.
Feed continuously as sole ration to provide 0.14 to 0.42 mg monensin/lb
body weight per day, depending on
the severity of the coccidiosis challenge, up to 480 mg/head/day and 60
to 90 mg/head/day tylosin. A withdrawal time has not been established
for pre-ruminating calves. Do not use
in calves to be processed for veal.
Tylosin provided by Nos. 016592 or
058198; monensin as provided by
No. 058198 in § 510.600(c) of this
chapter.
Feed continuously as the sole ration to
provide 22.7 mg of decoquinate per
100 lb body weight per day, 50 to
360 mg of monensin/head/day, and
60 to 90 mg of tylosin/head/day. Feed
at least 28 days during period of exposure to coccidiosis or when it is
likely to be a hazard. Do not feed to
animals producing milk for food. Do
not feed to lactating dairy cattle. A
withdrawal time has not been established for pre-ruminating calves. Do
not use in calves to be processed for
veal. Tylosin as provided by Nos.
016592 and 058198; monensin as
provided by No. 058198; decoquinate
as provided by No. 058198 in
§ 510.600(c) of this chapter.
Lasalocid, 100 to
1440 plus
melengestrol,
0.25 to 2.0.
Heifers fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
pyogenes; and for increased rate of
weight gain, improved feed efficiency,
and suppression of estrus (heat).
(iii) 90 to 360 ..........
Melengestrol, 0.25
to 2.0.
Heifers fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
pyogenes; and for increased rate of
weight gain, improved feed efficiency,
and suppression of estrus (heat).
(iv) 8 to 10 ..............
Monensin, 5 to 40 ..
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
(Actinomyces) pyogenes; and for improved feed efficiency.
(v) 8 to 10 ..............
Monensin, 10 to 40
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
(Actinomyces) pyogenes; and for prevention of coccidiosis caused by
Eimeria bovis and E zuernii.
(vi) 8 to 10 ..............
asabaliauskas on DSK3SPTVN1PROD with RULES
(ii) 90 to 360 ...........
Monensin, 5 to 30
plus decoquinate,
13.6 to 22.7.
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
pyogenes; for the prevention of coccidiosis caused by Eimeria bovis and
E. zuernii; and for improved feed efficiency.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00110
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsors
054771
016592
054771
016592
058198
016592
058198
016592
054771
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Combination in
grams/ton
Indications for use
Limitations
(vii) 8 to 10 .............
Monensin, 10 to 40
plus
melengestrol,
0.25 to 2.0.
Heifers fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
(Actinomyces) pyogenes; for prevention and control of coccidiosis caused
by Eimeria bovis and E zuernii; and
for increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
(viii) 8 to 10 ............
Monensin, 10 to 40
plus ractopamine,
8.2 to 24.6.
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
pyogenes; for prevention and control
of coccidiosis caused by Eimeria
bovis and E zuernii; and for increased
rate of weight gain and improved feed
efficiency in cattle fed in confinement
for slaughter for the last 28 to 42
days on feed.
(ix) 8 to 10 ..............
asabaliauskas on DSK3SPTVN1PROD with RULES
Tylosin
grams/ton
Monensin, 10 to 40
plus ractopamine,
not to exceed
800.
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
pyogenes; for prevention and control
of coccidiosis caused by Eimeria
bovis and E zuernii; and for increased
rate of weight gain and improved feed
efficiency in cattle fed in confinement
for slaughter for the last 28 to 42
days on feed.
Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per
head per day to provide 0.25 to 0.5
mg/head/day melengestrol acetate
and 0.14 to 0.42 mg monensin/lb
body weight per day, depending on
the severity of the coccidiosis challenge, up to 480 mg/head/day and 60
to 90 mg/head/day tylosin. The
melengestrol acetate portion of this
Type C medicated feed must be
mixed into the complete feed containing 10 to 40 g/ton monensin and
8 to 10 g/ton tylosin at feeding into
the amount of complete feed consumed by an animal per day. A withdrawal time has not been established
for pre-ruminating calves. Do not use
in calves to be processed for veal.
Tylosin provided by Nos. 016592 or
058198; monensin as provided by
No. 058198; melengestrol provided
by Nos. 054771 or 058198 in
§ 510.600(c) of this chapter.
Feed continuously as sole ration to provide 70 to 430 mg/head/day
ractopamine and 0.14 to 0.42 mg
monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/
head/day and 60 to 90 mg/head/day
tylosin for the last 28 to 42 days on
feed. A withdrawal time has not been
established for pre-ruminating calves.
Do not use in calves to be processed
for veal. Tylosin provided by Nos.
016592 or 058198; monensin as provided by No. 058198; ractopamine
provided by Nos. 054771 or 058198
in § 510.600(c) of this chapter.
Feed a minimum of 1.0 lb/head/day
ractopamine Type C top dress feed
continuously to cattle fed in confinement for slaughter, to provide 70 to
400 mg/head/day ractopamine for the
last 28 to 42 days on feed. Feed on
top of a ration containing 10 to 40 g/
ton monensin and 8 to 10 g/ton
tylosin phosphate, to provide 0.14 to
0.42 mg monensin/lb body weight/
day, depending on the severity of the
coccidiosis challenge, up to 480 mg/
head/day and 60 to 90 mg/head/day
tylosin. A withdrawal time has not
been established for pre-ruminating
calves. Do not use in calves to be
processed for veal. Tylosin provided
by Nos. 016592 or 058198; monensin
as provided by No. 058198;
ractopamine
provided
by
Nos.
054771 or 058198 in § 510.600(c) of
this chapter.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00111
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
95019
Sponsors
016592
054771
058198
054771
058198
054771
058198
95020
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Combination in
grams/ton
Indications for use
Limitations
(x) 8 to 10 ..............
Monensin 10 to 40
plus ractopamine
9.8 to 24.6.
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
pyogenes; for prevention and control
of coccidiosis caused by Eimeria
bovis and E zuernii; and for increased
rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for
slaughter for the last 28 to 42 days
on feed.
(xi) 8 to 10 ..............
Monensin, 10 to 40
plus ractopamine,
9.8 to 24.6 plus
melengestrol,
0.125 to 1 mg/lb.
Heifers fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
(Actinomyces) pyogenes; for prevention and control of coccidiosis caused
by Eimeria bovis and E zuernii; for increased rate of weight gain, improved
feed efficiency, and increased carcass leanness; and suppression of
estrus (heat).
(xii) 8 to 10 .............
Monensin, 10 to 40
plus zilpaterol,
6.8.
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
pyogenes; for prevention and control
of coccidiosis caused by Eimeria
bovis and E zuernii; and for increased
rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for
slaughter for the last 20 to 40 days
on feed.
(xiii) 8 to 10 ............
asabaliauskas on DSK3SPTVN1PROD with RULES
Tylosin
grams/ton
Monensin, 10 to 40
plus zilpaterol,
6.8 to 24.
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
pyogenes; for prevention and control
of coccidiosis caused by Eimeria
bovis and E zuernii; and for increased
rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for
slaughter for the last 20 to 40 days
on feed.
Feed continuously as sole ration to provide 90 to 430 mg/head/day
ractopamine and 0.14 to 0.42 mg
monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/
head/day and 60 to 90 mg/head/day
tylosin for the last 28 to 42 days on
feed. A withdrawal time has not been
established for pre-ruminating calves.
Do not use in calves to be processed
for veal. Tylosin provided by Nos.
016592 or 058198; monensin as provided by No. 058198; ractopamine as
provided by Nos. 054771 or 058198
in § 510.600(c) of this chapter.
Feed continuously as sole ration to provide 90 to 430 mg/head/day
ractopamine and 0.14 to 0.42 mg
monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/
head/day and 60 to 90 mg/head/day
tylosin for the last 28 to 42 days on
feed. Feed melengestrol as a top
dress or mixed with a complete ration
at the rate of 0.5 to 2.0 pound/head/
day (specify one level) to provide
0.25 to 0.5 mg melengestrol acetate/
head/day (specify one level). A withdrawal time has not been established
for pre-ruminating calves. Do not use
in calves to be processed for veal.
Tylosin provided by Nos. 016592 or
058198; monensin as provided by
No. 058198; ractopamine as provided
by Nos. 054771 or 058198 in
§ 510.600(c) of this chapter.
Feed continuously as the sole ration to
cattle during the last 20 to 40 days on
feed to provide 60 to 90 mg/head/day
zilpaterol, 0.14 to 0.42 mg/lb body
weight/day monensin, depending on
the severity of the coccidiosis challenge, up to 480 mg/head/day
monensin, and 60 to 90 mg/head/day
tylosin. Do not use in veal calves.
Withdrawal period 3 days. Tylosin
provided by Nos. 016592 or 058198;
monensin as provided by No.
058198; zilpaterol as provided by No.
000061 in § 510.600(c) of this chapter.
Feed this component feed continuously
to cattle during the last 20 to 40 days
on feed to provide 60 mg/head/day
zilpaterol, 0.14 to 0.42 mg/lb body
weight/day monensin, depending on
the severity of the coccidiosis challenge, up to 480 mg/head/day
monensin, and 60 to 90 mg/head/day
tylosin. Do not use in veal calves.
Withdrawal period 3 days. Tylosin
provided by Nos. 016592 or 058198;
monensin as provided by No.
058198; zilpaterol as provided by No.
000061 in § 510.600(c) of this chapter.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00112
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsors
054771
058198
054771
058198
000061
016592
000061
016592
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Tylosin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(xiv) 8 to 10 ............
Monensin, 10 to 40
plus zilpaterol,
6.8 plus
melengestrol,
0.125 to 1 mg/lb.
Heifers fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
(Actinomyces) pyogenes; for prevention and control of coccidiosis caused
by Eimeria bovis and E zuernii; and
for increased rate of weight gain, improved feed efficiency, and increased
carcass leanness in cattle fed in confinement for slaughter for the last 20
to 40 days on feed; and for suppression of estrus (heat).
(xv) 8 to 10 .............
Monensin, 10 to 40
plus zilpaterol,
6.8 to 24 plus
melengestrol,
0.125 to 1 mg/lb.
Heifers fed in confinement for slaughter:
For reduction of incidence of liver abscesses caused by Fusobacterium
necrophorum and Arcanobacterium
(Actinomyces) pyogenes; for prevention and control of coccidiosis caused
by Eimeria bovis and E zuernii; and
for increased rate of weight gain, improved feed efficiency, and increased
carcass leanness in cattle fed in confinement for slaughter for the last 20
to 40 days on feed; and for suppression of estrus (heat).
Feed continuously as the sole ration to
cattle during the last 20 to 40 days on
feed to provide 60 to 90 mg/head/day
zilpaterol, 0.14 to 0.42 mg/lb body
weight/day monensin, depending on
the severity of the coccidiosis challenge, up to 480 mg/head/day
monensin, and 60 to 90 mg/head/day
tylosin. Feed melengestrol as a top
dress or mixed with a complete ration
at the rate of 0.5 to 2.0 pound/head/
day (specify one level) to provide
0.25 to 0.5 mg melengestrol acetate/
head/day (specify one level). Do not
use in veal calves. Withdrawal period
3 days. Tylosin as provided by Nos.
016592 or 058198; monensin as provided by No. 058198; zilpaterol as
provided
by
No.
000061;
melengestrol provided by Nos.
054771 or 058198 in § 510.600(c) of
this chapter.
Feed this component feed continuously
to cattle during the last 20 to 40 days
on feed to provide 60 mg/head/day
zilpaterol, 0.14 to 0.42 mg/lb body
weight/day monensin, depending on
the severity of the coccidiosis challenge, up to 480 mg/head/day
monensin, and 60 to 90 mg/head/day
tylosin. Feed melengestrol as a top
dress or mixed with a complete ration
at the rate of 0.5 to 2.0 pound/head/
day (specify one level) to provide
0.25 to 0.5 mg melengestrol acetate/
head/day (specify one level). Do not
use in veal calves. Withdrawal period
3 days. Tylosin as provided by Nos.
016592 or 058198; monensin as provided by No. 058198; zilpaterol as
provided
by
No.
000061;
melengestrol provided by Nos.
054771 or 058198 in § 510.600(c) of
this chapter.
40. Revise § 558.630 to read as
follows:
■
§ 558.630
Tylosin and sulfamethazine.
asabaliauskas on DSK3SPTVN1PROD with RULES
(a) Specifications. Type A medicated
articles containing equal amounts of
tylosin phosphate and sulfamethazine,
available in concentrations of 5, 10, 20,
or 40 grams each, per pound.
(b) Sponsors. See sponsor numbers in
§ 510.600(c) of this chapter.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
(1) No. 058198 for use as in paragraph
(e)(1) of this section.
(2) No. 054771: 10 or 40 grams per
pound each for use as in paragraph
(e)(2) of this section.
(c) Related tolerances. See §§ 556.670
and 556.740 of this chapter.
(d) Special considerations—(1)
Federal law restricts medicated feed
containing this veterinary feed directive
(VFD) drug to use by or on the order of
PO 00000
Frm 00113
Fmt 4700
Sfmt 4700
95021
Sponsors
000061
016592
058198
000061
016592
058198
a licensed veterinarian. See § 558.6 for
additional requirements.
(2) The expiration date of VFDs for
tylosin and sulfamethazine medicated
feeds must not exceed 6 months from
the date of issuance. VFDs for tylosin
and sulfamethazine shall not be refilled.
(3) Labeling shall bear the statement:
‘‘Do not use in medicated feeds
containing in excess of 2% bentonite.’’
(e) Conditions of use. It is used in feed
for swine as follows:
E:\FR\FM\27DER1.SGM
27DER1
95022
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Tylosin phosphate
and sulfamethazine
in grams/ton
Combination in
grams/ton
Indications for use
Limitations
(1) 100 each ...........
................................
Withdraw 15 days before swine are
slaughtered.
058198
(2) 100 each ...........
................................
For reduction in the severity of effects
of atrophic rhinitis; lowering the incidence and severity of Bordetella
bronchiseptica rhinitis; prevention of
swine dysentery associated with
Brachyspira hyodysenteriae; control
of swine pneumonias caused by bacterial
pathogens
(Pasteurella
multocida and/or Arcanobacterium
pyogenes); reducing the incidence of
cervical lymphadenitis (jowl abscesses) caused by Group E
Streptococci. Only the sulfamethazine
portion of this combination is active in
controlling jowl abscesses.
For reduction in the severity of effects
of atrophic rhinitis; lowering the incidence and severity of Bordetella
bronchiseptica rhinitis; prevention of
swine dysentery associated with
Brachyspira hyodysenteriae; and control of swine pneumonias caused by
bacterial
pathogens
(Pasteurella
multocida and/or Arcanobacterium
pyogenes).
Withdraw 15 days before swine are
slaughtered.
054771
41. Revise § 558.635 to read as
follows:
■
§ 558.635
Virginiamycin.
(a) Specifications. Type A medicated
articles containing 5, 10, 20, 50, 136.2,
or 227 grams per pound virginiamycin.
(b) Sponsors. See No. 066104 in
§ 510.600(c) of this chapter.
(c) Related tolerances. See § 556.750
of this chapter.
(d) Special considerations—(1)
[Reserved]
(2) [Reserved]
Sponsors
(3) Not for use in breeding swine over
120 pounds.
(4) Dilute Type A article with at least
10 pounds of a feed ingredient prior to
final mixing in 1 ton of Type C feed.
(e) Conditions of use—(1) Chickens—
Combination in
grams/ton
Indications for use
Limitations
(i) 5 .........................
................................
066104
Monensin, 90 to
110.
Salinomycin, 40 to
60.
(iv) 5 .......................
Semduramicin, 22.7
Feed continuously as the sole ration.
Do not feed to laying chickens.
Virginiamycin as provided by No.
066104; monensin as provided by
No. 058198 in § 510.600(c) of this
chapter.
Feed continuously as the sole ration.
Do not feed to layers or to chickens
over 16 weeks of age. Not approved
for use with pellet binders. May be
fatal if accidentally fed to adult turkeys or horses. Virginiamycin as provided by No. 066104; salinomycin as
provided
by
No.
054771
in
§ 510.600(c) of this chapter.
Feed continuously as the sole ration.
Do not feed to laying hens.
Semduramicin as provided by No.
066104 in § 510.600(c) of this chapter.
066104
(iii) 5 .......................
Broiler chickens: For increased rate of
weight gain and improved feed efficiency.
Broiler chickens: For increased rate of
weight gain and improved feed efficiency; as an aid in the prevention of
coccidiosis
caused
by
Eimeria
necatrix, E. tenella, E. acervulina, E.
brunetti, E. maxima, and E. mivati.
Broiler chickens: For increased rate of
weight gain and improved feed efficiency; for prevention of coccidiosis
caused by Eimeria tenella, E.
necatrix, E. acervulina, E. maxima, E.
brunetti, and E. mivati.
Not for use in layers ..............................
(ii) 5 ........................
asabaliauskas on DSK3SPTVN1PROD with RULES
Virginiamycin
grams/ton
(v) 5 ........................
Semduramicin (biomass), 22.7.
(vi) 5 to 15 ..............
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
Broiler chickens: For increased rate of
weight gain and improved feed efficiency; for the prevention of coccidiosis caused by Eimeria acervulina, E.
brunetti, E. maxima, E. mivati/mitis,
E. necatrix, and E. tenella.
Broiler chickens: For increased rate of
weight gain and improved feed efficiency; for the prevention of coccidiosis caused by Eimeria acervulina, E.
brunetti, E. maxima, E. mivati/mitis,
E. necatrix, and E. tenella.
Broiler chickens: For increased rate of
weight gain.
PO 00000
Frm 00114
Fmt 4700
Sfmt 4700
Sponsors
066104
016592
066104
Feed continuously as the sole ration.
Withdraw 1 day before slaughter. Do
not feed to laying hens. Virginiamycin
and semduramicin as provided by No.
066104 in § 510.600(c) of this chapter.
066104
Not for use in layers ..............................
066104
E:\FR\FM\27DER1.SGM
27DER1
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
Virginiamycin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
Feed continuously as the sole ration
and as the sole source of amprolium.
Do not feed to laying chickens. Not
for chickens over 16 weeks of age.
Virginiamycin as provided by No.
066104; amprolium and ethopabate
as provided by No. 016592 in
§ 510.600(c) of this chapter.
Feed continuously as the sole ration.
Do not feed to laying chickens.
Monensin as provided by No. 000986
in § 510.600(c) of this chapter.
066104
Feed continuously as the sole ration.
Do not feed to layers or to chickens
over 16 weeks of age. Not approved
for use with pellet binders. May be
fatal if accidentally fed to adult turkeys or horses. Virginiamycin as provided by No. 066104; salinomycin as
provided by Nos. 016592 or 054771
in § 510.600(c) of this chapter.
Feed continuously as the sole ration.
Do not feed to laying hens.
Semduramicin as provided by No.
066104 in § 510.600(c) of this chapter.
016592
066104
Feed continuously as the sole ration.
Withdraw 1 day before slaughter. Do
not feed to laying hens. Virginiamycin
as provided by No. 066104;
semduramicin as provided by No.
066104 in § 510.600(c) of this chapter.
Feed continuously as the sole ration
and as the sole source of amprolium.
Do not feed to laying chickens. Not
for chickens over 16 weeks of age.
Virginiamycin as provided by No.
066104; amprolium and ethopabate
as provided by No. 016592 in
§ 510.600(c) of this chapter.
Not for use in layers ..............................
066104
(vii) 5 to 15 .............
Amprolium, 113.5
and ethopabate,
36.3.
Broiler chickens: For increased rate of
weight gain; as an aid in the prevention of coccidiosis where severe exposure to coccidiosis from Eimeria
acervulina, E. maxima, and E.
brunetti is likely to occur.
(viii) 5 to 15 ............
Monensin, 90 to
110.
(ix) 5 to 15 ..............
Salinomycin, 40 to
60.
Broiler chickens: For increased rate of
weight gain; as an aid in the prevention of coccidiosis caused by Eimeria
necatrix, E. tenella, E. acervulina, E.
brunetti, E. maxima, and E. mivati.
Broiler chickens: For increased rate of
weight gain; as an aid in the prevention of coccidiosis caused by Eimeria
tenella, E. necatrix, E. acervulina, E.
maxima, E. brunetti, and E. mivati.
(x) 5 to 15 ..............
Semduramicin, 22.7
(xi) 5 to 15 ..............
Semduramicin (biomass), 22.7.
(xii) 15 ....................
Amprolium, 113.5
and ethopabate,
36.3.
(xiii) 20 ...................
Lasalocid, 68 to
113.
(xv) 20 ....................
Monensin, 90 to
110.
(xvi) 20 ...................
asabaliauskas on DSK3SPTVN1PROD with RULES
(xiv) 20 ...................
Semduramicin, 22.7
(xvii) 20 ..................
Semduramicin (biomass), 22.7.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
95023
Broiler chickens: For increased rate of
weight gain; for the prevention of coccidiosis
caused
by
Eimeria
acervulina, E. brunetti, E. maxima, E.
mivati/mitis, E. necatrix, and E.
tenella.
Broiler chickens: For increased rate of
weight gain; for the prevention of coccidiosis
caused
by
Eimeria
acervulina, E. brunetti, E. maxima, E
mivati/mitis, E. necatrix, and E.
tenella.
Broiler chickens: For increased rate of
weight gain and improved feed efficiency; as an aid in the prevention of
coccidiosis where severe exposure to
coccidiosis from Eimeria acervulina,
E. maxima, and E. brunetti is likely to
occur.
Broiler chickens: For prevention of necrotic enteritis caused by Clostridium
spp. susceptible to virginiamycin.
Broiler chickens: For increased rate of
weight gain and improved feed efficiency; for prevention of coccidiosis
caused by Eimeria tenella, E.
necatrix, E. acervulina, E. brunetti, E.
mivati, and E. maxima.
Broiler chickens: For prevention of necrotic enteritis caused by Clostridium
spp. susceptible to virginiamycin; and
as an aid in the prevention of coccidiosis caused by Eimeria necatrix, E.
tenella, E. acervulina, E. brunetti, E.
maxima, and E. mivati.
Broiler chickens: For prevention of necrotic enteritis caused by Clostridium
spp. susceptible to virginiamycin; for
the prevention of coccidiosis caused
by Eimeria acervulina, E. brunetti, E.
maxima, E. mivati/mitis, E. necatrix,
and E. tenella.
Broiler chickens: For prevention of necrotic enteritis caused by Clostridium
spp. susceptible to virginiamycin; for
the prevention of coccidiosis caused
by Eimeria acervulina, E. brunetti, E.
maxima, E. mivati/mitis, E. necatrix,
and E. tenella.
PO 00000
Frm 00115
Fmt 4700
Sfmt 4700
Sponsors
066104
066104
066104
066104
Feed continuously as the sole ration.
Do not feed to laying chickens.
Lasalocid sodium as provided by No.
054771 in § 510.600(c) of this chapter.
066104
Feed continuously as the sole ration.
Do not feed to laying chickens.
Monensin as provided by No. 058198
in § 510.600(c) of this chapter.
066104
Feed continuously as the sole ration.
Do not feed to laying hens.
Semduramicin as provided by No.
066104 in § 510.600(c) of this chapter.
066104
Feed continuously as the sole ration.
Withdraw 1 day before slaughter. Do
not
feed
to
laying
hens.
Semduramicin as provided by No.
066104 in § 510.600(c) of this chapter.
066104
E:\FR\FM\27DER1.SGM
27DER1
95024
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
(2) Turkeys—
Virginiamycin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 10 to 20 .............
................................
Not for use in layers ..............................
066104
(ii) 10 to 20 .............
Lasalocid, 68 to
113.
Lasalocid sodium as provided by No.
054771 in § 510.600(c) of this chapter.
054771
(iii) 10 to 20 ............
Monensin, 90 to
110.
Growing turkeys: For increased rate of
weight gain and improved feed efficiency.
Growing turkeys: For increased rate of
weight gain and improved feed efficiency; and for the prevention of coccidiosis
caused
by
Eimeria
meleagrimitis, E. gallopavonis, and E.
adenoeides.
Growing turkeys: For increased rate of
weight gain and improved feed efficiency; and for the prevention of coccidiosis
caused
by
Eimeria
meleagrimitis, E. gallopavonis, and E.
adenoeides.
Monensin as provided by No. 058198 in
§ 510.600(c) of this chapter.
066104
Sponsors
(3) Swine—
Virginiamycin
grams/ton
Combination in
grams/ton
Indications for use
Limitations
(i) 5 or 10 ...............
................................
Growing-finishing swine: For increased
rate of weight gain and improved feed
efficiency.
(ii) 5 to 10 ...............
................................
Growing-finishing swine: For increased
rate of weight gain.
(iii) 25 .....................
................................
(iv) 50 or 100 .........
................................
(v) 100 ....................
................................
Growing-finishing swine: As an aid in
control of dysentery in swine up to
120 pounds in animals or on premises with a history of swine dysentery
but where symptoms have not yet occurred.
Growing-finishing swine: For treatment
and control of swine dysentery in
swine up to 120 pounds.
Growing-finishing swine: For treatment
of swine dysentery in nonbreeding
swine over 120 pounds.
Feed continuously from weaning to
market weight. Feed 10 grams per
ton from weaning up to 120 pounds,
followed by 5 grams per ton to market weight.
Feed continuously from weaning to
market weight. Feed 10 grams per
ton from weaning up to 120 pounds
for increased rate of weight gain and
improved feed efficiency, followed by
5 to 10 grams per ton to market
weight for increased rate of weight
gain.
................................................................
Sponsors
066104
066104
066104
Feed 100 grams per ton for 2 weeks,
50 grams per ton thereafter.
066104
Feed for 2 weeks ...................................
066104
(4) Cattle—
Combination in
grams/ton
Indications for use
Limitations
(i) 11.0 to 16.0 .......
................................
Cattle fed in confinement for slaughter:
For improved feed efficiency.
(ii) 13.5 to 16.0 .......
asabaliauskas on DSK3SPTVN1PROD with RULES
Virginiamycin
grams/ton
................................
Cattle fed in confinement for slaughter:
For reduction of incidence of liver abscesses.
(iii) 16.0 to 22.5 ......
................................
Cattle fed in confinement for slaughter:
For increased rate of weight gain.
Feed continuously as the sole ration to
provide 70 to 240 milligrams per head
per day. Not for use in animals intended for breeding.
Feed continuously as the sole ration to
provide 85 to 240 milligrams per head
per day. Not for use in animals intended for breeding.
Feed continuously as the sole ration to
provide 100 to 340 milligrams per
head per day. Not for use in animals
intended for breeding.
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
PO 00000
Frm 00116
Fmt 4700
Sfmt 4700
E:\FR\FM\27DER1.SGM
27DER1
Sponsors
066104
066104
066104
Federal Register / Vol. 81, No. 248 / Tuesday, December 27, 2016 / Rules and Regulations
42. In § 558.665, remove and reserve
paragraphs (e)(5) and (6); remove
paragraphs (e)(11) and (12); and add
paragraph (f) to read as follows:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
§ 558.665
21 CFR Part 558
■
Food and Drug Administration
Zilpaterol.
*
*
*
*
*
(f) Zilpaterol may also be used in
combination with tylosin as in
§ 558.625.
[Docket No. FDA–2016–N–0002]
43. In § 558.680, remove paragraph
(d)(1)(x); and add paragraph (e)(3) to
read as follows:
§ 558.680
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Zoalene.
Notification of withdrawal.
The Food and Drug
Administration (FDA) is withdrawing
approval of 11 new animal drug
applications (NADAs) and 4 abbreviated
new animal drug applications
(ANADAs). These withdrawals of
approval of NADAs and ANADAs for
antimicrobial drugs of importance to
human medicine that are administered
to food-producing animals in medicated
feed are being made because the
products are no longer being
manufactured or marketed. These
actions are consistent with the FDA
Center for Veterinary Medicine’s
initiative for the Judicious Use of
Antimicrobials.
DATES: Withdrawal of approval is
effective December 30, 2016.
SUMMARY:
*
*
*
*
*
(e) * * *
(3) Zoalene may also be used in
combination with lincomycin as in
§ 558.325.
Dated: December 20, 2016.
Tracey H. Forfa,
Deputy Director, Center for Veterinary
Medicine.
[FR Doc. 2016–31083 Filed 12–23–16; 8:45 am]
BILLING CODE 4164–01–P
File No.
035–287 ....
LINCOMIX (lincomycin hydrochloride monohydrate) Type A
Medicated Article.
OM–5 Premix (oleandomycin) Type A Medicated Article ............
046–668 ....
Penicillin G Procaine 50% Type A Medicated Article ..................
091–668 ....
CHLORMAX–SP 500 (chlortetracycline, sulfamethazine, penicillin G procaine) Type A Medicated Article.
LINCOMIX (lincomycin)/NICARB (nicarbazin) ..............................
108–116 ....
133–334 ....
139–473 ....
FDA is
withdrawing approval of 11 NADAs and
4 ANADAs. These applications were
identified as being affected by guidance
for industry (GFI) #213, ‘‘New Animal
Drugs and New Animal Drug
Combination Products Administered in
or on Medicated Feed or Drinking Water
of Food-Producing Animals:
Recommendations for Drug Sponsors for
Voluntarily Aligning Product Use
Conditions With GFI #209,’’ December
2013 (https://www.fda.gov/downloads/
AnimalVeterinary/GuidanceCompliance
Enforcement/GuidanceforIndustry/
UCM299624.pdf). Their withdrawal of
approval is consistent with the FDA
Center for Veterinary Medicine’s
initiative for the Judicious Use of
Antimicrobials.
Approval of the following
applications for new animal drugs
administered in medicated feed is being
voluntarily withdrawn at the sponsors’
requests because these products are no
longer manufactured or marketed:
Sponsor
140–443 ....
140–947 ....
141–090 ....
Virginiamycin Type A Medicated Article .......................................
STAFAC
(virginiamycin)/STENEROL
(halofuginone
hydrobromide).
LINCOMIX
(lincomycin)/STENOROL
(halofuginone
hydrobromide).
HYGROMIX 1.6 (hygromycin B) Type A Medicated Article .........
LINCOMIX (lincomycin)/MAXIBAN (narasin and nicarbazin) .......
STAFAC (virginiamycin)/CLINICOX (diclazuril) ............................
200–171 ....
LINCOMIX (lincomycin)/NICARMIX (nicarbazin) ..........................
200–569 ....
TYLAN (tylosin)/SACOX (salinomycin) .........................................
200–570 ....
TYLOVET 100 (tylosin)/BIO–COX (salinomycin) .........................
200–580 ....
TYLOVET 100 (tylosin)/SACOX (salinomycin) .............................
140–340 ....
asabaliauskas on DSK3SPTVN1PROD with RULES
Sujaya Dessai, Center for Veterinary
Medicine (HFV–212), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–402–5761,
sujaya.dessai@fda.hhs.gov.
Product name
034–085 ....
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
New Animal Drugs; Withdrawal of
Approval of New Animal Drug
Applications
■
Therefore, under authority delegated
to the Commissioner of Food and Drugs
and redelegated to the Center for
VerDate Sep<11>2014
19:06 Dec 23, 2016
Jkt 241001
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007.
Phibro Animal Health Corp., GlenPointe Centre East, 3d Floor,
300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666.
Phibro Animal Health Corp., GlenPointe Centre East, 3d Floor,
300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666.
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007.
Phibro Animal Health Corp., GlenPointe Centre East, 3d Floor,
300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666.
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007.
Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113
Sophia, Bulgaria.
Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113
Sophia, Bulgaria.
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007.
Elanco US, Inc., 2500 Innovation Way, Greenfield, IN 46140.
Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113
Sophia, Bulgaria.
Planalquimica Industrial Ltda., Rua das Magnolias nr. 2405,
Jardim das Bandeiras, CEP 13053–120, Campinas, Sao
Paulo, Brazil.
Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113
Sophia, Bulgaria.
Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113
Sophia, Bulgaria.
Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113
Sophia, Bulgaria.
Veterinary Medicine, and in accordance
with § 514.116 Notice of withdrawal of
approval of application (21 CFR
PO 00000
95025
Frm 00117
Fmt 4700
Sfmt 4700
514.116), notice is given that approval
of NADAs 034–085, 035–287, 046–668,
091–668, 108–116, 133–334, 139–473,
E:\FR\FM\27DER1.SGM
27DER1
Agencies
[Federal Register Volume 81, Number 248 (Tuesday, December 27, 2016)]
[Rules and Regulations]
[Pages 94991-95025]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31083]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 556 and 558
[Docket No. FDA-2016-N-0002]
New Animal Drugs for Use in Animal Feed; Approval of New Animal
Drug Applications; Withdrawal of Approval of New Animal Drug
Applications
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; technical amendment.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of 71 supplemental new animal drug
applications (NADAs) and 35 supplemental abbreviated new animal drug
applications (ANADAs) for revised labeling reflecting a change in
marketing status from over-the-counter (OTC) use to use by veterinary
feed directive (VFD) for antimicrobial drugs of importance to human
medicine administered to food-producing animals in medicated feed.
Where applicable, FDA is also withdrawing approval of those parts of
the NADAs that pertain to use of these antimicrobial drugs for growth
promotion indications. These actions are being taken at the sponsors'
requests because these particular medicated feeds will no longer be
manufactured or marketed. These applications were submitted in
voluntary compliance with the goals of FDA Center for Veterinary
Medicine's (CVM's) Judicious Use Initiative. In addition, the animal
drug regulations are being amended to reflect the voluntary withdrawal
of approval of certain entire NADAs and ANADAs that were affected by
this initiative. The animal drug regulations are also being amended to
reflect several non-substantive changes in format. These technical
amendments are being made to improve the consistency and readability of
the regulations.
DATES: This rule is effective December 30, 2016.
FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for
Veterinary Medicine (HFV-6), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, 240-402-5689,
george.haibel@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Supplemental Approval of Revised Labeling and Withdrawal of Approval
of Portions of NADAs Pertaining to Production Indications
FDA is amending the animal drug regulations to reflect approval of
71 supplemental NADAs and 35 supplemental ANADAs for revised labeling
reflecting a change in marketing status from OTC use to use by VFD for
antimicrobial drugs of importance to human medicine administered to
food-producing animals in medicated feed. Where applicable, FDA is also
withdrawing approval of those parts of the NADAs that pertain to use of
these antimicrobial drugs for growth promotion indications. These
actions are being taken at the sponsors' requests because these
particular medicated feeds will no longer be manufactured or marketed.
These applications were identified as being affected by guidance
for industry (GFI) #213, ``New Animal Drugs and New Animal Drug
Combination Products Administered in or on Medicated Feed or Drinking
Water of Food-Producing Animals: Recommendations for Drug Sponsors for
Voluntarily Aligning Product Use Conditions with GFI #209'', December
2013 (https://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM299624.pdf). Their
change to VFD marketing status is consistent with FDA CVM's initiative
for the Judicious Use of Antimicrobials.
The animal drug regulations for medicated feeds are also being
amended to reflect several non-substantive changes in format. These
technical amendments are being made to improve the consistency and
readability of the regulations.
The affected applications for Type A medicated articles for which
supplemental applications with revised labeling were approved follow:
------------------------------------------------------------------------
File No. Animal drug product Sponsor
------------------------------------------------------------------------
006-391............. S.Q. 40% Huvepharma EOOD, 5th
(sulfaquinoxaline) Type Floor, 3A Nikolay
A Medicated Article. Haytov Str., 1113
Sophia, Bulgaria
(Huvepharma EOOD).
008-804............. TM-50 or TM-100 Phibro Animal Health
(oxytetracycline) Type Corp., GlenPointe
A Medicated Article. Centre East, 3d Floor,
300 Frank W. Burr
Blvd., Suite 21,
Teaneck, NJ 07666
(Phibro Animal Health
Corp.).
010-092............. GALLIMYCIN-100P Cross Vetpharm Group
(erythromycin) Type A Ltd., Broomhill Rd.,
Medicated Article. Tallaght, Dublin 24,
Ireland (Cross Vetpharm
Group Ltd.).
010-918............. HYGROMIX 8 (hygromycin Elanco US Inc., 2500
B) Type A Medicated Innovation Way,
Article. Greenfield, IN 46140
(Elanco US Inc.).
012-491............. TYLAN (tylosin) Type A Elanco US Inc.
Medicated Article.
033-950............. Sulfamerazine In Fish Zoetis Inc., 333 Portage
Grade. St., Kalamazoo, MI
49007 (Zoetis Inc.).
035-688............. AUREOMIX S 40/40 Zoetis Inc.
(chlortetracycline and
sulfamethazine)
Granular Type A
Medicated Article.
035-805............. AUREO S 700 Zoetis Inc.
(chlortetracycline and
sulfamethazine)
Granular Type A
Medicated Article.
038-439............. TERRAMYCIN 200 Phibro Animal Health
(oxytetracycline) for Corp.
Fish Type A Medicated
Article.
040-209............. ROFENAID 40 Zoetis Inc.
(sulfadimethoxine and
ormetoprim) Type A
Medicated Article.
[[Page 94992]]
041-275............. TYLAN 40 Sulfa-G Elanco US Inc.
(tylosin and
sulfamethazine) Type A
Medicated Article.
041-647............. AUREOMIX S 700-A Zoetis Inc.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
041-648............. AUREOMIX S 700-D Zoetis Inc.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
041-649............. AUREOMIX S 700-G Zoetis Inc.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
041-650............. AUREOMIX S 700-E Zoetis Inc.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
041-651............. AUREOMIX S 700-F Zoetis Inc.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
041-652............. AUREOMIX S 700-C-2 Zoetis Inc.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
041-653............. AUREOMIX S 700-B Zoetis Inc.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
041-654............. AUREOMIX S 700-H Zoetis Inc.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
046-415............. Tylosin Type A Medicated Zoetis Inc.
Article.
046-699............. CHLORMAX Zoetis Inc.
(chlortetracycline)
Type A Medicated
Article.
048-480............. CHLORATET Pharmgate LLC, 1015
(chlortetracycline) Ashes Dr., Suite 102,
Type A Medicated Wilmington, NC 28405
Article. (Pharmgate LLC).
048-761............. AUREOMYCIN Zoetis Inc.
(chlortetracycline)
Type A Medicated
Article.
049-287............. CHLORACHEL Zoetis Inc.
(chlortetracycline)Type
A Medicated Article.
091-749............. TYLAN 40 Plus Sulfa-G Zoetis Inc.
(tylosin and
sulfamethazine) Type A
Medicated Article.
092-286............. CLTC-50 MR Phibro Animal Health
(chlortetracycline) Corp.
Type A Medicated
Article.
092-287............. CLTC 100 MR Phibro Animal Health
(chlortetracycline) Corp.
Type A Medicated
Article.
094-975............. NEO-TERRAMYCIN 100/100 Phibro Animal Health
(oxytetracycline and Corp.
neomycin) Type A
Medicated Article.
095-143............. TERRAMYCIN 10, 30, 50, Phibro Animal Health
100, or 200 Corp.
(oxytetracycline) Type
A Medicated Article.
097-505............. LINCOMIX 20 (lincomycin) Zoetis Inc.
Type A Medicated
Article.
098-431............. TYLAN 10 (tylosin) Phibro Animal Health
Premix Type A Medicated Corp.
Article.
100-901............. PFICHLOR 100S Zoetis Inc.
(chlortetracycline)
Milk Replacer Type A
Medicated Article.
125-933............. ROMET-30 (ormetoprim and Pharmaq AS.
sulfadimethoxine) Type
A Medicated Article.
126-050............. APRALAN 75 (apramycin) Elanco US Inc.
Type A Medicated
Article.
138-934............. PENNCHLOR S 40/40 Pharmgate LLC.
(chlortetracycline and
sulfamethazine) Type A
medicated article.
138-935............. PENNCHLOR 100 MR Pharmgate LLC.
(chlortetracycline)
Type A Medicated
Article.
138-938............. PENNOX 50, 100, or 200 Pharmgate LLC.
Hi-Flo, or 100-MR
(oxytetracycline) Type
A Medicated Article.
138-939............. NEO-OXY 100/100 MR Pharmgate LLC.
(oxytetracycline and
neomycin) Type A
Medicated Article.
140-976............. NEOMIX 325 Milk Replacer Zoetis Inc.
(neomycin) Type A
Medicated Article.
200-314............. PENNCHLOR S Pharmgate LLC.
(chlortetracycline and
sulfamethazine) Type A
Medicated Article.
200-484............. TYLOVET 100 (tylosin) Huvepharma.
Type A Medicated
Article.
200-510............. DERACIN 100 Pharmgate LLC.
(chlortetracycline)
Type A Medicated
Article.
------------------------------------------------------------------------
The affected applications for manufacturing combination drug
medicated feeds follow:
------------------------------------------------------------------------
File No. Animal drug product Sponsor
------------------------------------------------------------------------
036-361................ CTC Sodium Sulfate Zoetis Inc., 333
(chlortetracycline and Portage St.,
sodium sulfate)/AMPROL Kalamazoo, MI 49007
PLUS (amprolium and (Zoetis Inc.).
ethopabate).
045-444................ CHLORMAX Zoetis Inc.
(chlortetracycline)/
DECCOX (decoquinate).
046-209................ CTC (chlortetracycline)/ Huvepharma EOOD, 5th
COYDEN (clopidol). Floor, 3A Nikolay
Haytov Str., 1113
Sophia, Bulgaria
(Huvepharma EOOD).
092-507................ AUREOMYCIN Zoetis Inc.
(chlortetracycline)/
ROBENZ (robenidine).
099-006................ TERRAMYCIN Phibro Animal Health
(oxytetracycline)/ Corp., GlenPointe
COBAN (monensin). Centre East, 3d
Floor, 300 Frank W.
Burr Blvd., Suite 21,
Teaneck, NJ 07666
(Phibro Animal Health
Corp.).
101-666................ TERRAMYCIN Phibro Animal Health
(oxytetracycline)/ Corp.
ROBENZ (robenidine).
[[Page 94993]]
104-646................ TYLAN (tylosin)/ Elanco US Inc., 2500
RUMENSIN (monensin). Innovation Way,
Greenfield, IN 46140
(Elanco US Inc.).
110-047................ TYLAN (tylosin)/ Phibro Animal Health
BANMINTH (pyrantel). Corp.
116-044................ LINCOMIX (lincomycin)/ Phibro Animal Health
BANMINTH (pyrantel). Corp.
121-553................ AUREOMYCIN Zoetis Inc.
(chlortetracycline)/
COBAN (monensin).
138-870................ TYLAN (tylosin)/ Zoetis Inc.
RUMENSIN (monensin)/
MGA (melengestrol).
138-941................ LINCOMIX (lincomycin)/ Zoetis Inc.
BANMINTH (pyrantel).
138-992................ TYLAN (tylosin)/BOVATEC Zoetis Inc.
(lasalocid)/MGA
(melengestrol).
138-995................ TYLAN (tylosin)/MGA Zoetis Inc.
(melengestrol).
139-192................ TYLAN (tylosin)/MGA Zoetis Inc.
(melengestrol).
140-448................ TERRAMYCIN Phibro Animal Health
(oxytetracycline)/BIO- Corp.
COX (salinomycin).
140-859................ AUREOMYCIN Zoetis Inc.
(chlortetracycline)/
BIO-COX (salinomycin).
140-954................ LINCOMIX (lincomycin)/ Intervet, Inc.
SAFE-GUARD
(fenbendazole).
141-011................ CTC (chlortetracycline)/ Elanco US Inc.
DENAGARD (tiamulin).
141-054................ LINCOMIX (lincomycin)/ Merial, Inc., 3239
IVOMEC (ivermectin). Satellite Blvd.,
Bldg. 500, Duluth, GA
30096-4640.
141-059................ CHLORMAX Zoetis Inc.
(chlortetracycline)/
BMD (bacitracin).
141-147................ CHLORMAX Zoetis Inc.
(chlortetracycline)/
DECCOX (decoquinate).
141-149................ TYLAN (tylosin)/ Zoetis Inc.
RUMENSIN (monensin)/
DECCOX (decoquinate).
141-172................ TYLAN (tylosin)/PAYLEAN Elanco US Inc.
(ractopamine).
141-185................ AUREOMYCIN Zoetis Inc.
(chlortetracycline)/
DECCOX (decoquinate).
141-201................ AUREOMYCIN Zoetis Inc.
(chlortetracycline)/
CATTLYST (laidlomycin).
141-211................ TERRAMYCIN Phibro Animal Health
(oxytetracycline)/ Corp.
(carbadox).
141-224................ TYLAN (tylosin)/ Elanco US Inc.
RUMENSIN (monensin)/
OPTAFLEXX
(ractopamine).
141-233................ TYLAN (tylosin)/ Elanco US Inc.
RUMENSIN (monensin)/
OPTAFLEXX
(ractopamine)/MGA
(melengestrol).
141-250................ AUREOMYCIN Zoetis Inc.
(chlortetracycline)/
BOVATEC (lasalocid).
141-276................ TYLAN (tylosin)/ Intervet, Inc., 2
RUMENSIN (monensin)/ Giralda Farms,
ZILMAX (zilpaterol). Madison, NJ 07940
(Intervet, Inc.).
141-280................ TYLAN (tylosin)/ Intervet, Inc.
RUMENSIN (monensin)/
ZILMAX (zilpaterol)/
MGA (melengestrol).
200-095................ AUREOMYCIN Huvepharma EOOD.
(chlortetracycline)/
SACOX (salinomycin).
200-096................ TERRAMYCIN Huvepharma EOOD.
(oxytetracycline)/
SACOX (salinomycin).
200-242................ AUREOMYCIN Zoetis Inc.
(chlortetracycline)/
BMD (bacitracin).
200-261................ CHLORMAX Zoetis Inc.
(chlortetracycline)/
BIO-COX (salinomycin).
200-262................ CHLORMAX Zoetis Inc.
(chlortetracycline)/
SACOX (salinomycin).
200-263................ CHLORMAX Zoetis Inc.
(chlortetracycline)/
COBAN (monensin).
200-354................ PENNCHLOR Pharmgate LLC, 1015
(chlortetracycline)/ Ashes Dr., Suite 102,
COBAN (monensin). Wilmington, NC 28405
(Pharmgate LLC).
200-356................ PENNCHLOR Pharmgate LLC.
(chlortetracycline)/
DENAGARD (tiamulin).
200-357................ PENNCHLOR Pharmgate LLC.
(chlortetracycline)/
BIO-COX (salinomycin).
200-358................ PENNCHLOR Pharmgate LLC.
(chlortetracycline)/
BMD (bacitracin).
200-359................ PENNCHLOR Pharmgate LLC.
(chlortetracycline)/
DECCOX (decoquinate).
200-375................ TYLAN (tylosin)/ Elanco US Inc.
RUMENSIN (monensin)/
HEIFERMAX
(melengestrol).
200-424................ TYLAN (tylosin)/ Elanco US Inc.
RUMENSIN (monensin)/
OPTAFLEXX
(ractopamine)/
HEIFERMAX
(melengestrol).
200-427................ TYLAN (tylosin)/ Elanco US Inc.
HEIFERMAX 500
(melengestrol) Liquid.
200-430................ TYLAN (tylosin)/BOVATEC Elanco US Inc.
(lasalocid)/HEIFERMAX
500 (melengestrol)
Liquid.
200-480................ TYLAN (tylosin)/ Elanco US Inc.
RUMENSIN (monensin)/
ZILMAX (zilpaterol)/
HEIFERMAX 500
(melengestrol).
200-530................ TYLOVET (tylosin)/ Huvepharma EOOD.
PAYLEAN (ractopamine).
200-531................ TYLOVET (tylosin)/ Huvepharma EOOD.
RUMENSIN (monensin).
200-532................ TYLOVET (tylosin)/MGA Huvepharma EOOD.
(melengestrol).
200-533................ TYLOVET (tylosin)/ Huvepharma EOOD.
RUMENSIN (monensin)/
DECCOX (decoquinate).
200-534................ TYLOVET (tylosin)/ Huvepharma EOOD.
RUMENSIN (monensin)/
MGA (melengestrol).
200-535................ TYLOVET (tylosin)/ Huvepharma EOOD.
BOVATEC (lasalocid)/
MGA (melengestrol).
200-544................ TYLOVET (tylosin)/ Huvepharma EOOD.
RUMENSIN (monensin)/
ZILMAX (zilpaterol)/
MGA (melengestrol).
200-547................ TYLOVET (tylosin)/ Huvepharma EOOD.
RUMENSIN (monensin)/
ZILMAX (zilpaterol).
200-558................ TYLAN (tylosin)/ENGAIN Zoetis Inc.
(ractopamine).
200-561................ TYLAN (tylosin)/ Zoetis Inc.
RUMENSIN (monensin)/
ACTOGAIN (ractopamine).
200-562................ TYLAN (tylosin)/ Zoetis Inc.
RUMENSIN (monensin)/
ACTOGAIN (ractopamine).
200-566................ TYLOVET (tylosin)/ Huvepharma EOOD.
RUMENSIN (monensin).
200-567................ TYLOVET (tylosin)/ Huvepharma EOOD.
RUMENSIN (monensin).
[[Page 94994]]
200-583................ TYLOVET (tylosin)/ Zoetis Inc.
RUMENSIN (monensin)/
ACTOGAIN (ractopamine)/
MGA (melengestrol).
200-584................ TYLOVET (tylosin)/ Zoetis Inc.
ENGAIN (ractopamine).
200-585................ TYLOVET (tylosin)/ Zoetis Inc.
RUMENSIN (monensin)/
ACTOGAIN (ractopamine).
------------------------------------------------------------------------
The animal drug regulations are also being amended to reflect
several non-substantive changes in format. These technical amendments
are being made to improve the consistency and readability of the
regulations.
Elsewhere in this issue of the Federal Register, FDA is amending
the animal drug regulations to reflect approval of similar supplemental
NADAs and ANADAs changing the marketing status of antimicrobial drugs
administered to food-producing animals in medicated water.
II. Changes of Sponsorship
Elanco US Inc., 2500 Innovation Way, Greenfield, IN 46140 has
informed FDA that it has transferred ownership of, and all rights and
interest in, NADA 141-110, providing for the manufacture of combination
drug medicated turkey feeds containing STAFAC (virginiamycin) and COBAN
(monensin) to Phibro Animal Health Corp., GlenPointe Centre East, 3d
Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666. As
provided in the regulatory text of this document, the animal drug
regulations are amended to reflect this change of sponsorship.
III. Withdrawals of Approval
In addition, approval of the following applications for medicated
feeds containing antimicrobial drugs of importance to human medicine
administered to food-producing animals is being withdrawn at the
sponsors' requests because the products are no longer manufactured or
marketed:
------------------------------------------------------------------------
File No. Product name Sponsor
------------------------------------------------------------------------
034-085................ LINCOMIX (lincomycin Zoetis Inc., 333
hydrochloride Portage St.,
monohydrate) Type A Kalamazoo, MI 49007
Medicated Article. (Zoetis Inc.).
035-287................ OM-5 Premix Phibro Animal Health
(oleandomycin) Type A Corp., GlenPointe
Medicated Article. Centre East, 3d
Floor, 300 Frank W.
Burr Blvd., Suite 21,
Teaneck, NJ 07666
(Phibro Animal Health
Corp.).
046-668................ Penicillin G Procaine Phibro Animal Health
50% Type A Medicated Corp.
Article.
091-668................ CHLORMAX-SP 500 Zoetis Inc.
(chlortetracycline,
sulfamethazine,
penicillin G procaine)
Type A Medicated
Article.
108-116................ LINCOMIX (lincomycin)/ Phibro Animal Health
NICARB (nicarbazin). Corp.
133-334................ Virginiamycin Type A Zoetis Inc.
Medicated Article.
139-473................ STAFAC (virginiamycin)/ Huvepharma EOOD, 5th
STENEROL (halofuginone Floor, 3A Nikolay
hydrobromide). Haytov Str., 1113
Sophia, Bulgaria
(Huvepharma EOOD).
140-340................ LINCOMIX (lincomycin)/ Huvepharma EOOD.
STENOROL (halofuginone
hydrobromide).
140-443................ HYGROMIX 1.6 Zoetis Inc.
(hygromycin B) Type A
Medicated Article.
140-947................ LINCOMIX (lincomycin)/ Elanco US Inc., 2500
MAXIBAN (narasin and Innovation Way,
nicarbazin). Greenfield, IN 46140
(Elanco US Inc.).
141-090................ STAFAC (virginiamycin)/ Huvepharma EOOD.
CLINICOX (diclazuril).
200-171................ LINCOMIX (lincomycin)/ Planalquimica
NICARMIX (nicarbazin). Industrial Ltda., Rua
das Magnolias nr.
2405, Jardim das
Bandeiras, CEP 13053-
120, Campinas, Sao
Paulo, Brazil.
200-569................ TYLAN (tylosin)/SACOX Huvepharma EOOD.
(salinomycin).
200-570................ TYLOVET 100 (tylosin)/ Huvepharma EOOD.
BIO-COX (salinomycin).
200-580................ TYLOVET 100 (tylosin)/ Huvepharma EOOD.
SACOX (salinomycin).
------------------------------------------------------------------------
Elsewhere in this issue of the Federal Register, FDA gave notice
that approval of NADAs 034-085, 035-287, 046-668, 091-668, 108-116,
133-334, 139-473, 140-340, 140-443, 140-947, and 141-090, and ANADAs
200-171, 200-569, 200-570, and 200-580, and all supplements and
amendments thereto, is withdrawn, effective January 6, 2017. As
provided in the regulatory text of this document, the animal drug
regulations are amended to reflect these voluntary withdrawals of
approval.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
List of Subjects
21 CFR Part 556
Animal drugs, Foods.
21 CFR Part 558
Animal drugs, Animal feeds.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR parts 556 and
558 are amended as follows:
PART 556--TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD
0
1. The authority citation for part 556 continues to read as follows:
Authority: 21 U.S.C. 342, 360b, 371.
Sec. 556.480 [Removed]
0
2. Remove Sec. 556.480.
PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
0
3. The authority citation for part 558 continues to read as follows:
Authority: 21 U.S.C. 354, 360b, 360ccc, 360ccc-1, 371.
[[Page 94995]]
0
4. In Sec. 558.4, in paragraph (d), in the Category I table, in the
column headings for ``Assay limits \1\ percent type A'' and ``Assay
limits percent \1\ type B/C \2\'', remove ``type'' and in its place add
``Type'', and remove the row entries for ``Erythromycin (thiocyanate
salt)'' and ``Oleandomycin''; and in the Category II table,
alphabetically add an entry for ``Erythromycin'' to read as follows:
Sec. 558.4 Requirement of a medicated feed mill license.
* * * * *
(d) * * *
Category II
----------------------------------------------------------------------------------------------------------------
Assay limits Assay limits
Drug percent \1\ Type B maximum (100x) percent \1\
Type A Type B/C \2\
----------------------------------------------------------------------------------------------------------------
* * * * * * *
Erythromycin............................... 85-115 4.625 g/lb (1.02%)................. 75-125
* * * * * * *
----------------------------------------------------------------------------------------------------------------
* * * * *
0
5. In Sec. 558.58, remove and reserve paragraphs (e)(2), (7), and (8);
remove paragraphs (e)(10) and (11); and add paragraph (f) to read as
follows:
Sec. 558.58 Amprolium and ethopabate.
* * * * *
(f) Amprolium and ethopabate may also be used in combination with:
(1) [Reserved]
(2) [Reserved]
(3) Chlortetracycline as in Sec. 558.128.
(4) Lincomycin as in Sec. 558.325.
(5) Virginiamycin as in Sec. 558.635.
0
6. Revise Sec. 558.59 to read as follows:
Sec. 558.59 Apramycin.
(a) Specifications. Type A articles containing 75 grams apramycin
(as apramycin sulfate) per pound.
(b) Sponsor. See No. 058198 in Sec. 510.600(c) of this chapter.
(c) Related tolerances. See Sec. 556.52 of this chapter.
(d) Conditions of use in swine--
----------------------------------------------------------------------------------------------------------------
Combination in
Apramycin grams/ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(1) 150.......................... .............. For control of porcine Feed as the sole ration 058198
colibacillosis for 14 consecutive
(weanling pig scours) days. Withdraw 28 days
caused by susceptible before slaughter.
strains of Escherichia
coli.
(2) [Reserved]...................
----------------------------------------------------------------------------------------------------------------
0
7. In Sec. 558.76, redesignate paragraphs (e)(2)(iii) through (xvi) as
paragraphs (e)(2)(iv) through (xvii); and add new paragraph (e)(2)(iii)
to read as follows:
Sec. 558.76 Bacitracin methylenedisalicylate.
* * * * *
(e) * * *
(2) * * *
(iii) Chlortetracycline as in Sec. 558.128.
* * * * *
0
8. Revise Sec. 558.128 to read as follows:
Sec. 558.128 Chlortetracycline.
(a) Specifications. Type A medicated articles containing either
chlortetracycline calcium complex equivalent to chlortetracycline
hydrochloride, or for products intended for use in milk replacer,
chlortetracycline hydrochloride.
(b) Approvals. See sponsors in Sec. 510.600(c) of this chapter for
use as in paragraph (e) of this section.
(1) Nos. 054771: 50, 65, or 100 grams per pound (g/lb) Type A
medicated article.
(2) No. 066104: 10, 20, 30, 50, 70, or 100 g/lb of Type A medicated
article.
(3) No. 069254: 50, 90, or 100 g/lb of Type A medicated article.
(c) Related tolerances. See Sec. 556.150 of this chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for chlortetracycline medicated
feeds must not exceed 6 months from the date of issuance. VFDs for
chlortetracycline shall not be refilled.
(3) In milk replacers or starter feed; include on labeling the
warning: ``A withdrawal period has not been established for this
product in preruminating calves. Do not use in calves to be processed
for veal.''
(4) Manufacture for use in free-choice feeds as in paragraph
(e)(4)(iii) of this section must conform to Sec. 510.455 of this
chapter.
(5) When manufactured for use as in paragraph (e)(5)(iii) of this
section, include on labeling the warning: ``Psittacosis, avian
chlamydiosis, or ornithosis is a reportable communicable disease,
transmissible between wild and domestic birds, other animals, and man.
Contact appropriate public health and regulatory officials.''
(e) Conditions of use--(1) Chickens. It is used as follows:
----------------------------------------------------------------------------------------------------------------
Combination in
Chlortetracycline amount grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 100 to 200 g/ton....... .................. Chickens: For control Feed continuously for 054771 066104
of infectious 7 to 14 days. Do not 069254
synovitis caused by feed to chickens
Mycoplasma synoviae producing eggs for
susceptible to human consumption.
chlortetracycline.
[[Page 94996]]
(ii) 100 to 200 g/ton...... Clopidol, 113.5... Broiler and replacement Feed continuously as 016592
chickens: As an aid in the sole ration from
the prevention of the time chicks are
coccidiosis caused by placed in floor pens
Eimeria tenella, E. for 7 to 14 days. Do
necatrix, E. not feed to chickens
acervulina, E. maxima, over 16 weeks of age.
E. mivati, and E. Do not feed to
brunetti; and for chickens producing
control of infectious eggs for human
synovitis caused by M. consumption.
synoviae susceptible Chlortetracycline as
to chlortetracycline. provided by No.
054771; clopidol as
provided by No.
016592 in Sec.
510.600(c) of this
chapter.
(iii) 100 to 200 g/ton..... Decoquinate, 27.2. Chickens: For Feed continuously for 054771
prevention of 7 to 14 days.
coccidiosis caused by Bentonite should not
Eimeria tenella, E. be used in
necatrix, E. mivati, decoquinate feeds. Do
E. acervulina, E. not feed to chickens
maxima, and E. producing eggs for
brunetti; and for human consumption.
control of infectious Chlortetracycline and
synovitis caused by M, decoquinate as
synoviae susceptible provided by No.
to chlortetracycline. 054771 in Sec.
510.600(c) of this
chapter.
(iv) 100 g/ton............. Robenidine, 30.... Broiler and fryer Feed continuously as 054771
chickens: As an aid in sole ration. Do not
the prevention of use this product in
coccidiosis caused by feeds conta.
E. mivati, E. Chlortetracycline and
brunetti, E. tenella, robenidine as
E. acervulina, E. provided by No.
maxima, and E. 054771 in Sec.
necatrix; as an aid in 510.600(c) of this
the control of chronic chapter.
respiratory disease
(CRD) caused by
Mycoplasma
gallisepticum
susceptible to
chlortetracycline; and
as an aid in the
control of infectious
synovitis caused by M.
synoviae susceptible
to chlortetracycline.
(v) 200 to 400 g/ton....... .................. Chickens: For the Feed continuously for 054771 066104
control of chronic 7 to 14 days. Do not 069254
respiratory disease feed to chickens
(CRD) and air sac producing eggs for
infection caused by M. human consumption.
gallisepticum and
Escherichia coli
susceptible to
chlortetracycline.
(vi) 200 g/ton............. Amprolium, 227 and For chickens where Use in low calcium 054771
ethopabate, 3.6. immunity to feed containing 0.8%
coccidiosis is not dietary calcium and
desired: For 1.5% sodium sulfate;
prevention of feed continuously as
coccidiosis; and for sole ration for 7 to
treatment of chronic 14 days; do not feed
respiratory disease to chickens producing
(CRD) caused by M. eggs for human
gallisepticum consumption.
susceptible to Chlortetracycline as
chlortetracycline. provided by No.
054771; amprolium and
ethopabate as
provided by No.
016592 in Sec.
510.600(c) of this
chapter.
(vii) 200 g/ton............ Decoquinate, 27.2. Broilers: As an aid in Feed continuously as 054771
the prevention of the sole ration for
coccidiosis caused by no more than 8 weeks.
Eimeria tenella, E. Use in low calcium
necatrix, E. feed containing 0.8%
acervulina, E. mivati, dietary calcium.
E. maxima, and E. Bentonite should not
brunetti; and for the be used in
treatment of chronic decoquinate feeds. Do
respiratory disease not feed to chickens
(air sac infection) producing eggs for
and the prevention of human consumption.
synovitis. Chlortetracycline and
decoquinate as
provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(viii) 200 g/ton........... Robenidine 30..... Broiler and fryer Feed continuously as 054771
chickens: As an aid in sole ration. Do not
the prevention of use this product in
coccidiosis caused by feeds containing
E. mivati, E. bentonite. Do not
brunetti, E. tenella, feed to chickens
E. acervulina, E. producing eggs for
maxima, and E. human consumption.
necatrix; as an aid in Withdraw 5 days prior
the control of chronic to slaughter.
respiratory disease Chlortetracycline and
(CRD) caused by M. robenidine as
gallisepticum provided by No.
susceptible to 054771 in Sec.
chlortetracycline; and 510.600(c) of this
as an aid in the chapter.
control of infectious
synovitis caused by M.
synoviae susceptible
to chlortetracycline.
(ix) 500 g/ton............. .................. Chickens: For the 1. Feed for 5 days. To 054771 069254
reduction of mortality sponsor No. 054771
due to E. coli under NADA 048-761
infections susceptible and No. 069254 under
to chlortetracycline. ANADA 200-510: zero
withdrawal time.
2. Feed for 5 days; 054771
withdraw 24 hours 066104
prior to slaughter. 069254
Do not feed to
chickens producing
eggs for human
consumption.
[[Page 94997]]
(x) 500 g/ton.............. Monensin, 90 to Chickens: As an aid in Feed for 5 days as the 054771 069254
110. the reduction of sole ration. Do not
mortality due to E. feed to laying
coli infections chickens. Not to be
susceptible to fed continuously for
chlortetracycline; and more than 5 days. Do
as an aid in the not feed to chickens
prevention of over 16 weeks of age.
coccidiosis caused by Withdraw 24 hours
Eimeria tenella, E. before slaughter. See
necatrix, E. Sec. 558.355(d) of
acervulina, E. maxima, this chapter.
E. brunetti, and E. Chlortetracycline as
mivati. provided by No.
054771; monensin as
provided by No.
058198 in Sec.
510.600(c) of this
chapter.
(xi) 500 g/ton............. Robenidine, 30.... Broiler and fryer Feed continuously as 054771
chickens: As an aid in sole ration for up to
the prevention of 5 days. Do not use
coccidiosis caused by this product in feeds
Eimeria mivati, E. containing bentonite.
brunetti, E. tenella, Do not feed to
E. acervulina, E. chickens producing
maxima, and E. eggs for human
necatrix; as an aid in consumption. Withdraw
the reduction of 5 days prior to
mortality due to E. slaughter.
coli susceptible to Chlortetracycline and
chlortetracycline. robenidine as
provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xii) 500 g/ton............ Salinomycin, 40 to Broiler chickens: As an For use in low calcium 016592 054771
60. aid in the prevention feeds containing 0.8% 069254
of coccidiosis caused calcium. Not approved
by Eimeria tenella, E. for use with pellet
necatrix, E. binders. Not to be
acervulina, E. maxima, fed continuously for
E. brunetti, and E. more than 5 days. Do
mivati; and as an aid not feed to laying
in the reduction of chickens producing
mortality due to E. eggs for human
coli susceptible to consumption. Withdraw
chlortetracycline. 24 hours before
slaughter. May be
fatal if accidentally
fed to adult turkeys
or horses.
Chlortetracycline as
provided by Nos.
054771 or 069254;
salinomycin as
provided by Nos.
054771 or 016592 in
Sec. 510.600(c) of
this chapter.
----------------------------------------------------------------------------------------------------------------
(2) Turkeys. It is used as follows:
----------------------------------------------------------------------------------------------------------------
Combination in
Chlortetracycline amount grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 200 g/ton.............. .................. Turkeys: For control of Feed continuously for 054771
infectious synovitis 7 to 14 days. Do not 066104
caused by M. synoviae feed to turkeys 069254
susceptible to producing eggs for
chlortetracycline. human consumption.
(ii) 400 g/ton............. .................. 1. Turkeys: For control Feed continuously for 054771
of hexamitiasis caused 7 to 14 days. Do not 066104
by Hexamita feed to turkeys 069254
meleagridis producing eggs for
susceptible to human consumption.
chlortetracycline.
.................. 2. Turkey poults not ...................... 054771
over 4 weeks of age: 066104
For reduction of 069254
mortality due to
paratyphoid caused by
Salmonella typhimurium
susceptible to
chlortetracycline.
(iii) 25 mg/lb of body .................. Turkeys: For control of Feed continuously for 054771
weight. complicating bacterial 7 to 14 days. Do not 066104
organisms associated feed to turkeys 069254
with bluecomb producing eggs for
(transmissible human consumption.
enteritis; coronaviral
enteritis) susceptible
to chlortetracycline.
----------------------------------------------------------------------------------------------------------------
(3) Swine. It is used as follows:
----------------------------------------------------------------------------------------------------------------
Combination in
Chlortetracycline amount grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 50 to 100 g/ton........ .................. Swine: For reducing the ...................... 054771
incidence of cervical 066104
lymphadenitis (jowl 069254
abscesses) caused by
Group E Streptococci
susceptible to
chlortetracycline.
[[Page 94998]]
(ii) 400 g/ton............. .................. Breeding swine: For the Feed continuously for 054771
control of not more than 14 days. 066104
leptospirosis 069254
(reducing the
incidence of abortion
and shedding of
leptospirae) caused by
Leptospira pomona
susceptible to
chlortetracycline.
(iii) 10 mg/lb of body .................. Swine: For treatment of Feed approximately 400 054771
weight. bacterial enteritis g/ton, varying with 066104
caused by Escherichia body weight and feed 069254
coli and S. consumption to
choleraesuis and provide 10 mg/lb per
bacterial pneumonia day. Feed for not
caused by Pasteurella more than 14 days.
multocida susceptible Withdraw 5 d prior to
to chlortetracycline; slaughter for sponsor
for the control of No. 069254 in Sec.
porcine proliferative 510.600(c) of this
enteropathies chapter.
(ileitis) caused by
Lawsonia
intracellularis
susceptible to
chlortetracycline.
(iv) 10 mg/lb of body Bacitracin Swine: For treatment of Feed approximately 400 054771
weight. methylenedisalicy bacterial enteritis g/ton, varying with
late, 10 to 30. caused by E. coli and body weight and feed
S. choleraesuis and consumption to
bacterial pneumonia provide 10 mg/lb per
caused by P. multocida day. Feed for not
susceptible to more than 14 days.
chlortetracycline; for
the control of porcine
proliferative
enteropathies
(ileitis) caused by
Lawsonia
intracellularis
susceptible to
chlortetracycline; and
for increased rate of
weight gain and
improved feed
efficiency.
(v) 10 mg/lb of body weight Bacitracin Swine: For treatment of Feed chlortetracycline 069254
methylenedisalicy bacterial enteritis at approximately 400
late, 10 to 30. caused by E. coli and g/ton of feed,
S. choleraesuis and varying with body
bacterial pneumonia weight and food
caused by P. multocida consumption, to
susceptible to provide 10 mg/lb of
chlortetracycline; and body weight. Feed for
for increased rate of not more than 14
weight gain and days. Withdraw 5 d
improved feed prior to slaughter
efficiency. for sponsor No.
069254. Bacitracin
methylenedisalicylate
provided by No.
054771;
chlortetracycline
provided by Nos.
054771 and 069254 in
Sec. 510.600(c) of
this chapter.
(vi) 500 to 4,000 to Tiamulin hydrogen For control of swine Feed continuously as 058198
provide 10 mg/lb of body fumarate, 35. dysentery associated the sole ration for 069254
weight daily. with Brachyspira 14 days. Withdraw
(formerly Serpulina or medicated feed 2 days
Treponema) before slaughter.
hyodysenteriae Tiamulin as provided
susceptible to by Nos. 058198 or
tiamulin and for 069254in Sec.
treatment of swine 510.600(c) of this
bacterial enteritis chapter.
caused by E. coli and
Salmonella
choleraesuis sensitive
to chlortetracycline
and treatment of
bacterial pneumonia
caused by P. multocida
sensitive to
chlortetracycline.
----------------------------------------------------------------------------------------------------------------
(4) Cattle. It is used as follows:
----------------------------------------------------------------------------------------------------------------
Combination in
Chlortetracycline amount grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 0.5 mg/lb of body weight ................. Beef cattle (over 700 Withdraw 48 hours 054771
daily. lb): For control of prior to slaughter. 066104
active infection of To sponsor Nos. 069254
anaplasmosis caused 054771 and 069254:
by Anaplasma Zero withdrawal time.
marginale susceptible
to chlortetracycline.
[[Page 94999]]
(ii) 25 to 1,100 to provide Lasalocid, 30 to Pasture cattle Feed continuously on 054771
0.5 mg/lb of body weight 600. (slaughter, stocker, a hand-fed basis 0.5
daily. feeder cattle, beef mg chlortetracycline
replacement heifers) per lb. body weight
over 700 pounds: For per day and not less
control of active than 60 mg or more
infection of than 300 mg
anaplasmosis caused lasalocid per head
by A. marginale daily in at least 1
susceptible to pound of feed. Daily
chlortetracycline; lasalocid intakes in
and for increased excess of 200 mg/
rate of weight gain. head/day in pasture
cattle have not been
shown to be more
effective than 200
mg lasalocid/head/
day. Do not allow
horses or other
equines access to
feeds containing
lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(iii) 0.5 to 2.0 mg/lb of body ................. Beef cattle and In free-choice cattle 054771
weight daily. nonlactating dairy feeds such as feed
cattle: As an aid in blocks or salt-
the control of active mineral mixes
infection of manufactured from
anaplsmosis caused by approved Type A
A. marginale articles. See
susceptible to paragraph (d)(4) of
chlortetracycline. this section.
(iv) 10 mg/lb of body weight ................. 1. Calves, beef and Feed approximately 054771 066104
daily. nonlactating dairy 400 g/ton, varying 069254
cattle: For treatment with body weight and
of bacterial feed consumption to
enteritis caused by provide 10 mg/lb per
Escherichia coli and day. Treat for not
bacterial pneumonia more than 5 days. In
caused by Pasteurella feed including milk
multocida organisms replacers withdraw
susceptible to 10 days prior to
chlortetracycline. slaughter. To
sponsor No. 069254:
zero withdrawal
time. See paragraph
(d)(3) of this
section.
2. Calves (up to 250 See paragraph (d)(3) 054771
lb): For the of this section. 066104
treatment of 069254
bacterial enteritis
caused by E. coli
susceptible to
chlortetracycline.
(v) 10 mg/lb of body weight Laidlomycin, 5... Cattle fed in Feed continuously at 054771
daily. confinement for a rate of 30 to 75
slaughter: For mg laidlomycin
treatment of propionate potassium
bacterial enteritis per head per day for
caused by E. coli and not more than 5
bacterial pneumonia days. A withdrawal
caused by P. period has not been
multocida organisms established for this
susceptible to product in pre-
chlortetracycline; ruminating calves.
and for increased Do not use in calves
rate of weight and to be processed for
improved feed veal. See Sec.
efficiency. 558.305(d) of this
chapter. Laidlomycin
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(vi) 10 mg/lb of body weight Laidlomycin, 5 to Cattle fed in Feed continuously at 054771
daily. 10. confinement for a rate of 30 to 75
slaughter: For mg laidlomycin
treatment of propionate potassium
bacterial enteritis per head per day for
caused by E. coli and not more than 5
bacterial pneumonia days. A withdrawal
caused by P. period has not been
multocida organisms established for this
susceptible to product in pre-
chlortetracycline; ruminating calves.
and for improved feed Do not use in calves
efficiency. to be processed for
veal. See Sec.
558.305(d) of this
chapter. Laidlomycin
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(vii) 500 to 2,000 to provide Lasalocid, 10 to Cattle fed in Feed continuously in 054771
10 mg/lb of body weight daily. 30. confinement for complete feed for
slaughter: For not more than 5 days
treatment of to provide 10 mg
bacterial enteritis chlortetracycline
caused by E. coli and per lb. body weight
bacterial pneumonia per day and not less
caused by P. than 100 mg or more
multocida organisms than 360 mg
susceptible to lasalocid per head
chlortetracycline; per day. Do not
and for improved feed allow horses or
efficiency. other equines access
to feeds containing
lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
[[Page 95000]]
(viii) 500 to 1,200 to provide Lasalocid, 25 to Cattle fed in Feed continuously in 054771
10 mg/lb of body weight daily. 30. confinement for complete feed for
slaughter: For not more than 5 days
treatment of to provide 10 mg
bacterial enteritis chlortetracycline
caused by E. coli and per lb. body weight
bacterial pneumonia per day and not less
caused by P. than 250 mg or more
multocida organisms than 360 mg
susceptible to lasalocid per head
chlortetracycline; per day. Do not
and for increased allow horses or
rate of weight gain other equines access
and improved feed to feeds containing
efficiency. lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(ix) 500 to 4,000 to provide Lasalocid, 30 to Pasture cattle Feed continuously on 054771
10 mg/lb of body weight daily. 600. (slaughter, stocker, a hand-fed basis for
feeder cattle, dairy not more than 5 days
and beef replacement to provide 10 mg
heifers): For chlortetracycline
treatment of per lb. body weight
bacterial enteritis per day and not less
caused by E. coli and than 60 mg or more
bacterial pneumonia than 300 mg
caused by P. lasalocid per head
multocida organisms per day. Daily
susceptible to lasalocid intakes in
chlortetracycline; excess of 200 mg/
and for increased head/day in pasture
rate of weight gain cattle have not been
and improved feed shown to be more
efficiency. effective than 200
mg lasalocid/head/
day. Do not allow
horses or other
equines access to
feeds containing
lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(x) 500 to 4,000 g/ton........ ................. Calves, beef and Feed continuously for 054771
nonlactating dairy not more than 5 days 069254
cattle: For the to provide 10 mg/lb
treatment of body weight per day.
bacterial enteritis To sponsor No.
caused by E. coli and 054771 under NADA
bacterial pneumonia 046-699: 24-hour
caused by P. withdrawal period.
multocida susceptible To sponsor No.
to chlortetracycline. 054771 under NADA
048-761 and No.
069254 under ANADA
200-510: Zero
withdrawal period.
(xi) 500 to 4,000............. Decoquinate, 12.9 Calves, beef and non- Feed at a rate of 1g 054771
to 90.8. lactating dairy chlortetracycline 069254
cattle: For the per 100 lb body
treatment of weight/day and 22.7
bacterial enteritis mg decoquinate per
caused by E. coli and 100 lb of body
bacterial pneumonia weight/day for not
caused by P. more than 5 days.
multocida susceptible When it is fully
to chlortetracycline; consumed, resume
and for the feeding 22.7 mg
prevention of decoquinate per 100
coccidiosis caused by lb of body weight/
Eimeria bovis and E. day for a total of
zuernii. 28 days to prevent
coccidiosis.
Withdraw 24 hours
prior to slaughter.
A withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. Do not feed to
animals producing
milk for food.
Decoquinate as
provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xii) 4,000 to 20,000 g/ton... ................. Calves, beef and As a top dress, 054771
nonlactating dairy varying with body
cattle: For the weight and feed
treatment of consumption, to
bacterial enteritis provide 10 mg/lb per
caused by E. coli and day. Treat for not
bacterial pneumonia more than 5 days.
caused by P. See paragraph (d)(3)
multocida organisms of this section.
susceptible to
chlortetracycline.
[[Page 95001]]
(xiii) 4,000 to 20,000 g/ton.. Decoquinate, 90.8 Calves, beef and non- Administer as a top 054771
to 535.7. lactating dairy dress supplement or
cattle: For the mix into the daily
treatment of ration to provide
bacterial enteritis 22.7 mg decoquinate
caused by E. coli and per 100 lb of body
bacterial pneumonia weight per day and 1
caused by P. g chlortetracycline
multocida susceptible per 100 lb body
to chlortetracycline; weight/day for not
and for the more than 5 days.
prevention of When it is fully
coccidiosis caused by consumed, resume
E. bovis and E. feeding 22.7 mg
zuernii. decoquinate per 100
lb of body weight/
day for a total of
28 days to prevent
coccidiosis.
Withdraw 24 hours
prior to slaughter.
A withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. Do not feed to
animals producing
milk for food.
Decoquinate as
provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xiv) 70 mg/head/day.......... ................. Growing cattle (over See paragraph (d)(3) 054771
400 lb): For of this section. 066104
reduction of 069254
incidence of liver
abscesses.
(xv) 350 mg/head/day.......... ................. 1. Beef cattle: For Withdraw 48 h prior 054771 066104
control of bacterial to slaughter. To 069254
pneumonia associated sponsor No. 054771
with shipping fever under NADA 046-699:
complex caused by 48-hour withdrawal
Pasteurella spp. time. To sponsor No.
susceptible to 054771 under NADA
chlortetracycline. 048-761 and No.
069254 under ANADA
200-510: zero
withdrawal period.
2. Beef cattle (under Withdraw 48 h prior 054771 066104
700 lb): For control to slaughter. To 069254
of active infection sponsor No. 054771
of anaplasmosis under NADA 046-699:
caused by A. 48-hour withdrawal
marginale susceptible time. To sponsor No.
to chlortetracycline. 054771 under NADA
048-761 and No.
069254 under ANADA
200-510: zero
withdrawal time.
(xvi) 350 mg/head/day......... Laidlomycin, 5... Cattle fed in Feed continuously at 054771
confinement for a rate of 30 to 75
slaughter: For mg laidlomycin
control of bacterial propionate potassium
pneumonia associated per head per day. A
with shipping fever withdrawal period
complex caused by has not been
Pasteurella spp. established for this
susceptible to product in pre-
chlortetracycline; ruminating calves.
and for increased Do not use in calves
rate of weight and to be processed for
improved feed veal. See Sec.
efficiency. 558.305(d) of this
chapter. Laidlomycin
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xvii) 350 mg/head/day........ Laidlomycin, 5 to Cattle fed in Feed continuously at 054771
10. confinement for a rate of 30 to 75
slaughter: For mg laidlomycin
control of bacterial propionate potassium
pneumonia associated per head per day. A
with shipping fever withdrawal period
complex caused by has not been
Pasteurella spp. established for this
susceptible to product in pre-
chlortetracycline; ruminating calves.
and for improved feed Do not use in calves
efficiency. to be processed for
veal. See Sec.
558.305(d) of this
chapter. Laidlomycin
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xviii) 25 to 42.2 g/ton to Lasalocid, 25 to Cattle under 700 Feed continuously in 054771
provide 350 mg/head/day. 30. pounds fed in complete feed at a
confinement for rate of 350 mg
slaughter: For chlortetracycline
control of active and not less than
infection of 250 mg nor more than
anaplasmosis caused 360 mg lasalocid per
by A. marginale head daily. Do not
susceptible to allow horses or
chlortetracycline; other equines access
and for increased to feeds containing
rate of weight gain lasalocid. No
and improved feed withdrawal period is
efficiency. required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
[[Page 95002]]
(xix) 25 to 42.2 g/ton to Lasalocid, 25 to Cattle fed in Feed continuously in 054771
provide 350 mg/head/day. 30. confinement for complete feed at a
slaughter: For rate of 350 mg
control of bacterial chlortetracycline
pneumonia associated and not less than
with shipping fever 250 mg nor more than
complex caused by P. 360 mg lasalocid per
multocida organisms head daily. Do not
susceptible to allow horses or
chlortetracycline; other equines access
and for increased to feeds containing
rate of weight gain lasalocid. No
and improved feed withdrawal period is
efficiency. required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xx) 25 to 100 g/ton to Lasalocid, 10 to Cattle under 700 Feed continuously in 054771
provide 350 mg/head/day. 30. pounds fed in complete feed at a
confinement for rate of 350 mg
slaughter: For chlortetracycline
control of active and not less than
infection of 100 mg nor more than
anaplasmosis caused 360 mg lasalocid per
by A. marginale head daily. Do not
susceptible to allow horses or
chlortetracycline; other equines access
and for improved feed to feeds containing
efficiency. lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xxi) 25 to 100 g/ton to Lasalocid, 10 to Cattle fed in Feed continuously in 054771
provide 350 mg/head/day. 30. confinement for complete feed at a
slaughter: For rate of 350 mg
control of bacterial chlortetracycline
pneumonia associated and not less than
with shipping fever 100 mg nor more than
complex caused by P. 360 mg lasalocid per
multocida organisms head daily. Do not
susceptible to allow horses or
chlortetracycline; other equines access
and for improved feed to feeds containing
efficiency. lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xxii) 25 to 700 to provide Lasalocid, 30 to Pasture cattle Feed continuously on 054771
350 mg/head/day. 600. (slaughter, stocker, a hand-fed basis at
feeder cattle, dairy a rate of 350 mg
and beef replacement chlortetracycline
heifers): For control and not less than 60
of bacterial mg nor more than 300
pneumonia associated mg lasalocid per
with shipping fever head per day in at
complex caused by P. least 1 pound of
multocida organisms feed. Daily
susceptible to lasalocid intakes in
chlortetracycline; excess of 200 mg/
and for increased head/day in pasture
rate of weight gain. cattle have not been
shown to be more
effective than 200
mg lasalocid/head/
day. Do not allow
horses or other
equines access to
feeds containing
lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
[[Page 95003]]
(xxiii) 25 to 700 to provide Lasalocid, 30 to Pasture cattle Feed continuously on 054771
350 mg/head/day. 600. (slaughter, stocker, a hand-fed basis at
feeder cattle, beef a rate of 350 mg
replacement heifers) chlortetracycline
under 700 pounds: For and not less than 60
control of active mg nor more than 300
infection of mg lasalocid per
anaplasmosis caused head per day in at
by A. marginale least 1 pound of
susceptible to feed. Daily
chlortetracycline; lasalocid intakes in
and for increased excess of 200 mg/
rate of weight gain. head/day in pasture
cattle have not been
shown to be more
effective than 200
mg lasalocid/head/
day. Do not allow
horses or other
equines access to
feeds containing
lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xxiv) 25 to 2,800 to provide Lasalocid, 30 to Beef cattle weighing Hand feed 054771
350 mg/head/day. 181.8. up to 800 pounds: For continuously at a
control of bacterial rate of 350 mg
pneumonia associated chlortetracycline
with shipping fever and 1 mg lasalocid
complex caused by per 2.2 lb. body
Pasteurella spp. weight daily to
susceptible to cattle with a
chlortetracycline; maximum of 360 mg of
and for the control lasalocid per head
of coccidiosis caused per day. Do not
by E. bovis and E. allow horses or
zuernii. other equines access
to feeds containing
lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(xxv) 500 to 4,000 to provide Lasalocid, 30 to Cattle weighing up to Hand feed 054771
350 mg/head/day. 181.8. 800 pounds: For the continuously at a
treatment of rate of 350 mg
bacterial enteritis chlortetracycline
caused by E. coli and and 1 mg lasalocid
bacterial pneumonia per 2.2 lb. body
caused by P. weight daily to
multocida susceptible cattle with a
to chlortetracycline; maximum of 360 mg of
and for the control lasalocid per head
of coccidiosis caused per day. Do not
by E. bovis and E. allow horses or
zuernii. other equines access
to feeds containing
lasalocid. No
withdrawal period is
required. A
withdrawal period
has not been
established for this
product in pre-
ruminating calves.
Do not use in calves
to be processed for
veal. See Sec.
558.311(d) of this
chapter. Lasalocid
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
----------------------------------------------------------------------------------------------------------------
(5) Minor species. It is used as follows:
----------------------------------------------------------------------------------------------------------------
Chlortetracycline amount Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 80 mg/head/day................ Breeding sheep; reducing the ............................. 054771
incidence of (vibrionic) 066104
abortion caused by 069254
Campylobacter fetus
infection susceptible to
chlortetracycline.
(ii) 200 to 400 g/ton............. Ducks: For the control and Feed in complete ration to 054771
treatment of fowl cholera provide from 8 to 28 mg/lb
caused by Pasteurella of body weight per day,
multocida susceptible to depending upon age and
chlortetracycline. severity of disease, for not
more than 21 days. Do not
feed to ducks producing eggs
for human consumption.
(iii) 10 mg/g of finished feed Psittacine birds (cockatoos, Feed continuously for 45 054771
daily. macaws, and parrots) days. Each bird should
suspected or known to be consume daily an amount of
infected with psittacosis medicated feed equal to one
caused by Chlamydia psittaci fifth of its body weight.
sensitive to See paragraph (d)(5) of this
chlortetracycline. section.
----------------------------------------------------------------------------------------------------------------
[[Page 95004]]
(6) It is used as a free-choice, loose mineral Type C feed as
follows:
(i) Specifications.
------------------------------------------------------------------------
International
Ingredient Percent feed No.
------------------------------------------------------------------------
Dicalcium Phosphate............... 46.20 6-26-335
Sodium Chloride (Salt)............ 15.00 6-04-152
Magnesium Oxide................... 10.67 6-02-756
Cottonseed Meal................... 10.00 5-01-625
Trace Mineral/Vitamin Premix \1\.. 3.80 .................
Calcium Carbonate................. 3.50 6-01-069
Dried Cane Molasses............... 3.00 4-04-695
Potassium Chloride................ 2.00 6-03-755
Mineral Oil....................... 2.00 8-03-123
Iron Oxide........................ 0.50 6-02-431
Chlortetracycline Type A medicated 3.33 .................
article (90 gram/lb).............
------------------------------------------------------------------------
\1\ Content of vitamin and trace mineral premixes may be varied.
However, they should be comparable to those used for other free-choice
feeds. Formulation modifications require FDA approval prior to
marketing. Selenium must comply with 21 CFR 573.920. Ethylenediamine
dihydroiodide (EDDI) should comply with FDA Compliance Policy Guides
Sec. 651.100 (CPG 7125.18).
(ii) Amount. 6,000 grams per ton.
(iii) Indications for use. Beef and nonlactating dairy cattle: As
an aid in the control of active infection of anaplasmosis caused by
Anaplasma marginale susceptible to chlortetracycline.
(iv) Limitations. Feed continuously on a free-choice basis at a
rate of 0.5 to 2.0 mg chlortetracycline per pound of body weight per
day.
(v) Sponsor. See No. 054771 in Sec. 510.600(c) of this chapter.
0
9. In Sec. 558.140, redesignate paragraph (d) as paragraph (e) and add
new paragraph (d) to read as follows:
Sec. 558.140 Chlortetracycline and sulfamethazine.
* * * * *
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for chlortetracycline and
sulfamethazine medicated feeds must not exceed 6 months from the date
of issuance. VFDs for chlortetracycline and sulfamethazine shall not be
refilled.
* * * * *
Sec. 558.145 [Removed]
0
10. Remove Sec. 558.145.
0
11. In Sec. 558.175, in paragraph (b), remove ``Approvals'' and in its
place add ``Sponsor''; add paragraph (c); remove and reserve paragraphs
(d)(5) and (6); and add paragraph (e) to read as follows:
Sec. 558.175 Clopidol.
* * * * *
(c) Related tolerances. See Sec. 556.160 of this chapter.
* * * * *
(e) Clopidol may also be used in combination with:
(1) [Reserved]
(2) [Reserved]
(3) Chlortetracycline as in Sec. 558.128.
(4) Lincomycin as in Sec. 558.325.
0
12. In Sec. 558.195, remove and reserve paragraphs (e)(1)(iv) through
(vi), (e)(2)(ii), (e)(2)(iv), and (e)(2)(vii); and add paragraph (e)(4)
to read as follows:
Sec. 558.195 Decoquinate.
* * * * *
(e) * * *
(4) Decoquinate may also be used in combination with:
(i) [Reserved]
(ii) [Reserved]
(iii) Chlortetracycline as in Sec. 558.128.
(iv) Lincomycin as in Sec. 558.325.
0
13. In Sec. 558.198, remove and reserve paragraphs (d)(1)(iv) and (v);
and add paragraph (d)(3) to read as follows:
Sec. 558.198 Diclazuril.
* * * * *
(d) * * *
(3) Diclazuril may also be used in combination with virginiamycin
as in Sec. 558.635.
0
14. In Sec. 558.248, revise paragraph (a); redesignate paragraph (d)
as paragraph (e); add new paragraph (d); and revise redesignated
paragraph (e) to read as follows:
Sec. 558.248 Erythromycin.
(a) Specifications. Type A medicated articles containing 92.5 grams
per pound erythromycin (as the thiocyanate salt).
* * * * *
(d) Special considerations.--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for erythromycin medicated feeds
must not exceed 6 months from the date of issuance. VFDs for
erythromycin shall not be refilled.
(e) Conditions of use--(1) Chickens--
----------------------------------------------------------------------------------------------------------------
Combination in
Erythromycin in grams/ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 92.5................... .................. Chickens: As an aid in Feed for 2 days before 061623
the prevention of stress and 3 to 6
chronic respiratory days after stress.
disease during periods Withdraw 24 hours
of stress. before slaughter.
(ii) 92.5.................. .................. Chickens: As an aid in Feed for 7 to 14 days. 061623
the prevention of Withdraw 24 hours
infectious coryza. before slaughter.
(iii) 185.................. .................. Chickens: As an aid in Feed for 5 to 8 days. 061623
the prevention and Withdraw 48 hours
reduction of lesions before slaughter. Do
and in lowering not use in birds
severity of chronic producing eggs for
respiratory disease food.
(CRD).
----------------------------------------------------------------------------------------------------------------
[[Page 95005]]
(2) Turkeys--
----------------------------------------------------------------------------------------------------------------
Erythromycin thiocyanate in Combination in
grams/ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 92.5................... .................. Turkeys: As an aid in Feed for 2 days before 061623
the prevention of stress and 3 to 6
chronic respiratory days after stress.
disease during periods
of stress.
(ii) 185................... .................. Turkeys: As an aid in Feed for 5 to 8 days. 061623
the prevention and Do not use in birds
reduction of lesions producing eggs for
and in lowering food.
severity of chronic
respiratory disease
(CRD).
----------------------------------------------------------------------------------------------------------------
0
15. In Sec. 558.258, remove and reserve paragraphs (e)(2)(ii) through
(v); and add paragraph (e)(6) to read as follows:
Sec. 558.258 Fenbendazole.
* * * * *
(e) * * *
(6) Fenbendazole may also be used in combination with:
(i) [Reserved]
(ii) Lincomycin as in Sec. 558.325.
0
16. In Sec. 558.265, remove and reserve paragraphs (d)(1)(iii),
(d)(1)(iv), and (d)(1)(vii); and add paragraph (d)(4) to read as
follows:
Sec. 558.265 Halofuginone.
* * * * *
(d) * * *
(4) Halofuginone may also be used in combination with:
(i) [Reserved]
(ii) Lincomycin as in Sec. 558.325.
(iii) Virginiamycin as in Sec. 558.635.
0
17. Revise Sec. 558.274 to read as follows:
Sec. 558.274 Hygromycin B.
(a) Specifications. Type A medicated articles containing 2.4 or 8
grams hygromycin B per pound (g/lb).
(b) Sponsor. See No. 058198 in Sec. 510.600(c) of this chapter for
as follows:
(c) Related tolerances. See Sec. 556.330 of this chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for hygromycin B medicated feeds
must not exceed 6 months from the date of issuance. VFDs for hygromycin
B shall not be refilled.
(e) Conditions of use. It is used in feed as follows:
(1) Chickens--
----------------------------------------------------------------------------------------------------------------
Combination in
Hygromycin B grams/ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 8 to 12................ .................. Chickens: For control Use in complete feed. 058198
of infections of large Withdraw 3 days
roundworms (Ascaris before slaughter.
galli), cecal worms
(Heterakis gallinae),
and capillary worms
(Capillaria obsignata).
(ii) [Reserved]
----------------------------------------------------------------------------------------------------------------
(2) Swine--
----------------------------------------------------------------------------------------------------------------
Combination in
Hygromycin B grams/ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 12..................... .................. Swine: For control of In market hogs, use in 058198
infections of large complete feed for 8
roundworms (A. suis), weeks during the
nodular worms (O. growing period.
dentatum), and Withdraw 15 days
whipworms (Trichuris before slaughter.
suis).
(ii) [Reserved]
----------------------------------------------------------------------------------------------------------------
0
18. In Sec. 558.300, remove and reserve paragraphs (e)(4) through (7);
and add paragraph (f) to read as follows:
Sec. 558.300 Ivermectin.
* * * * *
(f) Ivermectin may also be used in combination with:
(1) [Reserved]
(2) Lincomycin as in Sec. 558.325.
0
19. In Sec. 558.305, remove paragraphs (e)(2), (e)(3), (e)(5), and
(e)(6); redesignate paragraph (e)(4) as new paragraph (e)(2); and add
paragraph (f) to read as follows:
Sec. 558.305 Laidlomycin.
* * * * *
(f) Laidlomycin may also be used in combination with
chlortetracycline as in Sec. 558.128.
0
20. In Sec. 558.311, in paragraph (e)(1)(i), in the row entry for
``Bambermycins 1 to 2'', in the ``Lasalocid sodium in grams per ton''
column, add ``(ii) 68 (0.0075 pct) to 113 (0.0125 pct).''; in
paragraphs (e)(1)(vi) and (vii), remove the row entries for
``Oxytetracycline 7.5''; in paragraph (e)(1)(xv), remove the row entry
for ``Virginiamycin 10 to 20''; remove and reserve paragraphs
(e)(1)(iii), (e)(1)(v), and (e)(1)(xx) through (e)(1)(xxviii);
redesignate paragraph (e)(5)(i) as paragraph (e)(5)(ii); and add new
paragraphs (e)(5)(i) and (e)(5)(iii) to read as follows:
Sec. 558.311 Lasalocid.
* * * * *
(e) * * *
(5) * * *
(i) Chlortetracycline as in Sec. 558.128.
* * * * *
(iii) Virginiamycin as in Sec. 558.635.
0
21. Revise Sec. 558.325 to read as follows:
[[Page 95006]]
Sec. 558.325 Lincomycin.
(a) Specifications. Type A medicated articles containing 20 or 50
grams of lincomycin (as lincomycin hydrochloride) per pound.
(b) Sponsors. See No. 054771 in Sec. 510.600(c) of this chapter.
(c) Related tolerances. See Sec. 556.360 of this chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for chlortetracycline and
sulfamethazine medicated feeds must not exceed 6 months from the date
of issuance. VFDs for chlortetracycline and sulfamethazine shall not be
refilled.
(3) Labeling of Type A medicated articles and Type B and Type C
medicated feeds containing lincomycin shall bear the following:
(i) ``CAUTION: Do not allow rabbits, hamsters, guinea pigs, horses,
or ruminants access to feeds containing lincomycin. Ingestion by these
species may result in severe gastrointestinal effects.''
(4) Labeling of medicated feeds containing lincomycin intended for
use in swine shall bear the following:
(i) ``CAUTION: Occasionally, swine fed lincomycin may within the
first 2 days after the onset of treatment develop diarrhea and/or
swelling of the anus. On rare occasions, some pigs may show reddening
of the skin and irritable behavior. These conditions have been self-
correcting within 5 to 8 days without discontinuing the lincomycin
treatment.''
(ii) ``CAUTION: The effects of lincomycin on swine reproductive
performance, pregnancy, and lactation have not been determined.''
(e) Conditions of use--(1) Chickens--
----------------------------------------------------------------------------------------------------------------
Combination in
Lincomycin grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(i) 2...................... .................. Broilers: For the Feed as the sole 054771
control of necrotic ration. Not for use
enteritis caused or in layers, breeders,
complicated by or turkeys.
Clostridium spp. or
other organisms
susceptible to
lincomycin.
(ii) [Reserved]
----------------------------------------------------------------------------------------------------------------
(2) Swine--
----------------------------------------------------------------------------------------------------------------
Combination in
Lincomycin grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(i) 40..................... .................. For control of swine Feed as sole ration. 054771
dysentery and the For use in swine on
control of porcine premises with a
proliferative history of swine
enteropathies dysentery but where
(ileitis) caused by symptoms have not yet
Lawsonia occurred, or
intracellularis. following use of
lincomycin at 100
grams (g)/ton for the
treatment of swine
dysentery and the
control of porcine
proliferative
enteropathies
(ileitis).
(ii) 40.................... Fenbendazole, 10 For control of swine Feed as sole ration to 000061
to 80. dysentery in animals provide a total dose
on premises with a of 9 mg fenbendazole/
history of swine kg of body weight
dysentery, but where within 3 to 12 days.
symptoms have not yet Do not feed to swine
occurred; and for the that weigh more than
removal of: Adult 250 pounds.
stage lungworms Lincomycin as
(Metastrongylus apri provided by No.
and M. pudendotectus); 054771; fenbendazole
adult and larvae (L3, as provided by No.
4 stages--liver, lung, 000061 in Sec.
intestinal forms) 510.600(c) of this
large roundworms chapter.
(Ascaris suum); adult
stage nodular worms
(Oesophagostomum
dentatum, O.
quadrispinulatum);
adult stage small
stomach worms
(Hyostrongylus
rubidus); adult and
larvae (L2, 3, 4
stages--intestinal
mucosal forms)
whipworms (Trichuris
suis); adult and
larvae kidney worms
(Stephanurus dentatus).
[[Page 95007]]
(iii) 40................... Ivermectin, 1.8... Weaned, growing and Feed as the only feed 050604
finishing swine: For for 7 consecutive
control of swine days to provide 0.1
dysentery on premises mg ivermectin/kg of
with a history of body weight per day.
swine dysentery, but A separate feed
where symptoms have containing 40 g/ton
not yet occurred; and lincomycin may be
for treatment and continued to complete
control of the lincomycin
gastrointestinal treatment. Not to be
roundworms (Ascaris fed to swine that
suum, adults and weigh more than 250
fourth-stage larvae; lbs. Withdraw 5 days
Ascarops strongylina, before slaughter.
adults; Hyostrongylus Lincomycin as
rubidus, adults and provided by No.
fourth-stage larvae; 054771; ivermectin as
Oesophagostomum spp., provided by No.
adults and fourth- 050604 in Sec.
stage larvae); kidney 510.600(c) of this
worms (Stephanurus chapter.
dentatus, adults and
fourth-stage larvae);
lungworms
(Metastrongylus spp.,
adults); lice
(Haematopinus suis);
and mange mites
(Sarcoptes scabiei
var. suis).
(iv) 40.................... Pyrantel, 96...... For control of swine Feed as the sole 066104
dysentery on premises ration. Not to be fed
with a history of to swine that weigh
swine dysentery, but more than 250 pounds.
where symptoms have Withdraw 6 days prior
not yet occurred; as to slaughter.
an aid in the Lincomycin as
prevention of provided by No.
migration and 054771; pyrantel as
establishment of large provided by No.
roundworm (Ascaris 066104 in Sec.
suum) infections; and 510.600(c) of this
as an aid in the chapter.
prevention of
establishment of
nodular worm
(Oesophagostomum spp.)
infections.
(v) 40..................... Pyrantel, 96...... For the treatment and/ Feed for 3 days as the 066104
or control of swine sole ration. Not to
dysentery; for removal be fed to swine that
and control of large weigh more than 250
roundworm (Ascaris pounds. Withdraw 24
suum) infections. hours prior to
slaughter. Lincomycin
as provided by No.
054771; pyrantel as
provided by No.
066104 in Sec.
510.600(c) of this
chapter.
(vi) 40 or 100............. Pyrantel, 96...... For the treatment and/ For treatment of swine 066104
or control of swine dysentery, feed 100
dysentery; as an aid grams of lincomycin
in the prevention of and 96 grams of
migration and pyrantel tartrate per
establishment of large ton of complete feed
roundworm (Ascaris for 3 weeks or until
suum) infections; and clinical signs of the
as an aid in the disease disappear,
prevention of following with 40
establishment of grams of lincomycin
nodular worm and 96 grams of
(Oesophagostomum spp.) pyrantel tartrate per
infections. ton of complete feed
as the sole ration.
Not to be fed to
swine that weigh more
than 250 pounds.
Withdraw 6 days prior
to slaughter.
Lincomycin as
provided by No.
054771; pyrantel as
provided by No.
066104 in Sec.
510.600(c) of this
chapter.
(vii) 100.................. .................. For treatment of swine Feed as the sole 054771
dysentery and the ration for 3 weeks or
control of porcine until clinical signs
proliferative of the disease
enteropathies disappear.
(ileitis) caused by
Lawsonia
intracellularis.
(viii) 100................. Fenbendazole, 10 For the treatment of Feed as sole ration to 000061
to 80. swine dysentery; and provide a total dose
for the removal of: of 9 mg fenbendazole/
Adult stage lungworms kg of body weight
(Metastrongylus apri within 3 to 12 days.
and M. pudendotectus); Do not feed to swine
adult and larvae (L3, that weigh more than
4 stages--liver, lung, 250 pounds. Do not
intestinal forms) use within 6 days of
large roundworms slaughter. Lincomycin
(Ascaris suum); adult as provided by No.
stage nodular worms 054771; fenbendazole
(Oesophagostomum as provided by No.
dentatum, O. 000061 in Sec.
quadrispinulatum); 510.600(c) of this
adult stage small chapter.
stomach worms
(Hyostrongylus
rubidus); adult and
larvae (L2, 3, 4
stages--intestinal
mucosal forms)
whipworms (Trichuris
suis); adult and
larvae kidney worms
(Stephanurus dentatus).
[[Page 95008]]
(ix) 100................... Ivermectin, 1.8... Weaned, growing and Feed as the only feed 050604
finishing swine: For for 7 consecutive
the treatment of swine days to provide 0.1
dysentery; and for mg ivermectin/kg of
treatment and control body weight per day.
of gastrointestinal A separate feed
roundworms (Ascaris containing 100 g/ton
suum, adults and lincomycin may be
fourth-stage larvae; continued to complete
Ascarops strongylina, the lincomycin
adults; Hyostrongylus treatment. Not to be
rubidus, adults and fed to swine that
fourth-stage larvae; weigh more than 250
Oesophagostomum spp., lbs. Withdraw 6 days
adults and fourth- before slaughter.
stage larvae); Lincomycin as
kidneyworms provided by No.
(Stephanurus dentatus, 054771; ivermectin as
adults and fourth- provided by No.
stage larvae); 050604 in Sec.
lungworms 510.600(c) of this
(Metastrongylus spp., chapter.
adults); lice
(Haematopinus suis);
and mange mites
(Sarcoptes scabiei
var. suis).
(x) 100.................... Pyrantel, 96...... For the treatment of Feed as the sole 066104
swine dysentery; as an ration for 3 weeks or
aid in the prevention until clinical signs
of migration and of the disease
establishment of large disappear. Not to be
roundworm (Ascaris fed to swine that
suum) infections; and weigh more than 250
as an aid in the pounds. Withdraw 6
prevention of days prior to
establishment of slaughter. Lincomycin
nodular worm as provided by No.
(Oesophagostomum spp.) 054771; pyrantel as
infections. provided by No.
066104 in Sec.
510.600(c) of this
chapter.
(xi) 100................... Pyrantel, 96...... For the treatment and/ Feed for 3 days as the 066104
or control of swine sole ration. Not to
dysentery; for removal be fed to swine that
and control of large weigh more than 250
roundworm (Ascaris pounds. Withdraw 24
suum) infections. hours prior to
slaughter. Lincomycin
as provided by No.
054771; pyrantel as
provided by No.
066104 in Sec.
510.600(c) of this
chapter.
(xii) 100.................. Pyrantel, 800..... For the treatment and/ Feed as a single 066104
or control of swine therapeutic
dysentery; for removal treatment. Not to be
and control of large fed to swine that
roundworm (Ascaris weigh more than 250
suum) and nodular worm pounds. Withdraw 24
(Oesophagostomum spp.) hours prior to
infections. slaughter. Lincomycin
as provided by No.
054771; pyrantel as
provided by No.
066104 in Sec.
510.600(c) of this
chapter.
(xiii) 200................. .................. For reduction in the Feed as sole ration 054771
severity of swine for 21 days.
mycoplasmal pneumonia
caused by Mycoplasma
hyopneumoniae.
(xiv) 200.................. Fenbendazole, 10 For reduction in the Feed as sole ration to 000061
to 80. severity of swine provide a total dose
mycoplasmal pneumonia of 9 mg fenbendazole/
caused by Mycoplasma kg of body weight
hyopneumoniae; and for within 3 to 12 days.
the removal of: Adult Do not feed to swine
stage lungworms that weigh more than
(Metastrongylus apri 250 pounds. Do not
and M. pudendotectus); use within 6 days of
adult and larvae (L3, slaughter. Lincomycin
4 stages--liver, lung, as provided by No.
intestinal forms) 054771; fenbendazole
large roundworms as provided by No.
(Ascaris suum); adult 000061 in Sec.
stage nodular worms 510.600(c) of this
(Oesophagostomum chapter.
dentatum, O.
quadrispinulatum);
adult stage small
stomach worms
(Hyostrongylus
rubidus); adult and
larvae (L2, 3, 4
stages--intestinal
mucosal forms)
whipworms (Trichuris
suis); adult and
larvae kidney worms
(Stephanurus dentatus).
[[Page 95009]]
(xv) 200................... Ivermectin, 1.8... For reduction in the Feed as the only feed 050604
severity of swine for 7 consecutive
mycoplasmal pneumonia days to provide 0.1
caused by Mycoplasma mg ivermectin/kg of
hyopneumoniae; and for body weight per day.
treatment and control A separate feed
of gastrointestinal containing 200 g/ton
roundworms (Ascaris lincomycin may be
suum, adults and continued for an
fourth-stage larvae; additional 14 days to
Ascarops strongylina, complete the
adults; Hyostrongylus lincomycin treatment.
rubidus, adults and Not to be fed to
fourth-stage larvae; swine that weigh more
Oesophagostomum spp., than 250 lbs.
adults and fourth- Withdraw 6 days
stage larvae); before slaughter.
kidneyworms Lincomycin as
(Stephanurus dentatus, provided by No.
adults and fourth- 054771; ivermectin as
stage larvae); provided by No.
lungworms 050604 in Sec.
(Metastrongylus spp., 510.600(c) of this
adults); lice chapter.
(Haematopinus suis);
and mange mites
(Sarcoptes scabiei
var. suis).
(xvi) 200.................. Pyrantel, 96...... For reduction in the Feed as the sole 054771
severity of swine ration for 21 days.
mycoplasmal pneumonia Not for use in swine
caused by Mycoplasma that weigh more than
hyopneumoniae; and as 250 pounds. Withdraw
an aid in the 6 days before
prevention of slaughter. Lincomycin
migration and as provided by No.
establishment of large 054771; pyrantel as
roundworm (Ascaris provided by No.
suum) infections; aid 066104 in Sec.
in the prevention of 510.600(c) of this
establishment of chapter.
nodular worm
(Oesophagostomum spp.)
infections.
----------------------------------------------------------------------------------------------------------------
0
22. In Sec. 558.342, remove and reserve paragraphs (e)(1)(iii),
(e)(1)(iv), (e)(1)(viii), (e)(1)(ix), and (e)(1)(xi); and revise
paragraph (e)(2) to read as follows:
Sec. 558.342 Melengestrol.
* * * * *
(e) * * *
(2) Melengestrol may also be used in combination with:
(i) Ractopamine as in Sec. 558.500.
(ii) Tylosin as in Sec. 558.625.
(iii) Zilpaterol as in Sec. 558.665.
0
23. In Sec. 558.355, revise paragraphs (a) and (b); remove and reserve
paragraphs (f)(1)(viii), (f)(1)(ix), (f)(1)(xiii), (f)(1)(xiv),
(f)(1)(xxi), (f)(1)(xxii), (f)(1)(xxxi), (f)(2)(iv), (f)(3)(ii), and
(f)(3)(xii); and revise paragraph (f)(8) to read as follows:
Sec. 558.355 Monensin.
(a) Specifications. Type A medicated articles containing 45, 60,
90.7, or 110 grams monensin, USP, per pound.
(b) Approvals. See sponsor numbers in Sec. 510.600(c) of this
chapter for conditions of use as in paragraph (f) of this section:
(1) No. 058198 for use as in paragraph (f) of this section.
(2) No. 054771 for use as in paragraphs (f)(1)(xxiv) and (xxv) of
this section.
(3) No. 058198 for use as in paragraphs (f)(1)(i), (iii), (iv), and
(v) of this section.
* * * * *
(f) * * *
(8) Monensin may also be used in combination with:
(i) Chlortetracycline as in Sec. 558.128.
(ii) Decoquinate as in Sec. 558.195.
(iii) Lincomycin as in Sec. 558.325.
(iv) Melengestrol acetate as in Sec. 558.342.
(v) Oxytetracycline as in Sec. 558.128.
(vi) Ractopamine alone or in combination as in Sec. 558.500.
(vii) Tilmicosin as in Sec. 558.618.
(viii) Tylosin as in Sec. 558.625.
(ix) Virginiamycin as in Sec. 558.635.
(x) Zilpaterol alone or in combination as in Sec. 558.665.
0
24. In Sec. 558.364, redesignate paragraph (d) as paragraph (e) and
revise paragraphs (a) through (d) to read as follows:
Sec. 558.364 Neomycin sulfate.
(a) Specifications. Type A medicated article containing 325 grams
neomycin sulfate per pound.
(b) Sponsor. See No. 054771 in Sec. 510.600(c) of this chapter.
(c) Related tolerances. See Sec. 556.430 of this chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for neomycin medicated feeds must
not exceed 6 months from the date of issuance. VFDs for neomycin shall
not be refilled.
* * * * *
0
25. In Sec. 558.366, in the table in paragraph (d), remove the row
entries under ``Nicarbazin in grams per ton'' ``27 to 45'' for
``Narasin 27 to 45 and Lincomycin 2 to 4''; and under ``Nicarbazin in
grams per ton'' ``113.5 (0.0125 pct)'' for ``Lincomycin 2 (0.00044
pct)''; and add paragraph (e) to read as follows:
Sec. 558.366 Nicarbazin.
* * * * *
(e) * * *
(6) Nicarbazin may also be used in combination with:
(i) [Reserved]
(ii) Lincomycin as in Sec. 558.325.
Sec. 558.435 [Removed]
0
26. Remove Sec. 556.435.
0
27. Revise Sec. 558.450 to read as follows:
Sec. 558.450 Oxytetracycline.
(a) Specifications. Each pound of Type A medicated article
contains:
(1) Oxytetracycline (from oxytetracycline quaternary salt)
equivalent to 50 or 100 grams oxytetracycline hydrochloride; or
oxytetracycline (from oxytetracycline dihydrate base) equivalent to 10,
30, 50, 100, or 200 grams oxytetracycline hydrochloride.
(2) Oxytetracycline (from oxytetracycline dihydrate base)
equivalent to 50, 100, or 200 grams oxytetracycline hydrochloride; or
100 grams oxytetracycline hydrochloride.
(b) Sponsors. See sponsors in Sec. 510.600(c) of this chapter as
follows:
[[Page 95010]]
(1) No. 066104: Type A medicated articles as in paragraph (a)(1) of
this section.
(2) No. 069254: Type A medicated articles as in paragraph (a)(2) of
this section.
(c) Related tolerances. See Sec. 556.500 of this chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for oxytetracycline medicated feeds
must not exceed 6 months from the date of issuance. VFDs for
oxytetracycline shall not be refilled.
(3) In accordance with Sec. 558.5, labeling shall bear the
statement: ``For use in dry animal feed only. Not for use in liquid
feed supplements.''
(e) Conditions of use--(1) Chickens--
----------------------------------------------------------------------------------------------------------------
Combination in
Oxytetracycline amount grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 100 to 200 g/ton....... .................. Chickens: For control Feed continuously for 066104
of infectious 7 to 14 days. Do not 069254
synovitis caused by feed to chickens
Mycoplasma synoviae producing eggs for
and control of fowl human consumption. Do
cholera caused by not use in feed
Pasteurella multocida containing less than
susceptible to 0.55% dietary
oxytetracycline. calcium. Use in such
low calcium feeds may
result in violative
residues. Zero-day
withdrawal period.
(ii) 200 g/ton............. Monensin, 90 to Broiler chickens: As an Feed continuously as 066104
110. aid in the prevention the sole ration. Do
of coccidiosis caused not feed to laying
by Eimeria necatrix, chickens. Do not feed
E. tenella, E. to chickens over 16
acervulina, E. weeks of age. Do not
brunetti, E. mivati, use in feed
and E. maxima; and for containing less than
the control of 0.55% dietary
complicated chronic calcium. Use in such
respiratory disease low calcium feeds may
(CRD or air sac result in violative
infection) caused by residues. Withdraw 72
Mycoplasma hours before
gallisepticum and slaughter. See Sec.
Escherichia coli. 558.355(d) of this
chapter
Oxytetracycline as
provided by No.
066104; monensin as
provided by No.
058198 in Sec.
510.600(c) of this
chapter.
(iii) 400 g/ton............ .................. Chickens: For control Feed continuously for 066104
of chronic respiratory 7 to 14 days. Do not 069254
disease (CRD) and air feed to chickens
sac infection caused producing eggs for
by Mycoplasma human consumption. Do
gallisepticum and not use in feed
Escherichia coli containing less than
susceptible to 0.55% dietary
oxytetracycline. calcium. Use in such
low calcium feeds may
result in violative
residues. Zero-day
withdrawal period.
(iv) 400 g/ton............. Robenidine, 30.... Broiler chickens: As an Feed continuously for 066104
aid in the prevention 7 to 14 days. Do not
of coccidiosis caused feed to chickens
by Eimeria necatrix, producing eggs for
E. tenella, E. human consumption. Do
acervulina, E. not use in feed
brunetti, E. mivati, containing less than
and E. maxima; and for 0.55% dietary
the control of chronic calcium. Use in such
respiratory disease low calcium feeds may
(CRD) and air sac result in violative
infection caused by residues. Withdraw 5
Mycoplasma days before
gallisepticum and slaughter.
Escherichia coli Oxytetracycline as
susceptible to provided by No.
oxytetracycline. 066104; robenidine as
provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(v) 500 g/ton.............. .................. Chickens: For reduction Feed continuously for 066104
of mortality due to 5 days. Do not feed 069254
air sacculitis (air to chickens producing
sac infection) caused eggs for human
by E. coli susceptible consumption. Do not
to oxytetracycline. use in feed
containing less than
0.55% dietary
calcium. Use in such
low calcium feeds may
result in violative
residues. Withdraw 24
hours before
slaughter.
(vi) 500 g/ton............. Monensin, 90 to Broiler chickens: As an Feed for 5 days as the 066104
100. aid in the prevention sole ration. Treat at
of coccidiosis caused first clinical signs
by Eimeria necatrix, of the disease. Do
E. tenella, E. not feed to laying
acervulina, E. chickens. Do not feed
brunetti, E. mivati, to chickens over 16
and E. maxima; and as weeks of age. Do not
an aid in the use in feed
reduction of mortality containing less than
due to air-sacculitis 0.55% dietary
(air sac infection) calcium. Use in such
caused by Escherichia low calcium feeds may
coli sensitive to result in violative
oxytetracycline. residues. Withdraw 72
hours before
slaughter. See Sec.
558.355(d) of this
chapter.
Oxytetracycline as
provided by No.
066104; monensin as
provided by No.
058198 in Sec.
510.600(c) of this
chapter.
[[Page 95011]]
(vii) 500 g/ton............ Salinomycin, 40 to Chickens: For the Feed for 5 days as the 066104
60. prevention of sole ration. Treat at 016592
coccidiosis caused by first clinical signs
Eimeria necatrix, E. of the disease. Do
tenella, E. not feed to laying
acervulina, E. chickens. Do not use
brunetti, E. mivati, in feed containing
and E. maxima; and as less than 0.55%
an aid in the dietary calcium. Use
reduction of mortality in such low calcium
due to air-sacculitis feeds may result in
(air sac infection) violative residues.
caused by E. coli Withdraw 24 hours
sensitive to before slaughter.
oxytetracycline. Oxytetracycline as
provided by No.
066104; salinomycin
as provided by No.
016592 in Sec.
510.600(c) of this
chapter.
----------------------------------------------------------------------------------------------------------------
(2) Turkeys--
----------------------------------------------------------------------------------------------------------------
Oxytetracycline amount Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 100 g/ton..................... Turkeys: For control of Feed continuously for 7 to 14 066104
hexamitiasis caused by days. Do not feed to turkeys 069254
Hexamita meleagridis producing eggs for human
susceptible to consumption. Zero-day
oxytetracycline. withdrawal period.
(ii) 200 g/ton.................... Turkeys: For control of Feed continuously for 7 to 14 066104
infectious synovitis caused days. Do not feed to turkeys 069254
by M. synoviae susceptible producing eggs for human
to oxytetracycline. consumption. For No. 066104,
withdraw 5 days before
slaughter. For No. 069254,
zero-day withdrawal period.
(iii) 25 mg/lb of body weight Turkeys: For control of Feed continuously for 7 to 14 066104
daily. complicating bacterial days. Do not feed to turkeys 069254
organisms associated with producing eggs for human
bluecomb (transmissible consumption. For No. 066104,
enteritis; coronaviral withdraw 5 days before
enteritis) susceptible to slaughter. For No. 069254,
oxytetracycline. zero-day withdrawal period.
----------------------------------------------------------------------------------------------------------------
(3) Swine--
----------------------------------------------------------------------------------------------------------------
Combination in
Oxytetracycline amount grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 10 mg/lb of body weight .................. 1. Swine: For treatment Feed continuously for 066104
daily. of bacterial enteritis 7 to 14 days. 069254
caused by Escherichia
coli and Salmonella
choleraesuis
susceptible to
oxytetracycline and
treatment of bacterial
pneumonia caused by
Pasteurella multocida
susceptible to
oxytetracycline.
2. Breeding swine: For Feed continuously for 066104
control and treatment 14 days. 069254
of leptospirosis
(reducing the
incidence of abortion
and shedding of
leptospirae) caused by
Leptospira pomona
susceptible to
oxytetracycline.
(ii) 10 mg/lb of body Carbadox, 10 to 25 Swine: For treatment of Feed continuously as 066104
weight daily. bacterial enteritis the sole ration for 7
caused by E. coli and to 14 days. Not for
Salmonella use in pregnant swine
choleraesuis or swine intended for
susceptible to breeding purposes. Do
oxytetracycline and not mix in feeds
treatment of bacterial containing bentonite.
pneumonia caused by Do not feed to swine
Pasteurella multocida within 42 days of
susceptible to slaughter.
oxytetracycline; and Oxytetracycline and
for increased rate of carbadox as provided
weight gain and by No. 066104 in Sec.
improved feed 510.600(c) of this
efficiency. chapter.
----------------------------------------------------------------------------------------------------------------
(4) Cattle--
[[Page 95012]]
----------------------------------------------------------------------------------------------------------------
Combination in
Oxytetracycline amount grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 10 mg/lb of body weight .................. 1. Calves and beef and Feed continuously for 066104
daily. nonlactating dairy 7 to 14 days. For No. 069254
cattle: For treatment 069254, withdraw 5
of bacterial enteritis days before
caused by Escherichia slaughter. For No.
coli and bacterial 066104, zero-day
pneumonia (shipping withdrawal period.
fever complex) caused
by Pasteurella
multocida susceptible
to oxytetracycline.
2. Calves: For Feed continuously for 066104
treatment of bacterial 7 to 14 days in milk 069254
enteritis caused by E. replacer or starter
coli susceptible to feed. This product is
oxytetracycline. not approved for use
in female dairy
cattle 20 months of
age or older,
including dry dairy
cows. Use in these
cattle may cause drug
residues in milk and/
or in calves born to
these cows. For No.
069254, withdraw 5
days before
slaughter. For No.
066104, zero-day
withdrawal period.
(ii) 75 mg/head/day........ .................. Growing cattle (over Feed continuously..... 066104
400 lb): For reduction 069254
of incidence of liver
abscesses.
(iii) 0.5 to 2.0 g/head/day .................. Cattle: For prevention Feed 3 to 5 days 066104
and treatment of the before and after 069254
early stages of arrival in feedlots.
shipping fever complex.
----------------------------------------------------------------------------------------------------------------
(5) Minor species--
----------------------------------------------------------------------------------------------------------------
Oxytetracycline amount Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 10 mg/lb of body weight daily... Sheep: For treatment of Feed continuously for 7 to 066104
bacterial enteritis caused 14 days; withdraw 5 days 069254
by E. coli and bacterial before slaughter.
pneumonia caused by P.
multocida susceptible to
oxytetracycline.
(ii) 200 mg/colony.................. Honey bees: For control of Remove at least 6 weeks 066104
American foulbrood caused prior to main honey flow. 069254
by Paenibacillus larvae and
European foulbrood caused
by Streptococcus pluton
susceptible to
oxytetracycline.
(iii) 250 mg/kilogram of fish/day Pacific salmon: For marking For salmon not over 30 g 066104
(11.35 g/100 lb of fish/day). of skeletal tissue. body weight; administer as
sole ration for 4
consecutive days; fish not
to be liberated for at
least 7 days following the
last administration of
medicated feed.
(iv) 2.5 to 3.75 g/100 lb of fish/ 1. Salmonids: For control of Administer in mixed ration 066104
day. ulcer disease caused by for 10 days; do not
Haemophilus piscium, liberate fish or slaughter
furunculosis caused by fish for food for 21 days
Aeromonas salmonicida, following the last
bacterial hemorrhagic administration of medicated
septicemia caused by A. feed.
liquefaciens, and
pseudomonas disease.
2. Catfish: For control of Administer in mixed ration 066104
bacterial hemorrhagic for 10 days; do not
septicemia caused by A. liberate fish or slaughter
liquefaciens and fish for food for 21 days
pseudomonas disease. following the last
administration of medicated
feed; do not administer
when water temperature is
below 16.7 [deg]C (62
[deg]F).
(v) 3.75 g/100 lb of fish/day....... 1. Freshwater-reared Administer in mixed ration 066104
salmonids: For control of for 10 days; do not
mortality due to coldwater liberate fish or slaughter
disease associated with fish for food for 21 days
Flavobacterium following the last
psychrophilum. administration of medicated
feed.
2. Freshwater-reared Administer in mixed ration 066104
Oncorhynchus mykiss: For for 10 days; do not
control of mortality due to liberate fish or slaughter
columnaris disease fish for food for 21 days
associated with following the last
Flavobacterium columnare. administration of medicated
feed.
(vi) 1 g/lb of medicated feed....... Lobsters: For control of Administer as sole ration 066104
gaffkemia caused by for 5 consecutive days;
Aerococcus viridans. withdraw medicated feed 30
days before harvesting
lobsters.
----------------------------------------------------------------------------------------------------------------
0
28. In Sec. 558.455, revise paragraph (d); remove and reserve
paragraphs (e)(1)(i), (e)(2)(i), (e)(3)(i), (e)(4)(i), (e)(4)(ii), and
(e)(4)(iv); and in paragraph (e)(4)(v), remove ``increased rate of
weight gain; improved feed efficiency, and'' to read as follows:
Sec. 558.455 Oxytetracycline and neomycin.
* * * * *
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for oxytetracycline and neomycin
[[Page 95013]]
medicated feeds must not exceed 6 months from the date of issuance.
VFDs for oxytetracycline and neomycin shall not be refilled.
(3) Cattle feeds shall bear the following warning statement: ``Use
of more than one product containing neomycin or failure to follow
withdrawal times may result in illegal drug residues.''
* * * * *
Sec. 558.460 [Removed]
0
29. Remove Sec. 558.460.
0
30. In Sec. 558.485, remove paragraphs (e)(1)(v) through (xii); and
add paragraph (e)(3) to read as follows:
Sec. 558.485 Pyrantel.
* * * * *
(e) * * *
(3) Pyrantel may also be used in combination with:
(i) Lincomycin as in Sec. 558.325.
(ii) Tylosin as in Sec. 558.325.
0
31. In Sec. 558.500, remove and reserve paragraphs (e)(1)(ii), (iii),
and (iv), (e)(2)(iv), (e)(2)(ix) and (x); remove paragraph
(e)(2)(xiii); and add paragraph (e)(4) to read as follows:
Sec. 558.500 Ractopamine.
* * * * *
(e) * * *
(4) Ractopamine may also be used in combination with tylosin in as
in Sec. 558.625.
0
32. In Sec. 558.515, in the table in paragraph (d), remove the row
entries for ``Chlortetracycline 100 to 200'', ``Chlortetracycline 200
to 400'', ``Chlortetracycline 500'', ``Lincomycin 2'', and
``Oxytetracycline 400'' in the ``Combination in grams/ton'' column; and
add paragraph (e) to read as follows:
Sec. 558.515 Robenidine.
* * * * *
(e) Robenidine may also be used in combination with:
(1) Chlortetracycline as in Sec. 558.128.
(2) Lincomycin as in Sec. 558.325.
(3) Oxytetracycline as in Sec. 558.450.
0
33. In Sec. 558.550, remove and reserve paragraphs (d)(1)(x),
(d)(1)(xi), (d)(1)(xiii), and (d)(1)(xvi); and revise paragraph (d)(4)
to read as follows:
Sec. 558.550 Salinomycin.
* * * * *
(d) * * *
(5) Salinomycin may also be used in combination with:
(i) [Reserved]
(ii) [Reserved]
(iii) Chlortetracycline as in Sec. 558.128.
(iv) Lincomycin as in Sec. 558.325.
(v) Oxytetracycline as in Sec. 558.450.
(vi) Virginiamycin as in Sec. 558.635.
0
34. In Sec. 558.555, remove paragraphs (d)(3) through (5); (e)(3) and
(e)(4); remove and reserve paragraph (e)(2); and add paragraph (f) to
read as follows:
Sec. 558.555 Semduramycin.
* * * * *
(f) Semduramycin may also be used in combination with virginiamycin
as in Sec. 558.635.
0
35. In Sec. 558.575, revise the section heading; redesignate
paragraphs (b), (c), and (d) as paragraphs (c), (d), and (e); revise
paragraph (a); and add new paragraphs (b) and (d) to read as follows:
Sec. 558.575 Sulfadimethoxine and ormetoprim.
(a) Specifications. Type A medicated articles containing either:
(1) 25 percent sulfadimethoxine and 15 percent ormetoprim; or
(2) 25 percent sulfadimethoxine and 5 percent ormetoprim.
(b) Sponsors. See sponsors in Sec. 510.600(c) of this chapter for
use as in paragraph (d) of this section:
(1) No. 054771 for use of the product described in paragraph (a)(1)
as in paragraphs (e)(1), (e)(2), (e)(3), (e)(4), and (e)(7) of this
section.
(2) No. 015331 for use of the product described in paragraph (a)(2)
as in paragraphs (e)(5) and (e)(6) of this section.
* * * * *
(d) Special considerations.--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for sulfadimethoxine and ormetoprim
medicated feeds must not exceed 6 months from the date of issuance.
VFDs for sulfadimethoxine and ormetoprim shall not be refilled.
* * * * *
0
36. Revise Sec. 558.582 to read as follows:
Sec. 558.582 Sulfamerazine.
(a) Specifications. Type A medicated articles containing 99 percent
sulfamerazine.
(b) Sponsor. See No. 054771 in Sec. 510.600(c) of this chapter.
(c) Related tolerances. See Sec. 556.660 of this chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for sulfamerazine medicated feeds
must not exceed 6 months from the date of issuance. VFDs for
sulfamerazine shall not be refilled.
(e) Conditions of use. It is used in fish feed for as follows:
----------------------------------------------------------------------------------------------------------------
Combination in
Sulfamerazine grams/ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(1) To deliver 10 grams of .................. Rainbow trout, brook Formulate to deliver 054771
sulfamerazine per 100 trout, and brown 10 grams of
pounds of fish per day. trout: For control of sulfamerazine per 100
furunculosis. pounds of fish per
day. Treat for not
more than 14 days. Do
not treat within 3
weeks of marketing or
stocking in stream
open to fishing.
(2) [Reserved]..............
----------------------------------------------------------------------------------------------------------------
0
37. Revise Sec. 558.586 to read as follows:
Sec. 558.586 Sulfaquinoxaline.
(a) Specifications. Type A medicated articles containing 40 percent
sulfaquinoxaline.
(b) Sponsor. See No. 016592 in Sec. 510.600(c) of this chapter.
(c) Related tolerances. See Sec. 556.685 of this chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for sulfaquinoxaline medicated
feeds must not exceed 6 months from the date of issuance. VFDs for
sulfaquinoxaline shall not be refilled.
(e) Conditions of use--(1) Chickens--
[[Page 95014]]
----------------------------------------------------------------------------------------------------------------
Sulfaquinoxaline in grams/ Combination in
ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 0.015 percent.......... .................. As an aid in preventing Feed continuously from 016592
outbreaks of the time birds are
coccidiosis caused by placed on litter and
Eimeria tenella, E. continue past the age
necatrix, E. when coccidiosis is
acervulina, E. maxima, ordinarily a hazard.
and E. brunetti under If death losses
average conditions of exceed 0.5 percent in
exposure. a 2-day period,
obtain a laboratory
diagnosis. If
coccidiosis is the
cause, use the
sulfaquinoxaline
levels recommended
for control of
outbreaks, returning
to the original
dosage schedule after
the outbreak has
subsided. Losses may
result from
intercurrent disease,
other conditions
affecting drug
intake, or variant
strains of coccidia
species which can
contribute to the
virulence of
coccidiosis under
field conditions. Do
not treat chickens
within 10 days of
slaughter. Do not
medicate chickens
producing eggs for
human consumption.
(ii) 0.0175 percent........ .................. As an aid in preventing Feed continuously from 016592
outbreaks of the time birds are
coccidiosis caused by placed on litter and
Eimeria tenella, E. continue past the age
necatrix, E. when coccidiosis is
acervulina, E. maxima, ordinarily a hazard.
and E. brunetti where If death losses
excessive exposure to exceed 0.5 percent in
coccidia is increased a 2-day period,
due to overcrowding or obtain a laboratory
other management diagnosis. If
factors. coccidiosis is the
cause, use the
sulfaquinoxaline
levels recommended
for control of
outbreaks, returning
to the original
dosage schedule after
the outbreak has
subsided. Losses may
result from
intercurrent disease,
other conditions
affecting drug
intake, or variant
strains of coccidia
species which can
contribute to the
virulence of
coccidiosis under
field conditions. Do
not treat chickens
within 10 days of
slaughter. Do not
medicate chickens
producing eggs for
human consumption.
(iii) 0.1 to 0.05 percent.. .................. As an aid in Feed at 0.1 percent 016592
controlling outbreaks level for first 48 to
of coccidiosis caused 72 hours. Skip 3
by Eimeria tenella, E. days; 0.05 percent
necatrix, E. for 2 days, skip 3
acervulina, E. maxima, days; 0.05 percent
and E. brunetti. for 2 days. If bloody
droppings recur, give
0.05 percent for
another 2 days. Do
not treat chickens
within 10 days of
slaughter. Do not
medicate chickens
producing eggs for
human consumption.
(iv) 0.05 or 0.1 percent... .................. As an aid in the Feed 0.1 percent for 016592
control of acute fowl 48 to 72 hours.
cholera caused by Mortality should be
Pasteurella multocida brought under
susceptible to control. After
sulfaquinoxaline and medication, move
fowl typhoid caused by birds to clean ground
Salmonella gallinarum or to a clean house.
susceptible to If disease recurs,
sulfaquinoxaline. use 0.05 percent in
feed again for 2
days. Do not treat
chickens or turkeys
within 10 days of
slaughter for food.
Do not medicate
chickens or turkeys
producing eggs for
human consumption.
----------------------------------------------------------------------------------------------------------------
(2) Turkeys--
[[Page 95015]]
----------------------------------------------------------------------------------------------------------------
Sulfaquinoxaline in grams/ Combination in
ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 0.0175 percent......... .................. As an aid in preventing Feed continuously 016592
outbreaks of during time birds are
coccidiosis caused by closely confined. May
Eimeria meleagrimitis be continued for a
and E. adenoeides. week to 10 days after
flock is transferred
to range to reduce
danger of an outbreak
following moving of
the flock. Do not
treat turkeys within
10 days of slaughter.
Do not medicate
turkeys producing
eggs for human
consumption.
(ii) 0.05 percent.......... .................. As an aid in Feed for 2 days. 016592
controlling outbreaks Follow with 3 days on
of coccidiosis caused regular feed and 2
by Eimeria more days on 0.05
meleagrimitis and E. percent
adenoeides. sulfaquinoxaline
feed. Again follow
with 3 days on
regular feed and 2
more days on 0.05
percent
sulfaquinoxaline
feed. Continue this
schedule if necessary
until all signs of
the outbreaks have
subsided. Do not
treat turkeys within
10 days of slaughter.
Do not medicate
turkeys producing
eggs for human
consumption.
(iii) 0.05 or 0.1 percent.. .................. As an aid in the Feed 0.1 percent for 016592
control of acute fowl 48 to 72 hours.
cholera caused by Mortality should be
Pasteurella multocida brought under
susceptible to control. After
sulfaquinoxaline and medication, move
fowl typhoid caused by birds to clean ground
Salmonella gallinarum or to a clean house.
susceptible to If disease recurs,
sulfaquinoxaline. use 0.05 percent in
feed again for 2
days. Do not treat
chickens or turkeys
within 10 days of
slaughter for food.
Do not medicate
chickens or turkeys
producing eggs for
human consumption.
----------------------------------------------------------------------------------------------------------------
(3) Rabbits--
----------------------------------------------------------------------------------------------------------------
Sulfaquinoxaline in grams/ Combination in
ton grams/ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 0.025 percent.......... .................. As an aid in preventing Treatment to be 016592
coccidiosis caused by started after
Eimeria stiedae. weaning. Feed
continuously for 30
days or feed
medicated feed for 2
days out of every
week until marketing.
Do not treat within
10 days of slaughter.
(ii) 0.1 percent........... .................. As an aid in Feed for 2 weeks. Do 016592
controlling outbreaks not treat within 10
of coccidiosis caused days of slaughter.
by Eimeria stiedae.
----------------------------------------------------------------------------------------------------------------
0
38. In Sec. 558.612, remove paragraphs (e)(1)(i) and (e)(1)(iii);
redesignate paragraphs (e)(1)(ii) and (e)(1)(iv) as new paragraphs
(e)(1)(i) and (ii); and add paragraph (e)(2) to read as follows:
Sec. 558.612 Tiamulin.
* * * * *
(e) * * *
(2) Tiamulin may also be used in combination with chlortetracycline
as in Sec. 558.128.
0
39. Amend Sec. 558.625 as follows:
0
a. Remove paragraph (d);
0
b. Redesignate paragraphs (c), (e), and (f) as paragraphs (d), (c) and
(e); and
0
c. Revise paragraph (b) and redesignated paragraphs (d) and (e).
The revisions read as follows:
Sec. 558.625 Tylosin.
* * * * *
(b) Sponsors. See sponsor numbers in Sec. 510.600(c) of this
chapter.
(1) No. 016592: Type medicated article containing 100 grams per
pound.
(2) No. 054771: Type medicated article containing 40 grams per
pound.
(3) No. 058198: Type medicated article containing 10, 40, or 100
grams per pound.
(4) No. 066104: Type medicated article containing 20 or 40 grams
per pound.
(c) Related tolerances. See Sec. 556.360 of this chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for oxytetracycline medicated feeds
must not exceed 6 months from the date of issuance. VFDs for
oxytetracycline shall not be refilled.
(3) Type C medicated feeds for cattle may be manufactured from
tylosin liquid Type B medicated feeds which have a pH between 4.5 and
6.0 and which bear appropriate mixing directions as follows:
(i) For liquid feeds stored in recirculating tank systems:
Recirculate immediately prior to use for not less than 10 minutes,
moving not less than 1 percent of the tank contents per minute from the
bottom of the tank to the top. Recirculate daily as described even when
not used.
(ii) For liquid feeds stored in mechanical, air, or other
agitation-type tank systems: Agitate immediately prior to use for not
less than 10 minutes, creating a turbulence at the bottom of
[[Page 95016]]
the tank that is visible at the top. Agitate daily as described even
when not used.
(e) Conditions of use--(1) Swine--
----------------------------------------------------------------------------------------------------------------
Combination in
Tylosin grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(i) 40 or 100.............. .................. For control of swine Feed as the sole 016592
dysentery associated ration 100 g of 054771
with Brachyspira tylosin per ton of 058198
hyodysenteriae. complete feed for at 066104
least 3 weeks. Follow
with 40 grams per ton
of complete feed
until market weight.
(ii) 40 or 100............. Pyrantel, 96...... For control of swine Feed as the sole 066104
dysentery associated ration 100 g of
with Brachyspira tylosin per ton of
hyodysenteriae; and as complete feed for at
an aid in the least 3 weeks. Follow
prevention of with 40 grams per ton
migration and of complete feed
establishment of large until market weight.
roundworm (Ascaris Tylosin phosphate and
suum) infections; aid pyrantel as provided
in the prevention of by No. 066104 in Sec.
establishment of 510.600(c) of this
nodular worm chapter.
(Oesophagostomum spp.)
infections.
(iii) 40 or 100............ .................. For control of porcine Feed as the sole 016592
proliferative ration 100 g of 054771
enteropathies tylosin per ton of 058198
(ileitis) associated complete feed for at 066104
with Lawsonia least 3 weeks. Follow
intracellularis. with 40 grams per ton
of complete feed
until market weight.
(iv) 40 or 100............. Pyrantel, 96...... For control of porcine Feed as the sole 066104
proliferative ration 100 g of
enteropathies tylosin per ton of
(ileitis) associated complete feed for at
with Lawsonia least 3 weeks. Follow
intracellularis; and with 40 grams per ton
as an aid in the of complete feed
prevention of until market weight.
migration and Tylosin phosphate and
establishment of large pyrantel as provided
roundworm (Ascaris by No. 066104 in Sec.
suum) infections; aid 510.600(c) of this
in the prevention of chapter.
establishment of
nodular worm
(Oesophagostomum spp.)
infections.
(v) 40 or 100.............. Ractopamine, 4.5 Finishing swine: For Feed continuously as 016592
to 9.0. the control of swine the sole ration to 054771
dysentery associated finishing swine 058198
with Brachyspira weighing not less
hyodysenteriae; for than 150 lbs for the
control of porcine last 45 to 90 lbs
proliferative (group average) of
enteropathies weight gain prior to
(ileitis) associated slaughter. Include
with Lawsonia 100 g/ton of tylosin
intracellularis; and for at least 3 weeks,
for increased rate of followed by 40 g/ton
weight gain, improved until market weight.
feed efficiency, and Tylosin phosphate as
increased carcass provided by Nos.
leanness in finishing 058198 and 016592;
swine weighing not ractopamine as
less than 150 lbs, fed provided by Nos.
a complete ration 058198 and 054771 in
containing at least Sec. 510.600(c) of
16% crude protein for this chapter.
the last 45 to 90 lbs
of gain prior to
slaughter.
(vi) 40 to 100............. .................. For the treatment and Administer as tylosin 016592
control of swine phosphate in feed 054771
dysentery associated continuously as the 058198
with Brachyspira sole ration for 2 to 066104
hyodysenteriae 6 weeks, immediately
immediately after after treatment with
medicating with tylosin tartrate in
tylosin in drinking drinking water for 3
water. to 10 days as in Sec.
520.2640(d)(3) of
this chapter.
(vii) 40 to 100............ Pyrantel, 96...... For the treatment and Administer as tylosin 066104
control of swine phosphate in feed
dysentery associated continuously as the
with Brachyspira sole ration for 2 to
hyodysenteriae 6 weeks, immediately
immediately after after treatment with
medicating with tylosin tartrate in
tylosin in drinking drinking water for 3
water; and as an aid to 10 days as in Sec.
in the prevention of 520.2640(d)(3) of
migration and this chapter. Tylosin
establishment of large phosphate and
roundworm (Ascaris pyrantel as provided
suum) infections; aid by No. 066104 in Sec.
in the prevention of 510.600(c) of this
establishment of chapter.
nodular worm
(Oesophagostomum spp.)
infections.
(viii) 40 to 100........... .................. For the control of Administer as tylosin 016592
porcine proliferative phosphate in feed 054771
enteropathies (PPE, continuously as the 058198
ileitis) associated sole ration for 2 to 066104
with Lawsonia 6 weeks, immediately
intracellularis after treatment with
immediately after tylosin tartrate in
medicating with drinking water for 3
tylosin in drinking to 10 days as in Sec.
water. 520.2640(d)(3) of
this chapter.
[[Page 95017]]
(ix) 40 to 100............. Pyrantel, 96...... For the control of Administer as tylosin 066104
porcine proliferative phosphate in feed
enteropathies (PPE, continuously as the
ileitis) associated sole ration for 2 to
with Lawsonia 6 weeks, immediately
intracellularis after treatment with
immediately after tylosin tartrate in
medicating with drinking water for 3
tylosin in drinking to 10 days as in Sec.
water; and as an aid 520.2640(d)(3) of
in the prevention of this chapter. Tylosin
migration and phosphate and
establishment of large pyrantel as provided
roundworm (Ascaris by No. 066104 in Sec.
suum) infections; aid 510.600(c) of this
in the prevention of chapter.
establishment of
nodular worm
(Oesophagostomum spp.)
infections.
(x) 40 to 100.............. Ractopamine, 4.5 Finishing swine: For Feed continuously as 016592
to 9.0. the treatment and the sole ration to 054771
control of swine finishing swine 058198
dysentery associated weighing not less
with Brachyspira than 150 lbs for the
hyodysenteriae, for last 45 to 90 lbs
control of porcine (group average) of
proliferative weight gain prior to
enteropathies (PPE, slaughter. Include 40
ileitis) associated to 100 grams of
with Lawsonia tylosin phosphate per
intracellularis; and ton of complete feed
for increased rate of for 2 to 6 weeks,
weight gain, improved immediately after
feed efficiency, and treatment with
increased carcass tylosin tartrate in
leanness in finishing drinking water for 3
swine weighing not to 10 days as in Sec.
less than 150 lbs, fed 520.2640(d)(3) of
a complete ration this chapter. Tylosin
containing at least phosphate as provided
16% crude protein for by Nos. 058198 and
the last 45 to 90 lbs 016592; ractopamine
of gain prior to as provided by Nos.
slaughter. 058198 and 054771 in
Sec. 510.600(c) of
this chapter.
(xi) 100................... .................. For reduction in Feed continuously as 016592
severity of effects of the sole ration. 054771
atrophic rhinitis. 058198
066104
(xii) 100.................. Pyrantel, 96...... For reduction in Feed continuously as 066104
severity of effects of the sole ration.
atrophic rhinitis; aid Tylosin phosphate and
as an aid in the pyrantel as provided
prevention of by No. 066104 in Sec.
migration and 510.600(c) of this
establishment of large chapter. Tylosin
roundworm (Ascaris phosphate and
suum) infections; aid pyrantel as provided
in the prevention of by No. 066104 in Sec.
establishment of 510.600(c) of this
nodular worm chapter.
(Oesophagostomum spp.)
infections.
(xiii) 100................. Ractopamine, 4.5 For the control of Feed continuously as 016592
to 9.0. porcine proliferative the sole ration to 054771
enteropathies (PPE, finishing swine 058198
ileitis) associated weighing not less
with Lawsonia than 150 lbs for the
intracellularis; and last 45 to 90 lbs
for increased rate of (group average) of
weight gain, improved weight gain prior to
feed efficiency, and slaughter. Include
increased carcass 100 g/ton of tylosin
leanness in finishing for 3 weeks. Tylosin
swine weighing not phosphate as provided
less than 150 lbs, fed by Nos. 058198 and
a complete ration 016592; ractopamine
containing at least as provided by Nos.
16% crude protein for 058198 and 054771 in
the last 45 to 90 lbs Sec. 510.600(c) of
of gain prior to this chapter.
slaughter.
----------------------------------------------------------------------------------------------------------------
(2) Cattle--
----------------------------------------------------------------------------------------------------------------
Combination in
Tylosin grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(i) 8 to 10................ .................. Beef cattle: For Feed continuously as 016592,
reduction of incidence the sole ration to 054771,
of liver abscesses provide 60 to 90 mg/ 058198, 066104
caused by head/day tylosin.
Fusobacterium
necrophorum and
Arcanobacterium
(Actinomyces) pyogenes.
[[Page 95018]]
(ii) 90 to 360............. Lasalocid, 100 to Heifers fed in Feed continuously as 054771
1440 plus confinement for sole ration. Feed to 016592
melengestrol, slaughter: For heifers at the rate
0.25 to 2.0. reduction of incidence of 0.5 to 2.0
of liver abscesses pound(s) per head per
caused by day (specify one
Fusobacterium level) to provide
necrophorum and 0.25 to 0.5 mg
Arcanobacterium melengestrol acetate
pyogenes; and for per head per day
increased rate of (specify one level),
weight gain, improved 100 to 360 mg
feed efficiency, and lasalocid per head
suppression of estrus per day (specify one
(heat). level), and 90 mg
tylosin per head per
day. This Type C
product may be top
dressed onto or mixed
into a complete feed
prior to feeding.
Tylosin as provided
by Nos. 058198 and
016592; lasalocid as
provided by No.
054771; melengestrol
as provided by Nos.
054771 and 058198 in
Sec. 510.600(c) of
this chapter.
(iii) 90 to 360............ Melengestrol, 0.25 Heifers fed in Feed continuously as 054771
to 2.0. confinement for sole ration. Each
slaughter: For pound contains 0.125
reduction of incidence to 1.0 mg
of liver abscesses melengestrol acetate
caused by and 45 to 180 mg of
Fusobacterium tylosin. Feed to
necrophorum and heifers at a rate of
Arcanobacterium 0.5 to 2.0 pounds per
pyogenes; and for head per day to
increased rate of provide 0.25 to 0.5
weight gain, improved mg melengestrol
feed efficiency, and acetate and 60 to 90
suppression of estrus mg tylosin per head
(heat). per day. Prior to
feeding, this Type C
product must be top-
dressed onto a
complete feed or
mixed into the amount
of complete feed
consumed by an animal
per day. Tylosin
provided by No.
058198; melengestrol
provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(iv) 8 to 10............... Monensin, 5 to 40. Cattle fed in Feed continuously as 016592
confinement for sole ration to 058198
slaughter: For provide 50 to 480
reduction of incidence monensin mg/head/day
of liver abscesses and 60 to 90 mg/head/
caused by day tylosin. A
Fusobacterium withdrawal time has
necrophorum and not been established
Arcanobacterium for pre-ruminating
(Actinomyces) calves. Do not use in
pyogenes; and for calves to be
improved feed processed for veal.
efficiency. Tylosin provided by
Nos. 016592 or
058198; monensin as
provided by No.
058198 in Sec.
510.600(c) of this
chapter.
(v) 8 to 10................ Monensin, 10 to 40 Cattle fed in Feed continuously as 016592
confinement for sole ration to 058198
slaughter: For provide 0.14 to 0.42
reduction of incidence mg monensin/lb body
of liver abscesses weight per day,
caused by depending on the
Fusobacterium severity of the
necrophorum and coccidiosis
Arcanobacterium challenge, up to 480
(Actinomyces) mg/head/day and 60 to
pyogenes; and for 90 mg/head/day
prevention of tylosin. A withdrawal
coccidiosis caused by time has not been
Eimeria bovis and E established for pre-
zuernii. ruminating calves. Do
not use in calves to
be processed for
veal. Tylosin
provided by Nos.
016592 or 058198;
monensin as provided
by No. 058198 in Sec.
510.600(c) of this
chapter.
(vi) 8 to 10............... Monensin, 5 to 30 Cattle fed in Feed continuously as 016592
plus decoquinate, confinement for the sole ration to 054771
13.6 to 22.7. slaughter: For provide 22.7 mg of
reduction of incidence decoquinate per 100
of liver abscesses lb body weight per
caused by day, 50 to 360 mg of
Fusobacterium monensin/head/day,
necrophorum and and 60 to 90 mg of
Arcanobacterium tylosin/head/day.
pyogenes; for the Feed at least 28 days
prevention of during period of
coccidiosis caused by exposure to
Eimeria bovis and E. coccidiosis or when
zuernii; and for it is likely to be a
improved feed hazard. Do not feed
efficiency. to animals producing
milk for food. Do not
feed to lactating
dairy cattle. A
withdrawal time has
not been established
for pre-ruminating
calves. Do not use in
calves to be
processed for veal.
Tylosin as provided
by Nos. 016592 and
058198; monensin as
provided by No.
058198; decoquinate
as provided by No.
058198 in Sec.
510.600(c) of this
chapter.
[[Page 95019]]
(vii) 8 to 10.............. Monensin, 10 to 40 Heifers fed in Feed continuously as 016592
plus confinement for sole ration to 054771
melengestrol, slaughter: For heifers at a rate of 058198
0.25 to 2.0. reduction of incidence 0.5 to 2.0 pounds per
of liver abscesses head per day to
caused by provide 0.25 to 0.5
Fusobacterium mg/head/day
necrophorum and melengestrol acetate
Arcanobacterium and 0.14 to 0.42 mg
(Actinomyces) monensin/lb body
pyogenes; for weight per day,
prevention and control depending on the
of coccidiosis caused severity of the
by Eimeria bovis and E coccidiosis
zuernii; and for challenge, up to 480
increased rate of mg/head/day and 60 to
weight gain, improved 90 mg/head/day
feed efficiency, and tylosin. The
suppression of estrus melengestrol acetate
(heat). portion of this Type
C medicated feed must
be mixed into the
complete feed
containing 10 to 40 g/
ton monensin and 8 to
10 g/ton tylosin at
feeding into the
amount of complete
feed consumed by an
animal per day. A
withdrawal time has
not been established
for pre-ruminating
calves. Do not use in
calves to be
processed for veal.
Tylosin provided by
Nos. 016592 or
058198; monensin as
provided by No.
058198; melengestrol
provided by Nos.
054771 or 058198 in
Sec. 510.600(c) of
this chapter.
(viii) 8 to 10............. Monensin, 10 to 40 Cattle fed in Feed continuously as 054771
plus ractopamine, confinement for sole ration to 058198
8.2 to 24.6. slaughter: For provide 70 to 430 mg/
reduction of incidence head/day ractopamine
of liver abscesses and 0.14 to 0.42 mg
caused by monensin/lb body
Fusobacterium weight per day,
necrophorum and depending on the
Arcanobacterium severity of the
pyogenes; for coccidiosis
prevention and control challenge, up to 480
of coccidiosis caused mg/head/day and 60 to
by Eimeria bovis and E 90 mg/head/day
zuernii; and for tylosin for the last
increased rate of 28 to 42 days on
weight gain and feed. A withdrawal
improved feed time has not been
efficiency in cattle established for pre-
fed in confinement for ruminating calves. Do
slaughter for the last not use in calves to
28 to 42 days on feed. be processed for
veal. Tylosin
provided by Nos.
016592 or 058198;
monensin as provided
by No. 058198;
ractopamine provided
by Nos. 054771 or
058198 in Sec.
510.600(c) of this
chapter.
(ix) 8 to 10............... Monensin, 10 to 40 Cattle fed in Feed a minimum of 1.0 054771
plus ractopamine, confinement for lb/head/day 058198
not to exceed 800. slaughter: For ractopamine Type C
reduction of incidence top dress feed
of liver abscesses continuously to
caused by cattle fed in
Fusobacterium confinement for
necrophorum and slaughter, to provide
Arcanobacterium 70 to 400 mg/head/day
pyogenes; for ractopamine for the
prevention and control last 28 to 42 days on
of coccidiosis caused feed. Feed on top of
by Eimeria bovis and E a ration containing
zuernii; and for 10 to 40 g/ton
increased rate of monensin and 8 to 10
weight gain and g/ton tylosin
improved feed phosphate, to provide
efficiency in cattle 0.14 to 0.42 mg
fed in confinement for monensin/lb body
slaughter for the last weight/day, depending
28 to 42 days on feed. on the severity of
the coccidiosis
challenge, up to 480
mg/head/day and 60 to
90 mg/head/day
tylosin. A withdrawal
time has not been
established for pre-
ruminating calves. Do
not use in calves to
be processed for
veal. Tylosin
provided by Nos.
016592 or 058198;
monensin as provided
by No. 058198;
ractopamine provided
by Nos. 054771 or
058198 in Sec.
510.600(c) of this
chapter.
[[Page 95020]]
(x) 8 to 10................ Monensin 10 to 40 Cattle fed in Feed continuously as 054771
plus ractopamine confinement for sole ration to 058198
9.8 to 24.6. slaughter: For provide 90 to 430 mg/
reduction of incidence head/day ractopamine
of liver abscesses and 0.14 to 0.42 mg
caused by monensin/lb body
Fusobacterium weight per day,
necrophorum and depending on the
Arcanobacterium severity of the
pyogenes; for coccidiosis
prevention and control challenge, up to 480
of coccidiosis caused mg/head/day and 60 to
by Eimeria bovis and E 90 mg/head/day
zuernii; and for tylosin for the last
increased rate of 28 to 42 days on
weight gain, improved feed. A withdrawal
feed efficiency, and time has not been
increased carcass established for pre-
leanness in cattle fed ruminating calves. Do
in confinement for not use in calves to
slaughter for the last be processed for
28 to 42 days on feed. veal. Tylosin
provided by Nos.
016592 or 058198;
monensin as provided
by No. 058198;
ractopamine as
provided by Nos.
054771 or 058198 in
Sec. 510.600(c) of
this chapter.
(xi) 8 to 10............... Monensin, 10 to 40 Heifers fed in Feed continuously as 054771
plus ractopamine, confinement for sole ration to 058198
9.8 to 24.6 plus slaughter: For provide 90 to 430 mg/
melengestrol, reduction of incidence head/day ractopamine
0.125 to 1 mg/lb. of liver abscesses and 0.14 to 0.42 mg
caused by monensin/lb body
Fusobacterium weight per day,
necrophorum and depending on the
Arcanobacterium severity of the
(Actinomyces) coccidiosis
pyogenes; for challenge, up to 480
prevention and control mg/head/day and 60 to
of coccidiosis caused 90 mg/head/day
by Eimeria bovis and E tylosin for the last
zuernii; for increased 28 to 42 days on
rate of weight gain, feed. Feed
improved feed melengestrol as a top
efficiency, and dress or mixed with a
increased carcass complete ration at
leanness; and the rate of 0.5 to
suppression of estrus 2.0 pound/head/day
(heat). (specify one level)
to provide 0.25 to
0.5 mg melengestrol
acetate/head/day
(specify one level).
A withdrawal time has
not been established
for pre-ruminating
calves. Do not use in
calves to be
processed for veal.
Tylosin provided by
Nos. 016592 or
058198; monensin as
provided by No.
058198; ractopamine
as provided by Nos.
054771 or 058198 in
Sec. 510.600(c) of
this chapter.
(xii) 8 to 10.............. Monensin, 10 to 40 Cattle fed in Feed continuously as 000061
plus zilpaterol, confinement for the sole ration to 016592
6.8. slaughter: For cattle during the
reduction of incidence last 20 to 40 days on
of liver abscesses feed to provide 60 to
caused by 90 mg/head/day
Fusobacterium zilpaterol, 0.14 to
necrophorum and 0.42 mg/lb body
Arcanobacterium weight/day monensin,
pyogenes; for depending on the
prevention and control severity of the
of coccidiosis caused coccidiosis
by Eimeria bovis and E challenge, up to 480
zuernii; and for mg/head/day monensin,
increased rate of and 60 to 90 mg/head/
weight gain, improved day tylosin. Do not
feed efficiency, and use in veal calves.
increased carcass Withdrawal period 3
leanness in cattle fed days. Tylosin
in confinement for provided by Nos.
slaughter for the last 016592 or 058198;
20 to 40 days on feed. monensin as provided
by No. 058198;
zilpaterol as
provided by No.
000061 in Sec.
510.600(c) of this
chapter.
(xiii) 8 to 10............. Monensin, 10 to 40 Cattle fed in Feed this component 000061
plus zilpaterol, confinement for feed continuously to 016592
6.8 to 24. slaughter: For cattle during the
reduction of incidence last 20 to 40 days on
of liver abscesses feed to provide 60 mg/
caused by head/day zilpaterol,
Fusobacterium 0.14 to 0.42 mg/lb
necrophorum and body weight/day
Arcanobacterium monensin, depending
pyogenes; for on the severity of
prevention and control the coccidiosis
of coccidiosis caused challenge, up to 480
by Eimeria bovis and E mg/head/day monensin,
zuernii; and for and 60 to 90 mg/head/
increased rate of day tylosin. Do not
weight gain, improved use in veal calves.
feed efficiency, and Withdrawal period 3
increased carcass days. Tylosin
leanness in cattle fed provided by Nos.
in confinement for 016592 or 058198;
slaughter for the last monensin as provided
20 to 40 days on feed. by No. 058198;
zilpaterol as
provided by No.
000061 in Sec.
510.600(c) of this
chapter.
[[Page 95021]]
(xiv) 8 to 10.............. Monensin, 10 to 40 Heifers fed in Feed continuously as 000061
plus zilpaterol, confinement for the sole ration to 016592
6.8 plus slaughter: For cattle during the 058198
melengestrol, reduction of incidence last 20 to 40 days on
0.125 to 1 mg/lb. of liver abscesses feed to provide 60 to
caused by 90 mg/head/day
Fusobacterium zilpaterol, 0.14 to
necrophorum and 0.42 mg/lb body
Arcanobacterium weight/day monensin,
(Actinomyces) depending on the
pyogenes; for severity of the
prevention and control coccidiosis
of coccidiosis caused challenge, up to 480
by Eimeria bovis and E mg/head/day monensin,
zuernii; and for and 60 to 90 mg/head/
increased rate of day tylosin. Feed
weight gain, improved melengestrol as a top
feed efficiency, and dress or mixed with a
increased carcass complete ration at
leanness in cattle fed the rate of 0.5 to
in confinement for 2.0 pound/head/day
slaughter for the last (specify one level)
20 to 40 days on feed; to provide 0.25 to
and for suppression of 0.5 mg melengestrol
estrus (heat). acetate/head/day
(specify one level).
Do not use in veal
calves. Withdrawal
period 3 days.
Tylosin as provided
by Nos. 016592 or
058198; monensin as
provided by No.
058198; zilpaterol as
provided by No.
000061; melengestrol
provided by Nos.
054771 or 058198 in
Sec. 510.600(c) of
this chapter.
(xv) 8 to 10............... Monensin, 10 to 40 Heifers fed in Feed this component 000061
plus zilpaterol, confinement for feed continuously to 016592
6.8 to 24 plus slaughter: For cattle during the 058198
melengestrol, reduction of incidence last 20 to 40 days on
0.125 to 1 mg/lb. of liver abscesses feed to provide 60 mg/
caused by head/day zilpaterol,
Fusobacterium 0.14 to 0.42 mg/lb
necrophorum and body weight/day
Arcanobacterium monensin, depending
(Actinomyces) on the severity of
pyogenes; for the coccidiosis
prevention and control challenge, up to 480
of coccidiosis caused mg/head/day monensin,
by Eimeria bovis and E and 60 to 90 mg/head/
zuernii; and for day tylosin. Feed
increased rate of melengestrol as a top
weight gain, improved dress or mixed with a
feed efficiency, and complete ration at
increased carcass the rate of 0.5 to
leanness in cattle fed 2.0 pound/head/day
in confinement for (specify one level)
slaughter for the last to provide 0.25 to
20 to 40 days on feed; 0.5 mg melengestrol
and for suppression of acetate/head/day
estrus (heat). (specify one level).
Do not use in veal
calves. Withdrawal
period 3 days.
Tylosin as provided
by Nos. 016592 or
058198; monensin as
provided by No.
058198; zilpaterol as
provided by No.
000061; melengestrol
provided by Nos.
054771 or 058198 in
Sec. 510.600(c) of
this chapter.
----------------------------------------------------------------------------------------------------------------
0
40. Revise Sec. 558.630 to read as follows:
Sec. 558.630 Tylosin and sulfamethazine.
(a) Specifications. Type A medicated articles containing equal
amounts of tylosin phosphate and sulfamethazine, available in
concentrations of 5, 10, 20, or 40 grams each, per pound.
(b) Sponsors. See sponsor numbers in Sec. 510.600(c) of this
chapter.
(1) No. 058198 for use as in paragraph (e)(1) of this section.
(2) No. 054771: 10 or 40 grams per pound each for use as in
paragraph (e)(2) of this section.
(c) Related tolerances. See Sec. Sec. 556.670 and 556.740 of this
chapter.
(d) Special considerations--(1) Federal law restricts medicated
feed containing this veterinary feed directive (VFD) drug to use by or
on the order of a licensed veterinarian. See Sec. 558.6 for additional
requirements.
(2) The expiration date of VFDs for tylosin and sulfamethazine
medicated feeds must not exceed 6 months from the date of issuance.
VFDs for tylosin and sulfamethazine shall not be refilled.
(3) Labeling shall bear the statement: ``Do not use in medicated
feeds containing in excess of 2% bentonite.''
(e) Conditions of use. It is used in feed for swine as follows:
[[Page 95022]]
----------------------------------------------------------------------------------------------------------------
Tylosin phosphate and Combination in
sulfamethazine in grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(1) 100 each............... .................. For reduction in the Withdraw 15 days 058198
severity of effects of before swine are
atrophic rhinitis; slaughtered.
lowering the incidence
and severity of
Bordetella
bronchiseptica
rhinitis; prevention
of swine dysentery
associated with
Brachyspira
hyodysenteriae;
control of swine
pneumonias caused by
bacterial pathogens
(Pasteurella multocida
and/or Arcanobacterium
pyogenes); reducing
the incidence of
cervical lymphadenitis
(jowl abscesses)
caused by Group E
Streptococci. Only the
sulfamethazine portion
of this combination is
active in controlling
jowl abscesses.
(2) 100 each............... .................. For reduction in the Withdraw 15 days 054771
severity of effects of before swine are
atrophic rhinitis; slaughtered.
lowering the incidence
and severity of
Bordetella
bronchiseptica
rhinitis; prevention
of swine dysentery
associated with
Brachyspira
hyodysenteriae; and
control of swine
pneumonias caused by
bacterial pathogens
(Pasteurella multocida
and/or Arcanobacterium
pyogenes).
----------------------------------------------------------------------------------------------------------------
0
41. Revise Sec. 558.635 to read as follows:
Sec. 558.635 Virginiamycin.
(a) Specifications. Type A medicated articles containing 5, 10, 20,
50, 136.2, or 227 grams per pound virginiamycin.
(b) Sponsors. See No. 066104 in Sec. 510.600(c) of this chapter.
(c) Related tolerances. See Sec. 556.750 of this chapter.
(d) Special considerations--(1) [Reserved]
(2) [Reserved]
(3) Not for use in breeding swine over 120 pounds.
(4) Dilute Type A article with at least 10 pounds of a feed
ingredient prior to final mixing in 1 ton of Type C feed.
(e) Conditions of use--(1) Chickens--
----------------------------------------------------------------------------------------------------------------
Combination in
Virginiamycin grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(i) 5...................... .................. Broiler chickens: For Not for use in layers. 066104
increased rate of
weight gain and
improved feed
efficiency.
(ii) 5..................... Monensin, 90 to Broiler chickens: For Feed continuously as 066104
110. increased rate of the sole ration. Do
weight gain and not feed to laying
improved feed chickens.
efficiency; as an aid Virginiamycin as
in the prevention of provided by No.
coccidiosis caused by 066104; monensin as
Eimeria necatrix, E. provided by No.
tenella, E. 058198 in Sec.
acervulina, E. 510.600(c) of this
brunetti, E. maxima, chapter.
and E. mivati.
(iii) 5.................... Salinomycin, 40 to Broiler chickens: For Feed continuously as 066104
60. increased rate of the sole ration. Do 016592
weight gain and not feed to layers or
improved feed to chickens over 16
efficiency; for weeks of age. Not
prevention of approved for use with
coccidiosis caused by pellet binders. May
Eimeria tenella, E. be fatal if
necatrix, E. accidentally fed to
acervulina, E. maxima, adult turkeys or
E. brunetti, and E. horses. Virginiamycin
mivati. as provided by No.
066104; salinomycin
as provided by No.
054771 in Sec.
510.600(c) of this
chapter.
(iv) 5..................... Semduramicin, 22.7 Broiler chickens: For Feed continuously as 066104
increased rate of the sole ration. Do
weight gain and not feed to laying
improved feed hens. Semduramicin as
efficiency; for the provided by No.
prevention of 066104 in Sec.
coccidiosis caused by 510.600(c) of this
Eimeria acervulina, E. chapter.
brunetti, E. maxima,
E. mivati/mitis, E.
necatrix, and E.
tenella.
(v) 5...................... Semduramicin Broiler chickens: For Feed continuously as 066104
(biomass), 22.7. increased rate of the sole ration.
weight gain and Withdraw 1 day before
improved feed slaughter. Do not
efficiency; for the feed to laying hens.
prevention of Virginiamycin and
coccidiosis caused by semduramicin as
Eimeria acervulina, E. provided by No.
brunetti, E. maxima, 066104 in Sec.
E. mivati/mitis, E. 510.600(c) of this
necatrix, and E. chapter.
tenella.
(vi) 5 to 15............... Broiler chickens: For Not for use in layers. 066104
increased rate of
weight gain.
[[Page 95023]]
(vii) 5 to 15.............. Amprolium, 113.5 Broiler chickens: For Feed continuously as 066104
and ethopabate, increased rate of the sole ration and
36.3. weight gain; as an aid as the sole source of
in the prevention of amprolium. Do not
coccidiosis where feed to laying
severe exposure to chickens. Not for
coccidiosis from chickens over 16
Eimeria acervulina, E. weeks of age.
maxima, and E. Virginiamycin as
brunetti is likely to provided by No.
occur. 066104; amprolium and
ethopabate as
provided by No.
016592 in Sec.
510.600(c) of this
chapter.
(viii) 5 to 15............. Monensin, 90 to Broiler chickens: For Feed continuously as 066104
110. increased rate of the sole ration. Do
weight gain; as an aid not feed to laying
in the prevention of chickens. Monensin as
coccidiosis caused by provided by No.
Eimeria necatrix, E. 000986 in Sec.
tenella, E. 510.600(c) of this
acervulina, E. chapter.
brunetti, E. maxima,
and E. mivati.
(ix) 5 to 15............... Salinomycin, 40 to Broiler chickens: For Feed continuously as 016592
60. increased rate of the sole ration. Do 066104
weight gain; as an aid not feed to layers or
in the prevention of to chickens over 16
coccidiosis caused by weeks of age. Not
Eimeria tenella, E. approved for use with
necatrix, E. pellet binders. May
acervulina, E. maxima, be fatal if
E. brunetti, and E. accidentally fed to
mivati. adult turkeys or
horses. Virginiamycin
as provided by No.
066104; salinomycin
as provided by Nos.
016592 or 054771 in
Sec. 510.600(c) of
this chapter.
(x) 5 to 15................ Semduramicin, 22.7 Broiler chickens: For Feed continuously as 066104
increased rate of the sole ration. Do
weight gain; for the not feed to laying
prevention of hens. Semduramicin as
coccidiosis caused by provided by No.
Eimeria acervulina, E. 066104 in Sec.
brunetti, E. maxima, 510.600(c) of this
E. mivati/mitis, E. chapter.
necatrix, and E.
tenella.
(xi) 5 to 15............... Semduramicin Broiler chickens: For Feed continuously as 066104
(biomass), 22.7. increased rate of the sole ration.
weight gain; for the Withdraw 1 day before
prevention of slaughter. Do not
coccidiosis caused by feed to laying hens.
Eimeria acervulina, E. Virginiamycin as
brunetti, E. maxima, E provided by No.
mivati/mitis, E. 066104; semduramicin
necatrix, and E. as provided by No.
tenella. 066104 in Sec.
510.600(c) of this
chapter.
(xii) 15................... Amprolium, 113.5 Broiler chickens: For Feed continuously as 066104
and ethopabate, increased rate of the sole ration and
36.3. weight gain and as the sole source of
improved feed amprolium. Do not
efficiency; as an aid feed to laying
in the prevention of chickens. Not for
coccidiosis where chickens over 16
severe exposure to weeks of age.
coccidiosis from Virginiamycin as
Eimeria acervulina, E. provided by No.
maxima, and E. 066104; amprolium and
brunetti is likely to ethopabate as
occur. provided by No.
016592 in Sec.
510.600(c) of this
chapter.
(xiii) 20.................. Broiler chickens: For Not for use in layers. 066104
prevention of necrotic
enteritis caused by
Clostridium spp.
susceptible to
virginiamycin.
(xiv) 20................... Lasalocid, 68 to Broiler chickens: For Feed continuously as 066104
113. increased rate of the sole ration. Do
weight gain and not feed to laying
improved feed chickens. Lasalocid
efficiency; for sodium as provided by
prevention of No. 054771 in Sec.
coccidiosis caused by 510.600(c) of this
Eimeria tenella, E. chapter.
necatrix, E.
acervulina, E.
brunetti, E. mivati,
and E. maxima.
(xv) 20.................... Monensin, 90 to Broiler chickens: For Feed continuously as 066104
110. prevention of necrotic the sole ration. Do
enteritis caused by not feed to laying
Clostridium spp. chickens. Monensin as
susceptible to provided by No.
virginiamycin; and as 058198 in Sec.
an aid in the 510.600(c) of this
prevention of chapter.
coccidiosis caused by
Eimeria necatrix, E.
tenella, E.
acervulina, E.
brunetti, E. maxima,
and E. mivati.
(xvi) 20................... Semduramicin, 22.7 Broiler chickens: For Feed continuously as 066104
prevention of necrotic the sole ration. Do
enteritis caused by not feed to laying
Clostridium spp. hens. Semduramicin as
susceptible to provided by No.
virginiamycin; for the 066104 in Sec.
prevention of 510.600(c) of this
coccidiosis caused by chapter.
Eimeria acervulina, E.
brunetti, E. maxima,
E. mivati/mitis, E.
necatrix, and E.
tenella.
(xvii) 20.................. Semduramicin Broiler chickens: For Feed continuously as 066104
(biomass), 22.7. prevention of necrotic the sole ration.
enteritis caused by Withdraw 1 day before
Clostridium spp. slaughter. Do not
susceptible to feed to laying hens.
virginiamycin; for the Semduramicin as
prevention of provided by No.
coccidiosis caused by 066104 in Sec.
Eimeria acervulina, E. 510.600(c) of this
brunetti, E. maxima, chapter.
E. mivati/mitis, E.
necatrix, and E.
tenella.
----------------------------------------------------------------------------------------------------------------
[[Page 95024]]
(2) Turkeys--
----------------------------------------------------------------------------------------------------------------
Combination in
Virginiamycin grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(i) 10 to 20............... .................. Growing turkeys: For Not for use in layers. 066104
increased rate of
weight gain and
improved feed
efficiency.
(ii) 10 to 20.............. Lasalocid, 68 to Growing turkeys: For Lasalocid sodium as 054771
113. increased rate of provided by No.
weight gain and 054771 in Sec.
improved feed 510.600(c) of this
efficiency; and for chapter.
the prevention of
coccidiosis caused by
Eimeria meleagrimitis,
E. gallopavonis, and
E. adenoeides.
(iii) 10 to 20............. Monensin, 90 to Growing turkeys: For Monensin as provided 066104
110. increased rate of by No. 058198 in Sec.
weight gain and 510.600(c) of this
improved feed chapter.
efficiency; and for
the prevention of
coccidiosis caused by
Eimeria meleagrimitis,
E. gallopavonis, and
E. adenoeides.
----------------------------------------------------------------------------------------------------------------
(3) Swine--
----------------------------------------------------------------------------------------------------------------
Combination in
Virginiamycin grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(i) 5 or 10................ .................. Growing-finishing Feed continuously from 066104
swine: For increased weaning to market
rate of weight gain weight. Feed 10 grams
and improved feed per ton from weaning
efficiency. up to 120 pounds,
followed by 5 grams
per ton to market
weight.
(ii) 5 to 10............... .................. Growing-finishing Feed continuously from 066104
swine: For increased weaning to market
rate of weight gain. weight. Feed 10 grams
per ton from weaning
up to 120 pounds for
increased rate of
weight gain and
improved feed
efficiency, followed
by 5 to 10 grams per
ton to market weight
for increased rate of
weight gain.
(iii) 25................... .................. Growing-finishing ...................... 066104
swine: As an aid in
control of dysentery
in swine up to 120
pounds in animals or
on premises with a
history of swine
dysentery but where
symptoms have not yet
occurred.
(iv) 50 or 100............. .................. Growing-finishing Feed 100 grams per ton 066104
swine: For treatment for 2 weeks, 50 grams
and control of swine per ton thereafter.
dysentery in swine up
to 120 pounds.
(v) 100.................... .................. Growing-finishing Feed for 2 weeks...... 066104
swine: For treatment
of swine dysentery in
nonbreeding swine over
120 pounds.
----------------------------------------------------------------------------------------------------------------
(4) Cattle--
----------------------------------------------------------------------------------------------------------------
Combination in
Virginiamycin grams/ton grams/ton Indications for use Limitations Sponsors
----------------------------------------------------------------------------------------------------------------
(i) 11.0 to 16.0........... .................. Cattle fed in Feed continuously as 066104
confinement for the sole ration to
slaughter: For provide 70 to 240
improved feed milligrams per head
efficiency. per day. Not for use
in animals intended
for breeding.
(ii) 13.5 to 16.0.......... .................. Cattle fed in Feed continuously as 066104
confinement for the sole ration to
slaughter: For provide 85 to 240
reduction of incidence milligrams per head
of liver abscesses. per day. Not for use
in animals intended
for breeding.
(iii) 16.0 to 22.5......... .................. Cattle fed in Feed continuously as 066104
confinement for the sole ration to
slaughter: For provide 100 to 340
increased rate of milligrams per head
weight gain. per day. Not for use
in animals intended
for breeding.
----------------------------------------------------------------------------------------------------------------
[[Page 95025]]
0
42. In Sec. 558.665, remove and reserve paragraphs (e)(5) and (6);
remove paragraphs (e)(11) and (12); and add paragraph (f) to read as
follows:
Sec. 558.665 Zilpaterol.
* * * * *
(f) Zilpaterol may also be used in combination with tylosin as in
Sec. 558.625.
0
43. In Sec. 558.680, remove paragraph (d)(1)(x); and add paragraph
(e)(3) to read as follows:
Sec. 558.680 Zoalene.
* * * * *
(e) * * *
(3) Zoalene may also be used in combination with lincomycin as in
Sec. 558.325.
Dated: December 20, 2016.
Tracey H. Forfa,
Deputy Director, Center for Veterinary Medicine.
[FR Doc. 2016-31083 Filed 12-23-16; 8:45 am]
BILLING CODE 4164-01-P